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 Brain function is dependent upon the active coordination of many different cell types and 
subtypes at cellular resolutions. While measuring neurochemistry at cellular resolutions is 
important for understanding emergent properties, such as cognition and memory, analyzing the 
chemical nature of the brain at the single cell level is primarily limited to a handful of analytical 
approaches which often are only capable of measuring a specific aspect of the cell. For instance, 
transcriptomics measures the expression level of different genes within a cell, while mass 
spectrometry (MS) measures gene products and metabolites themselves. Single cells are 
inherently sample limited, so means of extending or expanding the amount of information that 
can be garnered from an individual cell is important for understanding their complex 
neurochemistry. Here, we combine a multitude of analytical approaches with single cell matrix-
assisted laser desorption/ionization (MALDI) MS to increase the amount of information we can 
obtain from individual mammalian brain cells. We first developed an open source software, that 
simplifies microscopy-guided MALDI MS measurements and subsequent correlation of data 
from orthogonal approaches. Using this software, we analyzed tens of thousands of rodent 
cerebral cells with MALDI MS and detected over five hundred distinct lipid features. Using this 
metabolic information, we statistically clustered the cells in 101 unique clusters, while also 
finding rare lipids only present in a small fraction (<1%) of cells. Further, we extended single 
cell MALDI MS measurements to accommodate subsequent measurements using 
immunocytochemistry, infrared spectroscopy, stimulated Raman scattering microscopy, single 
cell transcriptomics, and capillary electrophoresis, allowing us to merge the rich metabolic 
information detected with MS to a variety of other systems to maximize the information that can 
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CHAPTER 1 
INTRODUCTION AND THESIS OVERVIEW 
1.1 Research Summary 
The mammalian brain is a highly complex system composed of billions to trillions of 
cells actively coordinated together to create emergent functions, such as learning and memory. 
Many of these cells have a unique function and can generally be subdivided into categories based 
on morphology, function, and chemical content. Because of the inherent chemical diversity 
within the brain, we use single cell matrix assisted laser desorption/ionization (MALDI) mass 
spectrometry (MS) approaches coupled to other techniques, such as immunocytochemistry (ICC) 
and vibrational spectroscopy, to study the chemical components of brain cells at single cell 
resolution.  
1.2 Single Cell Analysis  
Cells are the functional unit of biological systems, ranging from single cell organisms to 
humans, and are inherently responsible for many complex, emergent functions like learning[1] 
and memory[2] within the mammalian brain. Cell-to-cell diversity not only allows these emergent 
functions, but single cell changes can result in disease and disorders,[3] such as beta cell 
malfunction within type-1 and type-2 diabetes.[4] This inherent complexity in biological systems 
demonstrates a need to study them at single cell resolutions, and the ubiquitous presence of cells 
require methods capable of high-throughput and robust measurements.[3] Of particular interest is 
the mammalian brain, as it is one of the most complex and least understood organs, partly due to 
its chemical, cellular, and spatial heterogeneity.[5] New measurement approaches and 
instrumentation are required to understand these complex phenomena, particularly at the single 
cell level, where many of these complex processes begin.  
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From an analytical perspective, single cells are challenging due to their inherently low 
volumes, difficulty in sampling specific cells, diversity, and subsequent data analysis.[6] Several 
techniques have become the standard for exploring single cell heterogeneity: microscopy,[7, 8] 
transcriptomics,[910] vibrational spectroscopy,[11,12] electrophysiology,[13,14] capillary 
electrophoresis,[15,16] and MS[17-22]. Each of these techniques can measure a different aspect of the 
cell; for instance, transcriptomics analyzes the expression of genes by measuring the RNA 
compliment of a cell,[23] while microscopy images the morphology and often the localization of 
fluorescently labelled antigens.[24] 
While ground breaking work has been accomplished with each of these analytical 
approaches, they have limitations. Microscopy, for instance, can generally determine the 
localization of only a few compounds within a single experiment. Transcriptomics measure the 
expression of many cellular components, but this information does not always correlate with the 
physical presence of the gene product or cellular metabolites. This raises the question: Which 
technique allows you to obtain the most information from a single cell? In truth, it appears that 
the combination of multiple techniques (or multimodal analysis) together allows us to obtain a 
larger amount of information from single cells than any technique alone[25] and will be a central 
theme of this dissertation work.  
1.3 Mass Spectrometry 
MS is a label-free, multiplexed analytical technique that allows for the detection of 
discrete compounds within many different types of systems. A mass spectrometer can be broken 
down into three main parts: source, mass analyzer, and detector. The source is responsible for 
ionizing a chemical analyte of interest allowing the chemical to be manipulated by an electric 
field for entry into the mass analyzer. Many different types of ionization sources are available 
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ranging from electron impact to electrospray ionization, each designed to ionize different 
chemical classes from different sample matrices.[26]  
For most of this work, we employ matrix assisted laser desorption/ionization (MALDI) 
MS because it is minimally sample destructive allowing the process to be coupled to other 
techniques for enhanced chemical information.[27,28] MALDI MS is a soft ionization technique 
capable of attomole detection limits[26] of a broad range and number of chemicals, including 
proteins,[29] peptides,[30,31] lipids,[32,33] and small metabolites.[34,35] The analyte of interest is 
dissolved within an ultraviolet (UV) absorbing, organic matrix. Ionization begins with a focused 
UV laser irradiating the matrix, causing the UV-absorbing matrix to erupt outward as a cloud 
containing the matrix and co-crystalized analytes. The ionized matrix then transfers energy to co-
crystalized analytes, causing analytes to become charged and enter the mass analyzer of the 
instrument.[26] Additionally, electrospray ionization (ESI) was used alongside MALDI MS for 
lipid identifications throughout the thesis. ESI functions by creating ions via applying high 
current to a solution to produce an aerosol and thus is complementary to MALDI MS.[26]  
The mass analyzer is the portion of the instrument that separates the ionized chemicals 
based on their mass-to-charge ratios (m/z). As with sources, a plethora of analyzers can be used 
for determining the m/z value for a specific compound. Here, we primarily used time-of-flight 
(TOF) and Fourier transform ion cyclotron resonance (FT-ICR) analyzers for fast, low-resolution 
and slower, high-resolution measurements, respectively. TOF analyzers function by pushing ions 
with the same kinetic energy through a drift tube. Because the ions have the same kinetic energy, 
lower m/z value ions will travel through the drift tube and hit the detector (usually a 
microchannel plate or secondary emission multiplier) faster than higher m/z value ions, where the 
time it takes to travel through the tube can be converted to an m/z value with appropriate 
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calibrations. Reflectrons are often added to account and correct for the distributions of ions that 
exist and pushed into the TOF drift tube. TOF instruments can be used to measure a large range 
of m/z values, even as high as whole viral particles.[26,36] 
FT-ICR instruments start by injecting ions into the center of an ICR cell. These ions are 
then excited by an electric field and start to orbit within the ICR cell because of an external 
magnetic field that is perpendicular to the electric field. The frequency at which the ions orbit is 
proportional to their m/z value and is detected by the ions inducing a current on two detector 
plates within the ICR cell. High resolution measurements are achieved by extending the time an 
ion is orbiting within the ICR cell as an ion is measured multiple times. FT-ICR mass 
spectrometers have a higher resolving power than TOF instruments and are capable of the 
highest mass accuracy of all MS systems, although it is more difficult to measure ions above an 
m/z value of 10k and resolution falls quickly with an increase in m/z value.[36-38]  
1.4 Single Cell Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry 
MALDI MS is an apt choice for single cell analysis as it is highly sensitive, robust, fast, 
and nontargeted. While MALDI MS has been used for over a decade to study chemicals within 
single cells,[25] recent advances have been focused on improving cell analyses throughput.  
Three primary methods for high-throughput acquisition of cells have been developed: 
mass cytometry,[39] high-density micro-arrays for mass spectrometry (MAMS) with defined 
locations,[32] and microscopy-guided MS.[40] Mass cytometry employs multiatom elemental 
tagged antibodies that bind to proteins of interest within a cell for later inductively coupled 
plasma MS.[39] MAMS chips are fabricated from a scaffold covered with a hydrophobic coating, 
where “wells” restrict diffusion during matrix application. The wells are patterned so that the 
location of every well is known, and the hydrophobic coating isolates the single cells within each 
5   
 
well from contaminating other wells. MAMS were used to detect metabolites, such as adenosine 
triphosphate, from single yeast cells and lipids within single alga cells in the initial report.[32] MAMS 
has been successfully used to correlate single cell MS information with other techniques, such as 
Raman spectroscopy.[41] The first paper describing microscopy-guided MALDI MS of randomly 
seeded cells was reported by Ong et al. within our lab. They analyzed several thousand pituitary 
cells to detect peptides within individual cells.[42] The second paper describing this approach was 
reported by Jansson et al., where they profiled the peptides within pancreatic islet cells[43] and the 
first iteration of microMS is described before being made publicly available in 2017 and is at the 
center of this dissertation work.[40]  
In essence, cells are dispersed on a microscope slide that has etched fiducial markers on 
it. The cells are then incubated with Hoechst 33342, a fluorescent DNA intercalator, before being 
imaged with brightfield and fluorescence microscopy. Because the brightfield and fluorescence 
images are inherently overlaid, microMS can be used to automatically identify cell-like features 
with their respective pixel coordinates that can be translated to MS stage coordinates via labeling 
the stage coordinates of the fiducials. Using this approach, cells in an arbitrary pattern can be 
imaged quickly (~1 cell/sec and ~1 cell/ 30 sec on MALDI TOF and MALDI FT-ICR 
instruments, respectively) for multiplexed chemical analysis of biological systems.[40] Moreover, 
the use of microMS enables orthogonal techniques to be performed on the same single cell, such 
as MALDI MS and vibrational spectroscopy.  
1.5 Overview of Thesis  
Following the introduction in chapter 1, chapter 2 provides additional information for 
nontargeted, chemical analysis of single cells[25] and chapter 3 describes microMS in greater 
detail.[40] Chapter 4 details the use of microMS to study the peptide and small protein markers of 
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dorsal root ganglia cells.[44] To expand the amount of information that can be gained from an 
individual cell, we coupled MALDI MS with other chemically-rich and informative techniques: 
ICC (chapter 5 and 6), infrared (IR) spectroscopy (chapter 7),[28] and stimulated Raman 
scattering microscopy (SRSM, chapter 8). Finally, we end our discussion in chapter 9 with a 
MALDI imaging application to ginko leaves, demonstrating that while we spent most of our 
research effort on mammalian systems, our research efforts can easily be applied to other 
biological systems, such as plants.[45]  
1.6 Future Outlook 
  Single cell analysis using MS is only at its beginning stages and will continually expand 
in the coming years. While my thesis work has aided in the exploration of single cell lipid 
heterogeneity and combination of this information to other chemically rich techniques, there is 
still much work to be done. For instance, coupling single cell transcriptomics measurements to 
MALDI MS cannot be consistently performed concurrently, while still obtaining quality data 
from both approaches. Future work will clearly be aimed at improving the information and 
reproducibility of this correlated analysis. A similar statement could be applied to many of the 
other multimodal approaches, such as improving ICC staining post-MALDI MS and increasing 
the number of acquired vibrational bands in spectroscopic images. Even further, MALDI MS 
could be coupled to other analytical techniques not discussed here: flow cytometry, genetically-
encoded fluorescent probes, electrochemistry, and many others. 
 While initiatives that improve multimodal analysis is an important aspect of single cell 
analysis, I believe that improving sampling approaches will significantly improve the 
information garnered by both single cell MALDI MS and subsequently correlated techniques. 
Because we are enzymatically dissociating cells from brain tissue, we are removing each cell’s 
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processes and, as a result, their cell-to-cell connections. Through this process, we may also be 
destroying fragile cells and eliminating them from MS analysis, essentially biasing our chemical 
classifications towards more stable brain cells. Certainly, optimizing the dissociation procedure 
would allow analysis of different types of cells, but the first step is to determine if cell types are 
lost and, if so, what cells they are. After they are identified, measures can be taken to keep them 
in the analysis.  
 Moreover, we are determining the chemical profiles of the cell soma, as opposed to 
cellular process. Many cellular functions within the brain involve specific process, such as an 
axon, indicating that important chemical information can be garnered from them. Culturing cells, 
however, drastically changes the chemical composition of the individual cells and may perhaps 
lead to less biologically-significant chemical conclusions. This, however, has not been 
extensively studied and determining the chemical changes and differences among cultured cells 
could lead to their use (or disuse) in MALDI MS analysis, allowing us to study more than the 
cell soma. Additionally, incorporating single cell MALDI MS measurements into tissue systems 
to study cell-to-cell connections is also an important avenue. 
 Beyond the brain, single cell MALDI MS and multimodal analysis could also be used to 
study other biologically important systems and their respective disease states, such as the 
pancreas and diabetes. By building chemical profiles of these systems, we may begin to 
understand how single cells affect organ function and unravel lipid function and disfunction at 
cellular resolutions. I am certain that single cell MALDI MS can help us better understand many 
biological systems, particularly the brain, and will continue to be an active area of research.  
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2.1 Introduction 
Cell theory, first put forward in 1839 by Schleiden and Schwann,[1] originated from the 
concept that the cell is the basic structural and functional unit of all living organisms. Each cell is 
a marvel of detailed and complex architecture, with its history reflected in an inherited 
morphology. After observing the division of red blood cells in chicken embryos, Raspail and 
Remak[2] contributed an important tenet to cell theory with the knowledge that new cells are 
formed from pre-existing cells. The phrase “omnis cellula e cellula” − each cell stems from 
another cell – was popularized by Virchow,[3] and is a more precise version of Pasteur’s terse 
statement on biogenesis “omne vivum ex vivo” – all life is from life. A collection of individual 
cells may communicate, multiply, and differentiate to form a tissue. The variety of unicellular 
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communities and the complexity of multicellular organisms require an astonishing chemical 
diversity to produce a broad range of functions in an organism. Chemical cues in the surrounding 
microenvironment govern cell division, morphogenesis, and aging, and have the ability to alter 
the phenotypes of even genetically-identical cells. Although the concept that disease involves 
changes in normal cells was proposed by Virchow in the 1850s,[4] past technologies limited most 
research and clinical practices to bulk analyses of macroscopically homogeneous cell 
populations. Cell classification based on physical traits (e.g., size, shape, color, etc.) may be 
insufficient to unravel the complex nature of chemical information. Bulk measurement generates 
a population-averaged profile that hinders the investigation and identification of low-abundance 
cell subtypes that are implicated in disease etiology, progression, and exacerbation. In addition, 
extracting analytes from a homogenized sample dilutes analytes derived from rare cells while 
increasing the chemical complexity of the mixture. As such, the shift from bulk to single cell 
analysis is inevitable.  
Given the importance of single cell chemical measurements, why are they rare? Efforts to 
measure the chemical contents of individual cells must overcome the challenges of sampling the 
small quantity of chemically diverse analytes found within single cells. Due to their small 
volume, a technique with a femtomole limit of detection used to analyze a 1,000-µm3 cell (one 
picoliter; approximately the size of a typical mammalian cell) is only capable of detecting 
compounds at millimolar concentrations or above, which may be insufficient for most analytes. 
Other limitations include the ability to isolate single cells from tissues or cell cultures, the 
stability of cells, and difficult cell manipulations, which often lead to experimental artifacts.[5]  
The nature of cellular heterogeneity creates additional challenges for single cell 
measurements. In contrast to the investigation of more widespread cells, targeting uncommon 
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phenotypes requires the acquisition of larger samples to ensure a rare event with statistical 
confidence. Factors such as the ratio of cells to debris in the sample, the signal-to-noise ratio of 
detected signals to background, the frequency of rare cellular events, and the sensitivity of the 
instrument should all be considered. The number of total measurements depends on the desired 
standard error of the mean and the predicted frequency of the rare events occurring. Rare events 
can vary drastically from a few percent to one in several billion, as in the case of circulating 
tumor cells in the bloodstream of a metastatic cancer patient.[6] Researchers have devised clever 
approaches to overcome the challenge of finding rare cells, which include combining cell 
isolation/sorting schemes with analyses at single cell resolution. However, such schemes require 
a priori knowledge about the cells under investigation, and hence are limited to targeted 
analyses. Nevertheless, single cell analysis plays an essential role in modern cell biology, 
including measuring diversity within a population, identifying rare subpopulations, tracing cell 
lineages and phenotypes during normal development or disease stages, and discovering new cell 
types.[7]  
While a few earlier examples have been reported,[8] the current era of single cell chemical 
analysis began twenty years ago with several advances. For example, Jorgenson and Kennedy[9] 
used capillary separations to profile amino acids and neurotransmitters from three different 
neurons of the land snail Helix aspersa. Wightman and co-workers[10] monitored the secretion of 
catecholamines from single bovine chromaffin cells with a carbon-fiber microelectrode, and the 
Ewing group[11] estimated the free dopamine in the cytoplasm of the dopamine cell of Planorbis 
using voltammetry and capillary electrophoresis (CE). In 1992, Eberwine[12] performed more 
comprehensive single cell analysis and demonstrated that the molecular profile of a single, 
potentiated CA1 neuron depends on the abundance of multiple RNAs. These early examples 
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highlighted the need of single cell studies by establishing previously unknown molecular 
variation within individual cells.  
The links between genotype and phenotype are a consequence of the intricate pathways 
between gene transcription, mRNA translation, and protein-level regulation. Alone, the cellular 
genome does not fully explain the complexity and dynamics of the cellular peptidome and 
metabolome, which are important for intracellular function and intercellular communication. 
Therefore, while the genome and transcriptome continue to provide insights on cell function, 
single cell metabolomics and peptidomics (SCMP) measurement strategies are required to 
illuminate the identity, dynamics, and functions of key molecules and relate them to biological 
and physiological processes.  
While SCMP approaches have contributed to numerous advancements,[13] here we limit 
the scope of our discussion to non-targeted techniques. As each cell is a small-volume, mass-
limited sample, bioanalytical techniques have been downscaled and hyphenated to improve 
detection and characterization capabilities. The diverse repertoire of cells poses a tremendous 
challenge to obtaining distinct types of information associated with molecular processes that 
dictate cell-fate decisions. Matching biological questions with an appropriate SCMP technique 
requires balancing their competing requirements and understanding that is currently impossible 
to assay all chemicals present within every individual cell in a system. As illustrated in Figure 
2.1, we categorize the approaches based on their ability to deeply catalog the contents of a few 
cells, assess the native anatomical context of cellular analytes via chemical imaging, and 
measure dissociated cells at high(er) throughput. In the first case, the complexity of biological 
samples warrants the leading role of separation techniques in a “divide and conquer” scheme to 
maximize the chemical information gained from each measurement. With slower analyses, 
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fractionation coupled to mass spectrometry (MS) is practically limited to smaller numbers of 
cells. Because of this, the cells must be chosen carefully, further limiting the use of MS as a 
population-discovery technique. Anatomical information is maintained with chemical imaging 
approaches as they can map the two-dimensional (2D) or three-dimensional (3D) spatial 
distribution of biomolecules.  However, without a separation, they tend to detect more abundant 
and easily ionizable compounds. Finally, cells that are isolated from tissue first may be analyzed 
faster and more completely, but often at the cost of the original cellular context. Profiling 
measurements performed at high throughput increase the odds of observing minor phenotypic 
differences and detecting rare cells. When cells are isolated from each other before 
measurements, there are relaxed constraints on the sampling probe, allowing greater flexibility in 
solvent extraction protocols and matrix-assisted ionization modalities.  
The outlook that native context, increased metabolic coverage, and assay speed are 
dependent and often mutually exclusive may not appear encouraging. However, researchers are 
overcoming limitations by improving instrumentation or coupling multiple analytical methods. 
We largely focus on recently developed MS and MS hyphenated approaches that have pushed 
the limits of both the breath and the depth of cellular analysis.  
To an extent, improving chemical coverage, maintaining spatial integrity, and increasing 
throughput are active research areas. After centuries of scientific investigation, we are linking the 
fundamental connections between individual cells through transport, breakdown, and formation 
of molecules to the emergent functions of memory, learning, and behavior. In what follows, we 
outline the sample preparation approaches followed by the lower throughput comprehensive 
approaches, chemical imaging and finally, the high(er) throughput cell profiling techniques. As 
modern single cell analysis offers a glimpse at exploring biological systems at unprecedented 
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resolution, we end our discussion on the outlook of non-targeted SCMP and its applications to 
biological research.    
2.2 Sample Preparation for Single Cell Analysis 
Successful single cell measurements require well-designed sample preparation protocols 
to ensure meaningful results. Cells from the same tissue region may require different isolation 
techniques. The optimal sample treatment must be selected for the analyte of interest and will 
determine both the methods available for analysis and which analytes will be preserved.[14] In 
general, single cell analyses with non-targeted SCMP techniques are performed either at the 
tissue level using technologies that provide subcellular spatial resolution, or on isolated cells 
using methods that improve molecular characterization, but at the expense of spatial information. 
For subcellular imaging, the integrity and spatial organization of tissues must be maintained 
during the collection, storage, and treatment procedures prior to sectioning. A recent review by 
Chughtai and Heeren[15] listed common biological sample handling protocols for MS analysis, 
with an emphasis on sample storage, that minimize tissue deformation and degradation. For 
dissociated single cell samples, protocols for whole tissue digestion should be optimized to 
maintain the viability of fragile cells while removing connective matrices that may hinder the 
study of individual cells. The suitability of treatment options is often evaluated on a per-case 
basis, with attention to maintaining endogenous distributions of analytes.  
While direct tissue analysis places a stringent requirement for imaging probes to provide 
subcellular spatial resolution, recent advances have focused on sampling dissociated single cells 
at the expense of native spatial information. Manual cell isolation remains effective when 
examining a limited number of cells. Single cells with known features, morphologies, or precise 
anatomical positions can be isolated and then placed manually or seeded randomly on the 
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analysis surface. For example, the well-annotated central nervous system of Aplysia californica 
enables manual isolation with sharp tungsten needles after enzymatically degrading the 
connective tissues. After years of morphological, electrophysiological and biochemical research, 
neurons in many clusters have been characterized.[16] Unfortunately, many mammalian cell types 
are challenging to identify without the aid of staining techniques, such as immunohistochemistry, 
which are incompatible with most MS techniques.  
On the other hand, enzymatic treatments are applicable to tissue types where some cell 
loss during isolation is not a major concern. For example, neurons can be dissociated and 
cultured in a few hours from dorsal root ganglia (DRG), and remain alive and growing for 
weeks. In general, enzymatic dissociation increases throughput and mitigates the expertise 
required to perform manual isolation for cell systems that can withstand more rigorous 
treatments. Each dissociation protocol involves the combination of proteases (e.g., collagenase, 
papain, trypsin, etc.), inert proteins (e.g., bovine serum albumin), balanced salt solutions, and 
other added ingredients to preserve or stabilize cell contents. Once dissociated, cells can be 
cultured, sorted with microfluidic devices, or simply deposited on a substrate for MS analysis. A 
recent review by Hosic et al.[17] is dedicated to microfluidic sample preparation for single cell 
analysis. In many cases, the use of cell-sorting devices is optional, as recent methodologies make 
it possible for thousands of dispersed cells and non-cellular targets to be assayed in one 
experiment, as discussed in the following sections. 
2.3 Comprehensive Multimodal Chemical Analysis 
Separation techniques have historically played a key role in both preparative and 
analytical cellular level studies as they ensure the necessary selectivity and chemical purity as 
well as reduce isobaric interferences. The retention time within a chromatographic column 
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provides a metric for compound identification. Following fractionation, several detection 
modalities other than MS are available, including electrochemistry, ultraviolet–visible and laser-
induced fluorescence (LIF) spectroscopies, among others. LIF generally requires derivatization 
to attach a fluorophore, unless the analyte of interest is intrinsically fluorescent. While 
derivatization is sometimes impractical, fluorescence detection has the lowest limits of detection, 
at times less than a hundred molecules.[18] Electrochemical detection provides attomole detection 
limits[19] without derivatization and can be miniaturized without sensitivity losses.[20] 
Nonetheless, de novo identification of chemical analytes via optical or electrochemical methods 
is difficult due to the lack of chemical resolution.[20]  
While fundamental chemical information from single cells has been obtained by single 
cell liquid chromatography (LC),[21] most recent single cell separation experiments are performed 
with miniaturized CE systems that require only nL to pL quantities of solution and are suitable 
for analyses of whole cells, fractions of cells, or cellular extracts.[22] CE separates compounds 
based on differences in their electrophoretic mobility, which depends upon the number of 
charges, size, and shape of each compound.[23] A whole cell or portion of a cell can be manually 
injected onto the column using a microscope and micromanipulator with subsequent injection 
into the capillary using pressure or electroosmotic flow and lysis.  Alternatively, analytes are 
extracted from the cell and injected directly into the capillary.[24]  
CE analysis of cultured cells is especially challenging as cells can adhere to culture 
substrates, making them difficult to remove.[22] Mechanical or enzymatic removal of cells may 
lead to deformation and release of important compounds. The Allbritton laboratory[25] 
circumvented the challenges of mechanical isolation with a pulsed laser lysis system, allowing 
immediate capillary loading that reduces changes to cell physiology. An alternative, rapid lysis 
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scheme utilizes an electrode to induce a 30 V potential difference across the cell membrane.[26] 
To improve the throughput of single cell CE, many laboratories have coupled microfluidic 
devices to the front end of a CE system.[27] For example, a microfluidic device was used for cell 
lysis and CE separation before flowing through an ESI emitter into the mass spectrometer, 
increasing the analysis rate to 12 cells per minute.[27b] 
MS remains an effective choice for non-targeted analysis because of its mass selectivity, 
robustness, sensitivity and capability to identify unknown structures. MS is further enhanced 
when combined with separations for multi-modal analysis. Solvent-assisted ionization methods, 
such as electrospray ionization (ESI), help preserve the separation efficiency of capillary 
electrophoresis (CE) while achieving sensitive MS analysis.[28] Non-targeted CE-MS analysis 
has been successfully used to probe the metabolic contents in a variety of biological systems, 
such as neurons,[29] cancer cells,[30] plants,[31] and red blood cells.[32] CE-LIF and CE-ESI-MS of 
individual cells remain active areas of research, with samples ranging from developing embryos 
within the species Xenopus laevis[33] to human stomach cancer cells.[34] Recently, the Nemes 
group[35] quantified proteins using bottom-up CE-ESI-MS and detected over 438 non-redundant 
protein groups during different developmental stages of the X. laevis embryo. Further, they 
studied the metabolic contents within certain blastomeres that contribute to cell differentiation 
into neuronal, epidermal, and hindgut tissues within 16-cell X. laevis embryos. Overall, 80 
metabolites were detected and used to develop predictive metabolic profiles for undifferentiated 
cells. This same group further investigated temporal changes by utilizing live-cell CE-MS to 
probe metabolic differences between the dorsal and ventral side of X. laevis embryos at eight- 
and sixteen-cell stages. Metabolic differentiation occurred as early as eight cells, which is earlier 
than originally predicted.[35] 
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 Other metabolic investigations include quantitation of mono-, di-, and tri-nucleotides, 
along with other energy-related anionic molecules within single Aplysia R2 neurons. The energy 
balance within single cells from such measurements was found to be comparable to that obtained 
by bulk sampling.[36] CE is applicable to the separation and quantitation of isobaric metabolites, 
namely L- and D-amino acids. The Sweedler group incorporated sample stacking with single cell 
CE-LIF to allow chiral separations of the D- and L-forms of aspartate and glutamate within 
individual Aplysia neurons.[37] The separation power and large dynamic range of CE allowed 
statistically distinct levels of the D-amino acids to be quantitated within different cell types. CE-
LIF has also been used to study proteins within individual cancer cells, discovering heterogeneity 
within the expression of cysteine cathepsins.[38]  
While single cells are the smallest functional unit of life, subcellular organelles actively 
manage and participate in hierarchical organization, expression and intercellular communication. 
Within a decade of the first single cell analysis, CE progressed to enable investigation of 
structures as small as single vesicles. As early as 1998, Lundqvist et al.[39] extracted single, 
secretory vesicles from the atrial gland of A. californica and utilized CE-LIF to detect abundant 
amounts of taurine, supporting the role of taurine as a neuromodulator or hormone. The 
Allbritton group[40] later applied their laser system to selectively disrupt a portion of a cell, 
allowing selected CE-LIF analysis of specific portions of cell membranes and processes for 
localized detection of chemicals. Another strategy for subcellular analysis utilized on-column 
treatment of cell membranes with digitonin to selectively remove nuclei for CE-LIF analysis.[41] 
The combination of trypsin and digitonin treatment allows on-column isolation of mitochondria 
for CE quantification.[42]  
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Single cell CE analyses have successfully targeted diverse biochemical compounds from 
an eclectic collection of organisms. CE will continue to benefit from improvements in sampling 
throughput, as well as the sensitivity of the various detection modalities. An exciting prospect for 
single cell CE is the repeated analysis of living single cells to monitor biological phenomena 
such as cell development or reactions to stimuli. In 2017, Nemes and colleagues[33a] used CE-
ESI-MS to study the metabolic changes in the developing X. laevis embryo. They probed the 
V1R cell twice and obtained results comparable to a CE-MS analysis of the dissected cell 
(Figure 2.2A). Of note, they monitored metabolic changes during formation of a neural cell 
lineage (Figure 2.2B) and by continually analyzing the progenitor cell, detected 100 molecular 
features that displayed significant changes. For instance, daughter cells contained decreasing 
amounts of aspartate and increasing amounts of GABA. Coupling multiple techniques improve 
overall chemical information and is another exciting avenue for probing live cells. The Sweedler 
group[43] performed CE-MS analysis on thalamic neurons after patch clamp electrophysiology 
was used to characterize the electrical activity of selected cells. Figure 2.2C displays the cell 
recordings and metabolic profile from a ventral basal thalamocortical neuron as compared to the 
thalamic reticular nucleus shown in Figure 2.2D. Over 100 different metabolites were detected 
within the samples. Analysis of living single cells allows for dynamic chemical analysis, which 
will certainly provide a better understanding of many metabolic processes, particularly in disease 
states or developmental stages.   
Given the importance of mapping individual cell phenotypes, separation of cell contents 
maximizes the depth of cellular profiling, albeit, at the expense of cell throughput. Continued 
improvements in scalability will enable proportional increases in the breadth of these 
experiments. CE-MS is especially advantageous as the orthogonal mass separation ameliorates 
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degraded resolution during fractionation. Beyond accelerating separations, preparation and 
manipulation of cells or organelles prior to fractionation help stratify phenotypically distinct cells 
for comprehensive analysis, greatly improving the quality of data obtained in a limited time 
frame. From this aspect, antigen and microfluidic-based sorting are natural complements to the 
in-depth analysis provided by CE.  
Another strength of CE is its flexibility in performing several types of separations, which 
can target specific biochemical classes or separate enantiomers and other kinds of similar 
structures. Clever additives and covalent modifications will allow separation of currently 
unresolved peaks. Specific to single cell analysis, automated sorting and repeated analyses will 
likely find more applications and be adapted to commercial systems. Continued work with 
multimodal analyses will help streamline fractionation and optimize workflows, leading to more 
complete descriptions of single cells from smaller samples than ever before. 
2.4 Imaging Methods for Chemical Analysis of Single Cells  
Individual cells often have distinct roles that depend on their position within a tissue. 
Chemical imaging allows for recognition and identification of cells within their biological 
context. A prominent, non-targeted chemical imaging modality is MS imaging (MSI), which we 
will focus on here. MSI methods raster a desorption probe across a tissue sample at cellular 
spatial resolutions to acquire mass spectra from cells while recording their positions within the 
context of their native environment. The resulting images ideally represent the spatio-chemical 
distribution of ionizable compounds in the tissue. Realistically, the limit of detection determines 
observable analytes and is affected by instrumentation, sample complexity and other factors. 
Secondary Ionization Mass Spectrometry (SIMS) Imaging 
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One of the oldest chemical imaging methods used to obtain cellular resolution is SIMS, 
which uses a primary ion beam that can achieve submicron footprints to sputter a sample surface. 
The collisions of primary ions with the sample surface cause ejection and ionization of analytes 
that are subsequently detected by a mass analyzer. Traditionally, SIMS analyses are categorized 
into two operating modes: dynamic and static.[44] The commercial CAMECA SIMS instruments 
were developed for dynamic SIMS analysis, with primary ion sources focused down to 50 – 200 
nm probe diameters while maintaining high energy fluence. The term “NanoSIMS” was coined 
for many dynamic SIMS instruments, including those commercialized by CAMECA. Static 
SIMS is usually described as being less destructive due to its lower primary ion dose (below 1012 
ions/cm2). Originally used for analyzing organic molecules on the surface monolayer, static 
SIMS is becoming widely used in biological MSI.[45]  
SIMS imaging has been used to probe halogens, enriched metals, and isotopically labeled 
additives;[46] measure the cellular uptake and distribution of drugs in different co-cultured cell 
types;[47] and visualize different stages of cell cycles.[48] NanoSIMS has found wide application 
in biological geochemistry, cell biology, and microbiology to study the uptake, assimilation, 
storage, and translocation of trace elements.[49] A recent review by Musat et al.[49] highlighted the 
use of NanoSIMS-based methodologies to identify, quantify and visualize the incorporation of 
labeled substrates, many of which were performed at single cell resolution. In one pioneering 
work, Lechene et al.[50] used NanoSIMS imaging to quantify N2 fixation by individual bacterium 
inhabiting the gills of the ship-worm Lyrodus pedicellatus (i.e., single bacterium within an 
animal cell). Popa et al.[51] used NanoSIMS to characterize cellular development and metabolite 
exchange in and between individual vegetative and heterocyst cells of Anabaena oscillarioides, a 
filamentous freshwater cyanobacterium. The two cell types of A. oscillarioides coexist in the 
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same filament, but only heterocyst cells specialize in nitrogen fixation. Other vegetative cells 
participate in oxygenic photosynthesis and CO2 fixation. By adding tracer-levels of 
13C and 15N, 
tracking stable isotopes from inorganic pools to their cellular fate was achieved with 100-nm 
spatial resolution using NanoSIMS. In a similar study, Kuypers and colleagues[52] measured the 
assimilation of H13CO3
- and 15NH4
+ by individual cells of the anaerobic, phototropic bacterial 
species Chromatium okenii, Lamprocystis purpurea, and Chlorobium clathratiforme. The study 
revealed a large range of uptake rates of ammonium and inorganic carbon for single cells of the 
same species, which might result from genomic diversity in phylogenetically identical but 
physiologically distinct populations.  
SIMS can be combined with other single cell approaches. In environmental 
microbiology, NanoSIMS has been combined with fluorescence in situ hybridization (FISH),[53] 
Raman spectroscopy,[54] and high resolution optical microscopy.[55] McGlynn et al.[53a] coupled 
FISH and NanoSIMS to investigate the metabolic activities of single archaeal and bacterial cells 
within a consortium (see Figure 2.3A). Saka et al.[55a] correlated stimulated emission depletion 
microscopy with NanoSIMS imaging to visualize and quantify the turnover of isotopically 
labeled proteins in different organelles from cultured hippocampal neurons. These are a few of 
many examples where the combined methods allow simultaneous activity measurements and 
identification of single microbial cells.  
NanoSIMS has recently been applied in the field of biomedical imaging. Nolan and co-
workers[56] employed mass cytometry labels (e.g., affinity probes with metal isotope tags) in an 
imaging application referred to as multiplex ion beam imaging (MIBI). MIBI has several 
advantages over conventional immunohistochemistry techniques, including the absence of 
background auto-fluorescence signals, an order of magnitude larger dynamic range, and a higher 
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plexity of up to 60 targets. In a recent report, Angelo et al.[57] used MIBI to image human breast 
tumors and revealed immunophenotypes of cell subpopulations that could be related back to the 
original clinical pathology of the tissue (Figure 2.3B). Another recent, exciting development is 
the use of atomic recombination to measure distances that are smaller than instrumental imaging 
resolution. Atomic recombination occurs when atoms from different molecules combine to form 
diatomic ions and is sensitive to the pairwise distance between molecules. Moss and Boxer[58] 
exploited the atomic recombination of 13C and 15N to form 13C15N- to assess the lateral 
distribution heterogeneity of lipids at a spatial resolution of 100 nm. The recombination 
phenomenon may eventually allow probing the proximity of a lipid to a protein of interest at 
nanometer-length scales.  
While biological information has been and will continue to be gained from NanoSIMS, 
time-of-flight (TOF)-SIMS instruments are suitable for non-targeted analysis because of 
improved detection of intact molecular ions over a larger mass range. Rather than mapping 
internal, atomic species using dynamic mode, early TOF-SIMS experiments were performed in 
static mode and focused on the identification and localization of cell surface compounds. 
Pioneering work by the Winograd and Ewing groups[59] developed the unique strength of SIMS 
in biological imaging of single mammalian cells and intact tissues. The authors used a 15-keV 
In+ liquid metal ion beam to examine the lipid distribution along the conjugation junction of 
mating Tetrahymena, a model for studying membrane fusion. The images revealed a decrease in 
abundance of phosphatidylcholine and an increase in 2-aminoethylphosphonolipid at highly 
curved fusion pores, suggesting that Tetrahymena direct lipids to adjust membrane structure 
during conjugation. Shortly after, Monroe et al.[60] studied the subcellular localization of vitamin 
E in the soma-neurite junction of single, isolated neurons from A. californica using a TRIFT III 
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instrument equipped with a 22-keV Au+ liquid metal ion source. Using the same instrument, 
Tucker et al.[61] imaged the cultured neurons under different treatment conditions and mapped the 
distributions of cholesterol, vitamin E, and phosphocholine head groups in cell soma, neurites, 
and growth cones. 
The development of polyatomic ion beams, such as the C60
+ and Ar1000-4000
+, marked a 
new era for TOF-SIMS imaging of biological samples. The C60
+ ion beam developed by the 
Vickerman group and Ionoptika[62] has higher high mass ion yields, molecular depth profiling 
and reduced subsurface chemical damage compared to early Ga+ and SF5
+ ion sources. Advances 
in instrumentation have improved the compromise between high mass resolution and high spatial 
resolution, while further reducing analysis time.[63] They modified the Ionoptika J105 3D 
Chemical Imager by equipping the instrument with a 40-keV C60
+ ion gun with a minimum spot 
size of 200 nm. The capabilities of the instrument were demonstrated by performing 3D imaging 
of single benign prostatic hyperplasia (BPH) cells and 2D imaging of single HeLa, human cheek 
cells, and sectioned Xenopus blastomers (0.8 – 1.3 mm in diameter). The images of single cells 
revealed the distributions of adenine and lipids. The tandem MS capability of the J105 allowed 
the identification of several intact lipids.[63] Passarelli et al.[64] and Lanni et al.[65] further 
demonstrated the capability of TOF-SIMS with tandem MS in mapping various intact lipids 
across the cell surface of single neurons of A. californica.  
The use of cluster ion sources has demonstrated great potential for molecular 3D imaging 
of single cells (for a recent review on 3D imaging with SIMS, see[66]). A dual ion source system 
was shown to be useful in reports by Breitenstein et al.[67] and Nygren et al.,[68] who performed 
3D TOF-SIMS imaging of normal rat kidney and anaplastic thyroid carcinoma cells, 
respectively, at a spatial resolution of 300–350 nm using a 25-keV Bi3
+ liquid metal ion beam for 
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imaging and a 10-keV C60
+ for etching and removing the damaged layers caused by the Bi3
+ 
beam. A variety of endogenous amino acids, cholesterol, and intact phospholipids were detected 
(see Figure 2.4). Castner and colleagues[69] used the same ion beam combination but at higher 
energies (25 keV-Bi3+ and 20 keV C60
2+) to image NIH/3T3 fibroblasts in 2D and 3D. Brison et 
al.[70] applied a similar dual beam mode with the sputter depth calibrated using atomic force 
microscopy to perform 3D imaging of native and non-native chemical species in HeLa cells.   
Fletcher et al.[71] performed 3D TOF-SIMS analysis of individual oocyte cells mounted 
on copper tape using a single 40-kV C60
+ beam. Aside from common ions such as cholesterol 
and oleic acid, they observed groups of mass spectral peaks occurring at m/z 540–700 and m/z 
800–1000 that might originate from glycosphingolipids of the membrane constituents, although 
unambiguous identifications were not possible. Nonetheless, the signals at low mass, such as 
phosphocholine and adenine, produced 3D visualizations of the membrane and nucleus, as 
demonstrated by Vickerman and co-workers[72] for HeLa-M cells. The localization of small 
molecules and metabolites in single bacterial cells was recently reported by Tian et al.,[73] who 
showed direct localization of unlabeled tetracycline and ampicillin in single, antibiotic-dosed E. 
coli cells (about 2 µm long and 0.25–1.0 µm in diameter) using TOF-SIMS 3D imaging at 300 
nm spatial resolution.   
 MALDI MSI  
While SIMS imaging offers superior spatial resolution, it achieves a limited mass range 
because the ion beams can cause fragmentation. A complementary imaging approach, MALDI 
MSI, is a soft ionization method that can ionize large proteins, although the use of a matrix can 
cause other issues.  MALDI MS directly probes analytes from a solid sample, such as dispersed 
cells or tissue sections,[74] and is a highly sensitive analytical technique capable of attomole 
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detection limits.[75] MALDI MS is uniquely suited for single cell analysis because it can probe 
cells directly with minimal perturbations and can analyze low amounts of many chemical 
compounds. Most of the detected analytes are singly-charged positive or negative molecular 
ions.[76] The sample is prepared by “dissolving” analyte compounds in the matrix, typically a 
small, organic compound that absorbs UV light. Irradiating the sample with a focused UV laser 
causes the matrix to erupt and generate gas-phase matrix and analyte ions representative of the 
ablated area. In addition, MALDI is more tolerant of high concentrations of salt as often found in 
biological media.[77] The robustness of MALDI MS is particularly appreciated in the analysis of 
complex biological specimens, where sample treatments frequently fail to remove all analyte 
interference.  
Matrix application is critical for MALDI MS as the nature of matrix compounds and the 
methods used to apply the matrix determine the chemical coverage, analyte migration, and the 
overall quality of measurements. Several strategies for applying the matrix compound to the 
sample have been established, including sublimation,[78] nebulization,[79] inkjet printing,[80] and 
electrospray.[81] Each MALDI MS measurement strikes a balance between extraction efficiency 
and analyte diffusion, which is especially problematic for tissue imaging.[79] The choices for 
MALDI matrices and their application continues to expand as novel compounds are found to be 
suitable matrices for specific applications or classes of analytes. MALDI MS provides broad 
chemical coverage of analytes, including proteins,[82] peptides,[83] lipids,[84] and small 
metabolites.[85] A frequently cited limitation is isobaric interference from the MALDI matrix, 
which complicates metabolite detection without high-resolution mass analyzers. While MALDI 
MS is a destructive technique, it often consumes only a fraction of the sample,[86] allowing 
repeated or follow-up analyses to enhance the amount of information acquired from the same 
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target.[87] This is especially useful for prescreening cells to determine rare cells or to classify 
cells into subpopulations based on representative markers for subsequent analysis. Cellular and 
subcellular imaging (<10 µm) with MALDI MS is still not common using most commercial 
instruments. Laboratories have achieved single cell and subcellular analysis of tissue samples by 
using custom instrumentation capable of significantly smaller spatial resolution (several 
microns). High spatial resolution is dependent not only on the laser spot size, but also matrix 
crystal size and the sensitivity of the mass spectrometer. In 2010, 5-µm spatial resolution mouse 
bladder tissue imaging was accomplished by the Spengler group.[88] In 2012, Schober et al.[74b] 
developed an atmospheric MALDI source with 7-µm spatial resolution, capable of subcellular 
lipid and metabolite localization within HeLa cell cultures. Only months later, the Caprioli 
laboratory[89] demonstrated a 1-µm beam spot size achieved with transmission geometry 
illumination. The source arrangement was used to image individual HEK-293 cells and detected 
insulin differences between nuclei and cytoplasm within human pancreatic islets. More recently, 
in 2017 the Spengler group[90] developed an atmospheric pressure MALDI imaging source 
capable of 1.4-µm lateral resolution. The source capabilities were demonstrated by probing the 
subcellular lipid, metabolite, and peptide chemical differences between different sections of the 
Paramecium caudatum cellular membrane with a 3-µm pixel size (Figure 2.5A–F).  
Alternative Imaging Approaches  
While SIMS and MALDI MSI are the most common MSI techniques capable of cellular 
imaging, alternatives are being developed. The Zare group[91] developed laser 
desorption/ionization droplet delivery mass spectrometry, which is capable of 3-µm spatial 
resolution, to image tissue samples as well as measure both single cell apoptosis and live cell 
exocytosis. Laskin’s group[92] has been pushing the limit of NanoDESI, recently achieving a 
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spatial resolution of 11 µm. In another example, Yang and colleagues[93]  developed single-probe 
MS, which is effectively a miniaturized probe constructed from a fused silica capillary with an 
ESI emitter placed inside a dual-bore needle. The dual-bore needle can puncture cell membranes, 
gaining direct access to cell cytoplasm. Single-probe MS was first used to interrogate individual 
HeLa cells and detected many small molecules and lipids within individual cells. Single-probe 
MS has since been used within an imaging context, achieving an 8.5-µm spatial resolution,[94] 
allowing image acquisition of lipids within single cells. Single-probe MS offers the highest 
spatial resolution among solvent-based, ambient approaches.   
Although there are many options when choosing a chemical imaging modality, the 
selection of an ionization technique requires balancing the constraints of the required spatial 
resolution, mass range of interest, instrument availability, and cost. While SIMS has superior 
spatial resolution compared to other imaging modalities, most systems are too cost prohibitive to 
be owned by a single lab, and fragmentation prevents analysis of peptides, proteins, and larger 
nucleic acids. However, the “out-of-box” capabilities of SIMS imaging are impressive, and are 
becoming even more so. MALDI MS systems are more readily available, even if many of the 
above examples require modifications, and can more easily analyze higher mass compounds 
without fragmentation. Achieving the spatial resolution required to analyze single cells in the 
context of tissues is currently performed by a handful of laboratories using either MALDI MS or 
ambient ionization.  
2.5 Single Cell Profiling 
Performing subcellular resolution MSI introduces a host of challenges for sample 
preparation and instrument development, and is generally slow. An alternative method for 
probing the contents of single cells is to isolate them from their microenvironment and 
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individually interrogate each cell. While the spatial information is lost, profiling single cells is 
often faster and has better limit of detection than conventional MSI at single cell resolution. 
Commercial instruments can be used without alteration, providing access to single cell 
measurements to more researchers. Moreover, the latest developments allow the interrogation of 
thousands of cells for population studies and analysis of cell heterogeneity.  
Electrospray Ionization  
Probe electrospray ionization (PESI) directly inserts or touches the sample with an ESI 
emitter, effectively performing a surface extraction. Following extraction, the emitter (often a 
stainless steel needle) is repositioned directly in front of a mass spectrometer inlet for ESI 
analysis without further addition of liquid.[99] PESI allows live cell sampling as well as 
enrichment of metabolites by probing the sample multiple times before MS analysis. The Zhang 
laboratory[100] used the approach to analyze the outer and inner epidermal cells from Allium cepa. 
Several chemical differences were noted between the cell types, including a higher diversity of 
fructans localized within the inner epidermal cells and distinct lipid profiles.  
In 2018, the Vertes group[101] combined fluorescence microscopy with capillary 
microsampling  to perform ESI analysis of cells at different mitotic stages. The Huang lab[102] 
used a patch clamp capillary as an ESI emitter to study metabolic changes within single 
mammalian neurons after electrophysiological analysis. They determined that cells that had 
unusual patching profiles also had unusual chemical profiles, demonstrating the need to measure 
both physiology and chemistry on the same, living neuron, perhaps multiple times. 
A related method, “live-cell MS” developed by the Masujima group,[103] utilizes a sharp 
nano-ESI emitter to puncture a cell, extracting contents (even from an organelle) into the emitter. 
The emitter is then transferred to the inlet for MS analysis. Due to the size of the probe, 
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extraction does not appreciably perturb a living cell, allowing repeated sampling of the same cell. 
In a typical experiment, cells are observed under a microscope and when an event of interest 
occurs, such as a physical response to stimuli, the nano-ESI emitter is placed into the cell for 
extraction. While this technique allows for high selectivity of the analyzed region of the cell, it 
requires fine manipulations. The Masujima group has detected over 700 analytes within an 
individual cell with live-cell MS[103] and applied live-cell MS to study the metabolites within 
plants.[104] Similarly, the Huang lab[105]  demonstrated the analysis of proteins from live cells 
without destroying the cell. The Laskin group[106] used localized electro-osmotic extraction to 
drive picoliter volumes out of live cells into a nanopipette compatible with nano-ESI analysis. 
They detected more than 50 metabolites, including sugars and flavonoids, some of which could 
be quantified using sequential extraction of a known volume of an aqueous solution containing 
deuterated standards. These approaches hold great promise in measuring the changes in chemical 
content of the same cell as a function of disease or growth. Nevertheless, it is critical to carry out 
parallel measurements to monitor cell conditions, and to avoid mechanically-induced changes in 
cell states. 
MALDI MS  
 MALDI MS is the primary analytical technique capable of obtaining direct chemical 
information from cells and has been used more than the other approaches. Here we divide 
MALDI MS approaches into lower throughput manual isolation and higher throughput 
acquisitions.  Until the last decade, single cell MALDI MS required a combination of manual 
cell isolation, placement, and MS acquisition. Two methods for high-throughput acquisition of 
single cells were recently reported: high-density microarrays for mass spectrometry (MAMS) 
with defined locations (Figure 2.6A)[84a] and image-guided analysis of cells randomly seeded on 
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a transparent substrate (Figure 2.6B).[107] Each method offers unique performance advantages 
and enables the analysis of hundreds to thousands of cells within a single experiment. 
Direct MALDI MS Profiling 
The Greef group[95] reported the earliest examples of single cell MALDI MS in 1993, 
where they profiled peptides from individual Lymnaea stagnalis neurons. Improvements to mass 
spectrometer sensitivity allowed detection of more analytes from single cells and even tandem 
MS for structural identification without a priori knowledge. Important neuroscience findings 
have direct roots in the single cell MALDI MS experiments pioneered by Greef, Geraerts, 
Sweedler, Burke, and others.[16b, 83b, 96] Despite the limitations of this early research, hundreds of 
biologically important neuropeptides, neuromodulators, and neurotransmitters (among many 
other molecules) were discovered and correlated with physiological function. Discoveries were 
performed using samples ranging from large invertebrate neurons to small peptidergic 
mammalian cells.[83a, 97] One of the most recent studies involving low throughput MALDI MS 
was performed in 2018 by the Setou lab,[98] where they measured phosphocholine lipids in single 
neurons as they extended neurites.  
Microarrays for Mass Spectrometry 
The first single cell profiling using MAMS was reported in 2010 by the Zenobi group[84a] 
where they detected metabolites, such as adenosine triphosphate and uridine diphosphate 
glucose, from single Saccharomyces cerevisiae cells and lipids within single Chlamydomonas 
reinhardtii cells. MAMS chips are fabricated from a conductive slide covered with a 
hydrophobic coating. Wells, approximately 100 µm in diameter, are patterned by laser ablation 
of the coating. Each well contains a small volume that restricts diffusion during matrix 
application. When cells are added to the surface, they settle only within the wells. Since the wells 
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are located at known coordinates, sampling proceeds at rates of about two samples per second. 
Additionally, restricting each cell to a known address simplifies correlation between different 
analyses, such as native fluorescence and Raman spectroscopy (Figure 2.6C). In a follow-up 
study, the Zenobi group[75] characterized metabolites within yeast cells, facilitating investigation 
of metabolic heterogeneity at the single cell level. MAMS has since been applied to a variety of 
cell systems, such as human blood peripheral mononuclear cells[108] and Haematococcus 
pluvialis.[109]  
Microscopy Guided Profiling  
Ong et al.[107] reported high-throughput, optical microscopy-guided MALDI-TOF MS of 
randomly seeded cells in 2015. They analyzed several thousand pituitary cells, frequently 
detecting pro-opiomelanocortin peptides. The protocol begins by incubating cells with Hoechst 
33342, a fluorescent DNA intercalator, and acquiring a fluorescence image to locate the cells 
over the area of a microscope slide. Using the low background inherent in fluorescence images, 
the location of each cell is determined automatically. Registering fiducial marks that are visible 
in both the microscopy image and instrument camera enables the conversion of pixel positions 
into stage coordinates to automate the MALDI-TOF MS analysis. Knowing the location of each 
cell allows for mass spectral acquisition at defined points at high throughput.[107] After the initial 
demonstration of this approach, Jansson and coauthors[110] performed additional studies of single 
cells isolated from pancreatic islets of Langerhans and detected peptide hormones unique to cell 
types within the islet.  
 To expand optically guided single cell profiling beyond MALDI-TOF instrumentation, 
Comi et al.[111] developed the open source software, microMS, for analyzing microscopy images 
and correlating cell locations to instrument positions. The software provides automatic cell 
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finding and filtering by attributes such as size, fluorescence intensity, and distance between cells, 
and is simple to tailor to a variety of instruments, expanding the availability of single cell 
profiling. The ease of switching between output coordinate systems also facilitates analysis of 
the same cell on multiple instruments; an example being MALDI-TOF MS analysis with follow-
up CE-MS analysis (Figure 2.6D).[111] Do et al.[112] recently used microMS to set up sequential 
MALDI MS analyses of rat DRG cells. Lipids, peptides, and small proteins were detected in the 
same cells, many of which were not previously detected in tissue homogenates or releasates. The 
DRG populations were stratified with multivariate statistical analysis using peptides and proteins 
as potential markers. A similar method utilizing flexImaging software from Bruker Corp. was 
recently published by the Caprioli lab[113] to determine heterogeneity within cultured macrophage 
cells using a Bruker solariX XR FT-ICR mass spectrometer. The authors imaged single cells by 
rastering across the slide and comparing the ion images with optical images acquired beforehand. 
Ultimately, they were able to show changes in lipid expression of macrophages upon chemical 
stimulation.  
The optically guided single cell profiling approach was recently demonstrated for SIMS 
using microMS software.[111] In the study, Do et al.[114] utilized ionic liquid matrix-assisted 20-
keV C60
+ TOF-SIMS to profile metabolites and intact lipids in three cell types: large A. 
californica pedal neurons, medium-sized cell bodies of rat DRG, and small rat cerebellar cells at 
the rate of 600 cells/h. The single cell mass spectral datasets were subjected to multivariate 
statistical analyses, such as principal component analysis and t-distributed stochastic neighboring 
embedding, which helped distinguish cell types with similar lipid profiles, including DRG and 
cerebellum. In addition, these analyses suggested that lipid ratios could be endogenous markers 
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to define brain regions. Overall, advanced statistical analysis strategies are necessary to fully 
harness the utility of high-throughput data.  
The performance metrics of SIMS and MALDI MS imaging carry over to single cell 
analysis, as the limitations and advantages are inherent to the ionization technique. Moreover, the 
MALDI MS and SIMS examples discussed here largely sacrifice cellular connections, which can 
be consequential when the spatial organization of the system determines the function of a cell, 
such as the brain. To circumvent this loss of information, cells and organelles can be manually 
isolated from selected cells. While manual dissection allows for cellular even subcellular 
chemical analysis, it is laborious and low throughput. ESI-based methods do not always require 
removal from tissues, although these methods are often laborious and low throughput. 
Furthermore, ESI also benefits from multiply charged ions, improving detection of proteins of 
higher mass, but is less salt tolerant than MALDI or SIMS. As the field of single cell profiling 
progresses, each approach, whether it be low throughput with known spatial location or high 
throughput without spatial information, will need to be developed further for adoption in general 
labs for fundamental analysis of poorly understood systems, such as the brain, plant tissues, or 
disease states.  
2.6 Summary and Outlook 
While many approaches can provide information on individual cells, we have focused on 
methods that are capable of nontargeted chemical analysis. Single cell chemical analysis has 
evolved rapidly over recent decades to provide ‘omics-scale molecular information at the 
individual cell level. Front-end techniques such as CE and LC have been downscaled to enhance 
separation on minute samples, and in some cases, to perform repeated sampling of the same cell 
for real-time metabolomic information.[24, 33a, 115] MAMS and optically-guided MS profiling now 
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facilitate the assay of several thousands of cells within a couple of hours,[75, 110, 114] while cellular 
and subcellular spatial resolution chemical imaging can be achieved by selected MS probes such 
as NanoSIMS,[49-53, 57] SIMS[44c, 63, 66-67, 71-73, 116] and MALDI.[90] Future work will be  aimed at 
achieving faster analyses with higher mass and spatial resolution and developing more sensitive 
instrumentation. Several groups have achieved detection of 10 zeptomoles of material with 
modern MS instruments, equivalent to about 6000 molecules. Fluorescence detection can detect 
single selected molecules. These reported detection limits for MS should be sufficient for 
detecting most compounds within a single cell or most subcellular organelles. Why then is the 
scientific community unable to realize the limits of detection in ideal systems when applied to 
single cell chemical analyses? We attribute the lowered performance largely to limitations 
caused by the inherent chemical complexity of cells and less than ideal sampling protocols. 
Obtaining isolated single cells from a tissue requires dissection, dissociation, plating, rinsing, and 
finally, analysis. During every single step, different compounds are potentially released or 
removed from cells, reducing the number of molecules remaining for detection, as well as 
introducing other non-native contaminants. Sampling issues are compounded by ion suppression 
effects, transmission efficiency through the spectrometer or column, and the native background. 
As a final consideration, complex systems, such as single cells, require a high dynamic range to 
detect molecules at abundances over many orders of magnitude. The exciting aspect is that 
newer instruments have the necessary performance requirements. In addition, at least for some 
analytes, experiments are being performed that sample living cells within their native 
environment, ameliorating several of the issues related to sampling. Techniques such as CE and 
live-probe MS allow for live cell analyses and could be applied to native chemical analysis. 
Repeated sampling of individual cells can allow monitoring of the progression of disease, such 
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as cancer and diabetes, facilitating a better understanding of disease development on the single 
cell scale. In situ monitoring is not a panacea; many cell environments would require labeling of 
cells to track their position and allow reliable, repeated sampling, particularly for systems 
containing millions to billions of cells.  
An alternative route for increasing the chemical information detected within a single cell 
is to combine two or more techniques for multimodal analysis of individual cells. Multiple 
orthogonal approaches can increase the chemical information gained from one sample by 
merging the assets of each method. While simple in concept, multimodal analysis requires 
attention to details as each analytical technique has specific sample preparation requirements, 
substrates and conditions that may be incompatible with the other sampling protocols, and of 
course, the approaches must leave sufficient sample behind for the next measurement. In 2011, 
the Zenobi group[117] developed a method for coupling laser desorption/ionization MS with 
Raman and fluorescence imaging to analyze carotene and phospholipids within individual algal 
cells randomly seeded on a metal target. Furthermore, they coupled Raman and fluorescence 
microscopy with MALDI MS to study adenosine triphosphate, adenosine diphosphate, and beta-
carotene within individual algal cells.[109] These studies demonstrate that not only is the 
combination of MS methods with optical approaches possible, the union can enhance the 
chemical coverage of a single cell. We hyphenated various analytical techniques to obtain more 
complete measurements on small samples. In 2013, we used immunocytochemistry to label 
neurons within the insect, Periplaneta americana, with follow-up peptide analysis using MALDI 
MS.[118] Combining different toolsets, patch clamp electrophysiology was coupled to CE-MS in 
2014 to study the relation between physiological activity of gamma-aminobutyric acid 
containing neurons within the rat thalamus in relation to neurochemical condition.[43] More 
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recently, we combined several MS approaches together such as MALDI MS and SIMS on the 
same cells.  In 2017 an optically-guided liquid microjunction extraction probe was utilized to 
hyphenate MALDI MS with CE-MS for analysis of single α and β pancreatic islets cells.[87] 
MALDI MS is used first to prescreen cells for peptides indicative of a specific cell type, while 
CE-MS is used to analyze metabolite profiles of cells representative of a cell type. This 
combination can be further employed to study both the small metabolite and peptide 
heterogeneity possessed by different cell types. We expect multimodal measurements to remain a 
rapidly developing approach for increasing chemical coverage. By coupling single cell MS 
techniques with complementary targeted and untargeted techniques, such as single cell 
transcriptomics, spectroscopy and staining, even more information can be garnered.  
Looking back to the days of Schleiden and Schawnn[1] when cell theory was first 
described, the scientific community has learned much about this fundamental unit of life. 
Numerous technological advances have greatly expanded the information content that can be 
obtained from single cell analyses. Systems that have been explored include algae, plants, sea 
slugs and mammals, suggesting that single cell analysis has been effectively transforming many 
areas of biological science. Future advancements may allow scientists to probe more complex 
systems and glean information on some of the least understood emergent properties of 
organisms, such as memory within the brain. While challenging, probing the chemical profiles 
and activity of individual cells is most certainly a field worth pursuing.  
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Figure 2.1 Analytical techniques for single cell analysis discussed in the review. (Top) 
Fractionation techniques include capillary electrophoresis combined with different detection 
methods. (Bottom) Cells are directly probed for their contents using a variety of ionization 
methods that have a range of capabilities and performance specifications.  




Figure 2.2 Several examples of single cell CE-MS approaches highlighting the chemical 
information obtained. A) Comparison between CE electropherograms of the V1R cell dissected 
and probed twice consecutively. Similar metabolites were detected in either approach. B) 
Significant changes in GABA and aspartate were detected between the progenitor cell and 
daughter cells, while creatine was not determined to be significantly different. Patch clamp 
profiles of two different neurons. A and B are adapted from Onjiko et al., Anal. Chem. 2017, 89, 
7069–7076. Copyright 2017 American Chemical Society. C) Ventral basal thalamocortical and 
D) thalamic reticular nucleus, as well as metabolic CE electropherograms of each cell. The 
authors detected ornithine, GABA, glycine, serine, tryptophan, glutamine, glutamate, tyrosine, 
and proline. C and D are adapted from Aerts et al., Anal Chem. 2014, 86, 3203–3208. Copyright 
2014 American Chemical Society. 
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Figure 2.3 A series of cellular chemical images demonstrating the information that can be 
gained from SIMS. A) Anaerobic oxidation of methane of consortia of anaerobic methanotrophic 
archaea (green) paired with Deltaproteobacteria (pink) identified by fluorescence in situ 
hybridization (FISH) (left panels) and NanoSIMS imaging (middle panels). Single cell activities 
(right panels) are measured as 15N atom percentages for regions of interest representing the 
FISH-identified archaea and bacteria in each consortium. Lighter shaded cells are more enriched 
in 15N, which corresponds with higher levels of anabolic activity and 15NH4
+ assimilation. Scale 
bars, 3 µm. Adapted from McGlynn et al., Nature 2015, 526, 531–535. Copyright 2015 Nature 
Publishing Group. B) Multidimensional, composite image obtained from multiplexed ion beam 
imaging (MIBI) illustrating quantitatively protein expression and colocalization of E-cadherin 
(green), actin (red) and vimentin (blue), qualitatively categorization of cell nuclei into two 
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Figure 2.3 (cont.) subpopulations: ERα+PR+Ki-67+ (yellow) and ERα+PR+(aqua). Scale bars, 25 
µm. Adapted from Angelo et al., Nat. Med. 2014, 20, 436–442. Copyright 2014 Nature 
Publishing Group. 




Figure 2.4 SIMS imaging can be used to determine the localization of a variety of different 
chemical classes within single cells. For instance, A) pooled signals of amino acid fragment ions 
are represented in red, B) those of phospholipids in green, and C) substrate-derived secondary 
ions are depicted in blue. D–F) Red–green–blue color overlay for correlation analysis of a 
confluent monolayer of normal rat kidney cells. Both horizontal xy and vertical xz sections are 
shown. Adapted from Breitenstein et al., Angew. Chem. Int. Ed. 2007, 46, 5332–5335. 
Copyright 2007 Wiley InterScience.  
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Figure 2.5 High spatial resolution MALDI-MSI can be also be used to determine subcellular 
localization of chemical classes that are often different than those obtaining with SIMS imaging. 
A, C and E) Optical images of P. caudatum before MALDI-MSI analysis. B, D and F) MSI 
images (RGB mode) of different lipids (i.e. [DG(31:0) + NH4]
+, [PS(32:1) + H - H2O]
+, 
[DG(38:1) + NH4]
+) or small peptides (e.g. [(Lys3Ala) + H]
+) present within the cell. MS images 
were acquired at 3-µm spatial resolution, showing discrete subcellular locations of the different 
lipids or small peptides. Some of the metabolites correlated well with structures such as cilia. 
Scale bar: 100 µm. Figure adapted from Kompauer et al., Nat. Methods 2017, 14, 90–96. 
Copyright 2017 Nature Publishing Group. 




Figure 2.6 Two approaches are highlighted that provide high throughput single cell 
measurements via direct profiling MALDI MS.  A) Schematic of the MAMS process, where 
cells are seeded within evenly spaced wells for MS analysis, and of B) optically-guided MS 
analyses, where cells are randomly seeded on a glass slide. C) MAMS has facilitated multi-
modal analysis of algal cells by both MALDI-MS and Raman spectroscopy. Adapted from Urban 
et al., Lab Chip 2010, 10, 3206–3209. Copyright 2010 The Royal Society of Chemistry. D) 
Similarly, microMS has facilitated the analysis of the same pancreatic islet cell by both MALDI-
MS and CE-MS. This specific method allowed MALDI-MS to prescreen single islet cells for 
CE-MS analysis of ß-cells. Adapted from Comi et al., Anal. Chem. 2017, 89, 7765–7772. 
Copyright 2017 American Chemical Society. 
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CHAPTER 3 
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3.1 Introduction  
Image-guided mass spectrometry (MS) provides a link between the spatial dimensions in 
a digital image and the physical location of a sample within a microprobe system. MS imaging 
(MSI) is a subset of image guided chemical sampling that frequently utilizes regularly spaced 
acquisition positions overlaid on an optical scan to recreate the spatial distribution of analytes 
within a sample. However, traditional MSI is low throughput and less sensitive than targeted 
profiling when the target objects (e.g. biological cells and bacterial colonies) are widely 
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dispersed or smaller than the microprobe size. In the past decades, single cell analysis with MS 
has attracted great interest due to its sensitivity and ability to handle volume-limited samples.[1-6] 
Many classes of biomolecules within individual cells are detectible with a variety of MS probes, 
facilitating new discoveries of single cell heterogeneity and a better understanding of the 
relationship between chemical contents and cellular functions. When MSI is applied to tissue 
sections,[7-10] the resolution to differentiate neighboring cells requires sampling each cell multiple 
times, effectively splitting available analytes among pixels. Due to difficulties in sample 
preparation and stringent instrument requirements, MSI at or below single cell resolution is far 
from routine in most laboratories. In the case of dispersed cells,[11-12] traditional MS imaging is 
not an optimal approach as most of the measurement time is spent characterizing the space 
between the cells. The limitations of MSI for high throughput analysis of single cells have led to 
the development of new methods to locate or deposit cells.  
Recently, high throughput approaches to single cell MS have driven analyses of 
dissociated single cells which are either chemically labeled[13] or coordinate registered. MS 
profiling of adhered cells provides advantages in data fusion by simplifying data processing and 
allowing sequential analysis of the same cell. Microarrays for mass spectrometry[14-16] (MAMS) 
have demonstrated such capabilities by combining Raman microspectroscopy with MS.[17] As an 
alternative to MAMS, cells may be randomly seeded on a substrate, greatly relaxing fabrication 
requirements at the expense of a necessarily gentle sample extraction. Ong et al. presented such 
an approach, by locating single cells on an indium tin oxide (ITO)-coated glass slide based on 
their position in a whole-slide fluorescence microscopy image.[18] A challenge with this initial 
report was the complex scheme for generating custom geometry files, which required manual 
interaction through several disjointed pieces of software. To facilitate broader adoption of 
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optically-guided single cell profiling, we sought to streamline the process of directing MS 
acquisition with whole-slide microscopy images. As reported by Jansson et al., the first iteration 
utilized a point-based similarity registration scheme, which improved target localization 
accuracy over the previously reported piece-wise linear transform.[19] User interaction was also 
simplified, allowing fluid interaction with microscope images through a graphical user interface 
(GUI). All functions required to begin acquiring single cell mass spectra on a Bruker 
ultrafleXtreme instrument were contained in the single piece of software. 
Here we present the first version of microMS to support microscopy-guided MS for a 
variety of image files and mass spectrometers. The software architecture permits new 
microprobe instruments to be supported with minor modifications to the source code. Virtually 
any spatially restricted sampling probe capable of precisely recording and moving to a given 
location can perform such profiling.  
First, the unique features of microMS are described along with the necessary 
modifications to expand device support for both commercial and customized instruments. We 
then illustrate an example of using microMS on three MS systems for off-line, targeted profiling 
of single cells from the mammalian nervous system. 
3.2 Materials and Methods 
Software microMS is written in python v3.5. In addition to base components, microMS 
requires the matplotlib, PyQt5, numpy, scipy, openslide, skimage, pyserial packages. Installation 
instructions, usage details and most recent source code may be found at 
github.com/troycomi/microms. 
The program structure is modeled in Supporting Information Figure S1, with a partial 
representation in Figure 1. The main GUI class is composed of two widgets in the GUICanvas 
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package for displaying a microscope image or population-level statistics as a histogram. Each 
widget interacts with a microMSModel object, which represents a single microscopy experiment 
(as a blobList and slideWrapper) and mass spectrometer (as a coordinateMapper).  
Targets in microMS are represented as objects called “blobs”, to generalize a biological 
cell as any object formed by a group of high intensity pixels. In Figure 3.2, there are three blobs; 
each with a unique Cartesian (x, y) location on the image, a corresponding effective radius, and 
circularity. The circularity is a ratio of the blob area to its perimeter squared, scaled between 0 
and 1, with 1 being a perfect circle, i.e. blobs 1 and 3 are single cells whereas blob 2 is not. A 
collection of blobs is stored in a blobList object, which also implements methods to query and 
filter a population of targets. 
A slideWrapper provides an object for interacting with a set of microscopy images 
representing brightfield and multiple fluorescence channel images. The current field of view is 
maintained to simplify controller interaction with the image. The ImageUtilities package also 
contains modules for cell finding, patterning target positions, and optimizing travel paths. 
Object models for MS instruments are contained in the coordinateMappers package, as 
shown in the model in Figure 3.1. The coordinateMapper is an abstract base class providing an 
interface which the GUI software utilizes to interact with different instrument systems. The core 
functionality of the mapper is to align pixel positions with physical coordinates and provide a 
means to translate target positions on an image to instrument-specific directions. The design of 
the software architecture simplifies the addition of new instruments. Integration of ambient 
ionization methods, including the single-probe[20-21] or nanoDESI[22] are enticing candidates as 
they have demonstrated single cell sensitivities in imaging and profiling applications. Currently, 
four concrete implementations are supplied in the CoordianteMappers package: a Bruker 
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UltrafleXtreme, a Bruker SolariX, the AB Sciex oMALDI sample stage attached to a custom 
hybrid MALDI/C60
+-SIMS, and a lab-built 3-axis liquid microjunction probe. Details about the 
implementations will be discussed in the next section. Demonstrations for the addition of new 
instruments to microMS may be found in the user manual packaged with the source code. 
Single cell dissociation.  
All chemicals were purchased from Sigma Aldrich (St. Louis, MO) and used without 
further purification. Two, 2-2.5-month-old male Sprague Dawley outbred rats (Rattus 
norvegicus) (www.envigo.com) were housed on a 12-h light cycle and fed ad libitum. Animal 
euthanasia was performed in accordance with the appropriate institutional animal care guidelines 
(the Illinois Institutional Animal Care and Use Committee), and in full compliance with federal 
guidelines for the humane care and treatment of animals. Dissected cerebellum and 
suprachiasmatic nucleus (SCN) tissues were incubated in a solution of 1% Hoechst 33342 in 
oxygenated modified Gey’s balanced salt solution (mGBSS) for 30 minutes at 37°C. The 
mGBSS solution was removed and the tissues were incubated in an oxygenated solution of 6 
units of papain, 1 mM L-cysteine, and 0.5 mM ethylenediaminetetraacetic acid for 80 minutes at 
37°C. Tissue was then mechanically dissociated in mGBSS with 0.04% paraformaldehyde. A 
solution of 80% glycerol in mGBSS was added to a final concentration of 40% glycerol. The cell 
suspension was then transferred onto ITO-coated glass slides (Delta Technologies, Loveland, 
CO) with at least 12 fiducial marks etched by a diamond-tipped pen. 
Microscopy Imaging.  
Brightfield and fluorescence images were acquired on a Zeiss Axio Imager M2 (Zeiss, 
Jena, Germany) equipped with an Ab cam Icc5 camera, X-CITE Series 120 Q mercury lamp 
(Lumen Dynamics, Mississauga, Canada), and a HAL 100 halogen illuminator (Zeiss, Jena, 
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Germany). The 31000v2 DAPI filter set was used for fluorescence excitation. The images were 
acquired in mosaic mode with a 10x objective and 13% overlap. Images were processed and 
exported as tiff files using ZEN software version 2 blue edition (Zeiss, Jena, Germany).  
Sample Preparation.  
Slides were coated with 50 mg/mL 2,5-dihydroxybenzoic acid (DHB) dissolved in 1:1 
(v/v) LC-grade ethanol:water with 0.1% trifluoroacetic acid with an automatic sprayer described 
previously.[19,23] The matrix solution was supplied at 10 mL/hr and nebulized with N2 gas at 50 
psi over 100 passes. Samples were affixed to a rotating plate with the nebulizer positioned 1.5 
cm above the samples, resulting in a MALDI matrix thickness of ~0.1-0.2 mg/cm2. 
Instrument Parameters.  
Single cell analysis was performed on three instruments. The UltrafleXtreme mass 
spectrometer (Bruker Daltonics, Billerica, MA) was set with a mass window of m/z 400-3000. 
The “Ultra” (~100 mm footprint) laser setting was used with 300 laser shots at 1000 Hz for each 
cell to generate a matrix assisted laser desorption/ionization (MALDI)-TOF spectrum at each 
cell. The second instrument is a 7T SolariX FT-ICR mass spectrometer (Bruker Daltonics, 
Billerica, MA), operated with a mass window of m/z 150-3000, yielding a 4 Mword time-domain 
transient. Spectra were calibrated to the phosphatidylcholine headgroup at m/z 184.07332. 
Adsorption mode was used to effectively double the mass resolving power. Each MALDI 
spectrum was acquired with 20 laser shots at 1000 Hz and 60% laser energy. The laser setting 
produced a ~100 mm footprint. The last instrument is a custom hybrid MALDI/C60
+ Q-TOF mass 
spectrometer, described in detail elsewhere.[11] The C60
+ ion beam was utilized for secondary ion 
mass spectrometry (SIMS), with the mass analyzer operated in positive mode with a mass range 
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of m/z 60-850. Correctly parsing the spectra requires additional instrument modifications and 
data analysis routines, described elsewhere.[24]  
3.3 Results and Discussion 
Instrument support in microMS. 
Bruker instruments are discussed first as their MALDI sample stages and coordinate 
mappers are similar. The commonality is exploited by the brukerMapper abstract base class, 
which is a derived class of coordinateMapper. BrukerMapper implements methods for reading 
and writing xeo geometry files, which are required in Bruker software for automatic acquisition. 
The brukerMapper class also defines an intermediate coordinate system between physical, motor 
coordinates and the fractional distances used in xeo files. The classes derived from 
brukerMapper require a limited set of concrete method implementations to be fully functional as 
many features are supported in the bases class. The simplest case is ultraflexMapper, for the 
Bruker ultrafleXtreme instrument, which defines the required methods to parse user input.  
The solarixMapper class for a Bruker SolariX instrument is similar to the 
ultraflexMapper class with three minor modifications: 1) the xeo files are limited to 400 
positions, 2) an xlsx Excel file is also required for automatic acquisition, and 3) input coordinates 
are read directly from the system clipboard. The flexImagingSolarix object extends 
solarixMapper and overrides the saved file format for import in flexImaging software. These two 
instruments provide examples of supporting microscopy-guided MS on Bruker MALDI sources. 
Instruments from other vendors inherit directly from the coordinateMapper. One example 
is the oMALDIMapper for interfacing with an AB Sciex oMALDI server. With this instrument, 
the sample positions are encoded in ptn pattern files which contain an x,y coordinate relative to 
the starting position with calibrated motor steps. Hence, in comparison to brukerMapper, 
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oMALDIMapper transforms motor coordinates to ptn coordinates instead of fractional distances.  
To further simplify correlation of mass spectra to image coordinates, a corresponding text file is 
also exported with pixel positions of each target. As a final consideration, the sample stage was 
found to have significant motor slop upon changing direction. The motor slop is corrected before 
exporting the ptn file to ensure accurate targeting.  
In the preceding examples, microscopy images are correlated with physical positions on a 
mass spectrometer sample stage to generate instrument-specific target coordinates. This off-line 
workflow is ideal for instruments lacking support for external control of the sample stage, as is 
usually the case. To demonstrate capabilities with on-line analysis and instrument control, 
additional interfaces were developed for controlling Zaber linear actuators. The zaberMapper 
class contains a simple implementation of the abstract base class coordinateMapper. It also has 
an instance variable connectedInstrument, which is used by microMS to interact with the sample 
stage. Another abstract base class, connectedInstrument specifies the method signatures 
necessary for a connected instrument. The concrete implementation provided is a system with 
three linear actuator stages, zaber3axis. This module inherits from zaberInterface, containing 
serial wrappers to simplify interaction with each stage, and implements the connectedInstrument 
interface. In addition to reading the current, physical position for coordinate registration, the user 
directs stage movement on the optical image or with key strokes.  
microMS functionalities.  
General features of microMS include locating targets, filtering the target population, 
patterning each target, and coordinating the image with the physical location of a mass 
spectrometer stage. Only the last step is instrument specific. Users should refer to the User Guide 
in Supporting Information for a comprehensive illustration of these functionalities.  
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  (a) Locating targets. Targets may be specified on the microscope image either by 
manually selecting locations or by performing automatic blob finding. In the former approach, 
targets are added via holding the “shift” key and left mouse clicking on the center of the feature 
of interest. This generates a blob of default radius and circularity of 1. A custom radius is 
specified by clicking and dragging from the circumference to the center of the feature. 
In automatic blob finding, the search takes place over the entire image area unless a 
region of interest (ROI) is specified. ROIs are defined by clicking and dragging a rectangular 
area or drawing the region a vertex at a time. The blob finding algorithm thresholds the specified 
image color and then groups together pixels above that threshold, as shown in Figure 2B. Each 
group is then evaluated for its size and circularity. Putative blobs falling outside the user-
specified parameters are discarded. Several features are available to assist with selection of 
suitable blob finding parameters. Different blob finding parameters are interactively tested on the 
current image field of view. Additionally, microMS reports pixel intensities, object size and 
circularity of positions selected with a middle mouse button click. Judicious selection of these 
parameters will find most cells while excluding imaging and background artifacts. 
After the targets are located, their properties are stored as lists within microMS. Up to ten 
separate target lists are maintained and each list is displayed as a different color. New target sets 
generated by filtering or patterning are automatically stored in an empty list with the original 
target set left intact. 
(b) Filtering targets. Frequently, it is beneficial to filter the target list, either to refine 
putative blobs or to stratify targets based on morphology. Basic filtering methods provided by 
microMS are selected through the menu bar which include ROI filtering and distance filtering. 
Within a specific ROI, the blobs can be selectively removed or exclusively retained in a new 
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target list. ROI filtering is especially useful for removing targets which are near fiducials or 
potentially contaminated by substrate background. Distance filtering helps to ensure each MS 
target position will correspond to a unique object (e.g. a single cell). An appropriate value for 
distance filtering is chosen based on the microprobe size, target accuracy, and the desired 
number of samples per blob. For example, a 100 µm diameter probe on a system with 50 µm 
target accuracy would require distance filtering of at least 100 µm to minimize the chance of 
sampling a nearby blob. During distance filtering, any target with a neighbor closer than the 
specified value is removed from the blob list.  
In addition to common filtering functions, microMS supports interactive examination of 
population-level statistics through the histogram window to partition the target list (Figure 3.3). 
Metrics include blob size, circularity, nearest neighbor distance, and fluorescence intensity. Note 
that there is some redundancy between histogram filtering and blob finding. The overlap permits 
the selection of lenient blob finding parameters to exhaustively identify all putative cells which 
are then refined to the final target set. Such a scheme allows distance filtering to identify all 
possible contaminating objects and sub-classification based on size. 
High and low pass filters of the targets may be defined on the histogram window. Targets 
falling within a filter range are dynamically displayed on the microscope image in the 
corresponding color (Figure 3.3B-C). Selecting a blob in the microscope image highlights its 
value on the histogram to assist with defining filter limits. High and low pass filters define new 
target lists that may be further refined by additional histogram operations. This function allows 
operations such as filtering a population based on size followed by selection of targets with a 
particular fluorescent stain. More routinely, the histogram provides a simple method to identify 
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and remove artifacts from blob finding. Figure 3.3C shows an example of isolating unresolved 
cells, which helps ensure data quality. 
(c) Patterning targets. By default, microMS generates one acquisition target per blob. 
Single target sampling is sufficient when the microprobe size is similar to or larger than the 
target object. However, when the object is larger than the probe, a single acquisition is 
insufficient to robustly sample heterogeneous objects. Alternatively, MSI of each blob can be 
acquired at each target location. To address advanced sampling requirements, microMS provides 
three sample patterning schemes.  
The first option is a rectangular packed array of points centered on the target. Users select 
a raster spacing and number of layers to define the overall size of the image. Alternatively, the 
size is dynamically adjusted to the target radius to ensure complete sampling of heterogeneously 
sized populations. The resulting data is directly interpretable as an MS image with common MSI 
software. 
Similar to rectangular packing is the hexagonal close packing pattern. With a circular 
desorption probe, the hexagonal packing provides denser sampling of the target. Users define the 
target separation, number of layers, and specify dynamic layering. While hexagonally packed 
data are more difficult to reconstruct into an image, averaging the spectra yields a representative 
spectrum for the blob. 
Finally, the circular pattern generates targets around the circumference of each blob. In 
some cases, analyzing the center of a blob produces low sensitivity due to the morphology of the 
target or the biological nature of the samples. Instead, targets are placed immediately outside of a 
blob to acquire representative spectra. For circular patterning, the user defines a minimum target-
to-target distance, maximum number of targets, and offset from the circumference. The actual 
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number of targets around a blob is determined by the blob size and the specified offset while 
maintaining the target-to-target distance above the minimum limit. Targets are then equally 
spaced around the blob. Averaging the resulting data provides a characteristic spectrum of the 
area directly surrounding each blob. 
(d) Coordinate transformation to instrument systems. Once all targets are determined, the 
pixel positions must be translated into the physical coordinates of a mass spectrometer or similar 
platform. Image correlation in microMS is accomplished through a point-based similarity 
registration. In point-based registration, the target localization error scales inversely with the 
square root of the number of fiducial points. As such, while microMS supports arbitrary numbers 
of fiducials, at least 12 fiducials are recommended for robust coordinate training. Similarity 
transformations do not correct for shearing of images, so the field of view must remain normal to 
the sample surface during image acquisition and MS analysis. 
  Generally, a fiducial is located in the microscope image and the instrument system with 
the assistance of an integrated video camera. When the microprobe is positioned over the center 
of a fiducial mark, the same location is selected on the image in microMS with a right mouse 
click. This opens a popup window requesting the physical x, y position. A default x, y position is 
displayed in the popup which directly reads the stage position, pastes text from the computer 
clipboard, or predicts the closest location, depending on the selected instrument. 
Fiducials are displayed on the microscope image as blue circles with labels corresponding 
to the nearest set position on the instrument, as shown in the schematic of Figure 3.4. A few 
feedback features are included to help the user assess the quality of the current registration. If 
applicable, labels display set points of the instrument coordinate system. The labels shown in 
Figure 3.4B correspond to a Bruker MTP slide II adapter. For some instruments, a set of 
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preprogrammed positions are displayed, showing the predicted location of those points on the 
microscope image. A large deviation, typically due to an inaccurate input will be detected by a 
discrepancy in the expected and displayed label. Finally, the fiducial with the worst fiducial 
localization error is highlighted in red, indicating that specific position assignment should be 
reconsidered. Correcting the problematic fiducial will cause the next worst fiducial to be 
highlighted. Once the same fiducial stays highlighted, the registration is close to optimal. 
Adjusting the worst fiducial is good practice to produce accurate targets. 
With a full set of fiducials, the target positions may be saved in instrument-specific 
format for offline analysis. Alternatively, microMS can communicate directly with an instrument 
to instruct it to move and perform an analysis. Due to limited vendor support, direct instrument 
control is demonstrated on a lab-built stage.  
The current microMS distribution supports the Bruker ultrafleXtreme, Bruker solariX, 
AB Sciex oMALDI server, and a lab-built liquid microjunction extraction stage. For the 
supported MS systems, the user registers fiducials and saves instrument positions without 
modifications. Furthermore, microMS has ample room for customization due to the abstract base 
class construction of the CoordinateMappers package. The general framework remains 
unchanged, but there are opportunities to tune each function to a specific application. Examples 
include the ability to directly read fiducial positions from an instrument, grab the contents of the 
computer clipboard, and perform stage movement slop correction.  
Accuracy of point-based similarity registration.  
A vital metric for optically guided profiling is the target localization error. An accurate 
transformation between optical image and physical location ensures that each sample 
corresponds to the position of interest. microMS allows training sets of arbitrary sizes. Including 
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more fiducials reduces target localization error, effectively distributing uncertainty of a given 
fiducial over the entire transformation. Several factors influence accuracy including the precision 
of stage movement, fiducial localization accuracy (in both image and physical coordinate 
systems), number of fiducials, whole-slide image stitching, and proper sample positioning during 
image and MS acquisition. Users should carefully consider these factors to establish adequate 
probe size and distance cutoffs prior to data acquisition. To assess the accuracy of an MS system 
with microMS, an image based method was developed to link the requested and actual target 
positions, as shown in Figure 3.5. The target localization error is defined as the Euclidean 
distance between a requested position and the actual, transformed position during coordinate 
registration and is synonymous with accuracy. To assess this value, a thin layer of DHB matrix 
was coated on an ITO glass slide to act as a tracer for the probe position. A standard sample was 
prepared with 16-24 fiducials along the exterior of a target. An additional set of fiducials were 
included within this region to mimic the location of samples in a profiling experiment. The 
interior marks were not used for coordinate registration, but rather to assist with overlaying the 
pre- and post-analysis images. Several target locations were manually placed around each 
interior fiducial. Dividing the targets between multiple trials is useful for designing experiments 
to test the effect of possible confounding variables.  
Next, fiducial training was performed with the MS system and the set of targets was 
desorbed with sufficient time to noticeably remove the DHB matrix. After desorption, the target 
area was optically imaged again to reveal the actual position of sampling events. Desorption 
locations and sizes are marked as blobs in microMS and saved for further analysis. To overlay 
the two images, subsets of the pre- and post-desorption image were cropped and roughly 
positioned prior to intensity-based registration with custom scripts in MATLAB (R2015b). The 
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resulting transformation was used to map the target pixel positions onto the post-extraction 
image. The distance between the requested and actual desorption positions is a direct 
measurement of the target localization error. With this method, the target localization of the 
Bruker ultrafleXtreme was found to be 38.3 ± 3.9 µm (mean ± S.E.M, n = 71, Figure 3.5), while 
the liquid microjunction extraction stage accuracy is 42.8 ± 2.3 µm (n = 48; data not shown) over 
an area of approximately half a microscope slide, an error of about one part per thousand. As 
previously mentioned, the probe radius should be as large as the target localization error and the 
distance filter applied should be larger than the sum of this error and the probe radius.  
In experiments to assess the effect of various confounding factors on target accuracy, 
desorption was repeated multiple times with the same sample and slide image. Different laser 
spot sizes, users, target locations and fiducial training sets were examined. The only significant 
factor found was the fiducial training set (Figure 3.5D).  Overall accuracy is not dependent on 
the target location (Figure 3.5E), laser spot size or user (data not shown). Within an experiment, 
the accuracy is fairly constant, independent of the user or location on the sample. However, 
repeating an experiment with the same sample could produce significantly different accuracy. 
This result confirms the profound effect of quality fiducial training sets on the target accuracy. 
Extreme care is required when training fiducials to ensure the image target locations correspond 
to the expected mass spectra. 
A demonstration: Sequential analysis of the same target.  
For single cell profiling experiments, the physical location of a cell on the slide 
effectively isolates it from neighbors and prevents mixing, which greatly simplifies data fusion. 
microMS provides a utility for performing sequential analysis of the same target on different 
instruments with ease. Using the optical image as a map to record each target address, the image 
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position can be transformed into any supported instrument coordinate system. A careful selection 
of the order of experiments facilitates the repeated analysis of a sample to provide 
complementary chemical information. 
Figure 6 shows two examples of sequential single cell profiling using MS instruments 
with different capabilities. In panel A, dispersed, rat cerebellum cells were initially profiled with 
a Bruker ultrafleXtreme to rapidly assess the lipid content with moderate resolution and mass 
accuracy. From the initial mass spectral dataset, cells without significant lipid signals are 
discarded from further consideration as they likely represent artifacts from optical imaging or 
sample preparation such as dust particles. The resulting population is then selected for follow-up, 
high resolution, high mass accuracy analysis with a Bruker solariX FT-ICR. Due to the increased 
sample acquisition time, exhaustive analysis of large populations is cost-prohibitive. Performing 
a preliminary filtering maximizes the efficiency of subsequent data analysis, without consuming 
the entire cellular content. 
While the overall lipid profiles are similar, there are some discrepancies between lipid 
ratios of the two methods. This could represent changes in the sample layers that each technique 
is analyzing. Nonetheless, the advantage of single cell FT-ICR is immediately apparent with the 
ppm mass accuracy and over an order of magnitude higher mass resolution, shown in each inset 
for putative [PC(32:0)+H]+. Once the MALDI-TOF has identified cells with abundant lipid 
signal, they are filtered to locate individuals requiring exact mass measurement for elemental 
composition analysis. Such a workflow facilitates exhaustive cell population analysis while 
efficiently utilizing the FT-ICR as needed. 
As a second example, Figure 3.6B displays a C60
+-SIMS mass spectrum and the 
corresponding MALDI-TOF mass spectrum of a single cell derived from the rat suprachiasmatic 
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nucleus. Here, the low sample consumption of SIMS was leveraged by follow-up MALDI-TOF 
to provide more, complementary information than would be possible with either technique alone. 
In the low mass range, peaks corresponding to phosphatidylcholine headgroup and a cholesterol 
fragment are apparent in the SIMS spectrum at m/z 184.09 and 369.31 respectively. MALDI-
TOF demonstrates better sensitivity to intact lipids and detects lipid dimers and peptides. 
Comparing the identity of lipids over the same range, SIMS appears to favor sodiated adducts 
([PC(32:0)+Na]+ and [PC(34:1)+Na]+ at m/z 756.47 and 782.55 respectively) more than the 
protonated forms seen in MALDI-TOF ([PC(32:0)+H]+ and [PC(34:1)+H]+ at m/z 734.54 and 
760.55 respectively). These relative intensities likely reflect the different ionization processes 
occurring in each instrument. Together, a wide mass range is covered to provide a more 
complete profile of the sample.  
These examples may represent the first demonstration of multiple MS platforms 
measuring the same individual cells with high throughput. In each example, the ability to 
repeatedly analyze the same cell was leveraged to acquire complementary information from 
multiple instruments. Such an experiment would be difficult to perform at high throughput 
without linking the target locations by the optical image of each sample. With microMS, 
sequential analysis is facile, enabling each cell to be exhaustively characterized by multiple 
techniques. 
3.4 Conclusions and Future Directions 
microMS is the first generation of an open source python package for robust image 
analysis and coordinate registration, which are essential for optically-guided MS profiling. 
microMS provides a rich feature set for image analysis suited for optically-guided MS profiling. 
Targets may be automatically located, filtered, stratified and patterned prior to MS analysis. 
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These functions provide access to single cell profiling with multichannel fluorescence image 
analysis. The unique aspect of microMS is how mass spectrometers are represented for MS 
profiling. The implementation of specific MS systems through an abstract base class and 
software architecture provides a straightforward means for adapting microMS to arbitrary 
microprobe instruments. While this simplifies connecting microMS to new systems, it also 
facilitates sequential analysis of the same target by uniquely addressing each cell coordinate. We 
believe the rich feature set and ease of extending microMS to a variety of mass spectrometers 
and other instruments will facilitate the growth of single cell profiling. 
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Figure 3.1 Partial unified modeling language diagram of microMS class structure. Each 
experiment is contained in a microMSModel object, consisting of a list of targets (blobList), a 
microscopy image (slideWrapper), and an instrument mapper (coordinateMapper). 
CoordianteMapper defines the set of instructions required for each inheriting class. Four concrete 
instrument implementations are provided with microMS. 
 




Figure 3.2 Overview of blob finding with microMS. From an input image (A), the pixel intensity 
is filtered by a threshold intensity. B) Pixels above the threshold are grouped with neighboring 
pixels to generate putative blobs. Each group of pixels is evaluated for its size (in pixels) and 
circularity. The area (A) and perimeter (P) are directly measured from the threshold image. 
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Figure 3.3 Population-level filtering through the histogram window. A) A population of found 
blobs may be filtered by size, circularity, minimum pairwise distance, or fluorescence intensity. 
The histogram can be divided into a low pass, high pass, or single interval with the appropriate 
blobs dynamically colored in the microscope image (B and C).  
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Figure 3.4 Schematic of fiducial training. A) The input image includes several fiducial points, 
such as etched x marks on the glass slide. B) An initial attempt at registration with labels of the 
nearest named coordinate for each fiducial. Fiducials are shown in blue, except the point with the 
worst fiducial localization error, which is in red. A set of predicted locations in yellow are also 
be displayed. C) After removing and retraining the worst fiducial the next worst fiducial is 
dynamically highlighted. 
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Figure 3.5 Determination of target localization error. A) Target locations (green) are marked 
around an image of an etched x mark. The sample is then coated with a thin layer of MALDI 
matrix and analyzed by optically-guided MS to generate desorption craters in the matrix. B) The 
location of resulting desorption events (red) are determined by optical microscopy. C) Image 
registration of panels A and B allows the direct mapping of requested target locations onto the 
desorption marks.  Overlap is shown in yellow. The distance between these positions is the target 
localization error of the registration set. The effect of various parameters may be assessed 
simultaneously including multiple training sets, location on slide, or size of microprobe, as 
shown here. A three-way linear ANOVA demonstrated that while the specific fiducial training 
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Figure 3.5 (cont.) set significantly affected accuracy (p << 0.05), the location on the slide (p = 
0.6) and spot size (p = 0.3) did not. 




Figure 3.6 Sequential analysis of the same cell with two separate MS systems. Once a cell has 
been located in the optical image (top), its location remains fixed through multiple analyses 
allowing two instruments to probe the same set of selected cells. A) MALDI-TOF MS (middle) 
of a cerebellum-derived cell followed by MALDI-FT-ICR MS (bottom). MALDI-TOF provides 
high throughput screening of thousands of cells to highlight rare or representative individuals. 
Here, FT-ICR provides high mass resolution and high mass accuracy for unequivocal elemental 
composition of selected cellular contents. B) SIMS profiling (middle) followed by MALDI-TOF 
MS (bottom) with a DHB-coated, suprachiasmatic nucleus derived cell. SIMS provides  
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Figure 3.6 (cont.) information on small molecule compounds while MALDI-TOF MS 
effectively detects larger species, such as lipid dimers and peptides. The inset demonstrates some 
overlap of intact lipid coverage from each modality.  
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CHAPTER 4 
OPTICALLY GUIDED SINGLE CELL MASS SPECTROMETRY OF RAT DRG TO PROFILE 
LIPIDS, PEPTIDES AND PROTEINS 
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4.1 Introduction 
Dorsal root ganglia (DRG) consist of neuronal cell bodies, myelinated and non-
myelinated axons (here termed neurites), cells related to vasculature and blood, immune cells, as 
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well as several types of glia, including satellite cells. DRG are vital for conveying sensory 
information from the periphery to the spinal cord and brain stem as part of the peripheral 
sensory-motor system in mammals.[1,2] Because DRG integrate and discriminate diverse types of 
sensory inputs, such as proprioception and nociception, efforts to identify and characterize the 
cell types dedicated to relaying specific kinds of sensory information are critical for 
understanding fundamental mechanisms of the sensory-motor system. In general, DRG cell 
populations can be stratified by their anatomy, morphology, and electrophysiology, and also via 
a range of intracellular markers, from patterns of gene expression to proteome, peptidome, 
lipidome, and metabolome heterogeneity. In 1978,  Fields et al.[3] utilized cell surface markers to 
classify DRG cellular populations into four cell types: neurons, Schwann cells, fibroblasts, and 
unidentified flat cells. McMahon and Priestley[1,4] divided DRG cells into a minimum of three 
major subclasses based on size and neurochemical content, consisting of small cells 
(predominantly nociceptors,[2] 10–30 µm) having unmyelinated axons that either (a) express 
calcitonin gene-related peptide (CGRP) or (b) bind to the lectin Griffonia simplicifolia IB4, and 
(c) larger cells (25–60 µm in diameter) having high levels of neurofilaments and myelinated 
axons. The three populations overlap (as some cells belong to multiple groups), suggesting the 
presence of additional cellular subpopulations. Recently, multiple research groups have revealed 
more details about the molecular and functional diversity of DRG neurons with the application of 
single cell transcriptomics/RNA sequencing.[5-7] Notably, Usoskin et al.[7] performed single cell 
transcriptomics to identify 11 cell types in DRG, two of which were peptidergic. Our MS 
imaging study of DRG chemical profiles highlighted striking chemical complexity, including the 
presence of distinct morphologically defined spatio-chemical regions,[8] although at the level of 
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tissue sections. Here, we report label-free, multiplexed detection of endogenous lipids, peptides, 
and small proteins in populations of individual rat DRG cells.  
Single cell metabolomics and peptidomics aim to recognize the similarities and 
distinctions between individual cells by linking their chemical dynamic profiles to cellular fate, 
function, homeostatic balance, and other biological phenomena.[9-12] Among the bioanalytical 
techniques used in single cell metabolomic and peptidomic investigations, mass spectrometry 
(MS) is at the forefront, owing to its high analyte coverage, low limits of detection (LOD), 
versatile analyte sampling methods, and unique ability to be coupled with in situ or off-line 
orthogonal characterizations.[9, 11-20] MS imaging (MSI) focuses on direct analysis of tissue 
sections to determine the relative abundance and spatial distribution of analytes in tissue 
sections.[11, 21-25] In addition, multimodal MSI approaches have facilitated detection of diverse 
analyte classes from the same samples by utilizing different matrices and sequential tissue 
imaging.[26] Single cell chemical imaging remains relatively specialized due to the limited 
number of MS technologies capable of routinely providing micron resolution;[25, 27-33] 
discriminating a typical mammalian cell within an intact tissue slice requires the footprint of the 
MS probe to be less than 3 µm.[32] To circumvent the challenges of cellular and sub-cellular 
imaging, several MS-based approaches have been developed. Low density populations of 
individual cells produced by enzymatic dissociation of different tissues can be deposited on a 
substrate and processed for MS analysis, significantly reducing cell-to-cell cross contamination, 
even when using microprobes exceeding cell sizes, albeit at the expense of native tissue context. 
Populations of individual cells are suitable for subsequent high-throughput MS analysis enabled 
by fabricated microwell devices[34, 35] and optical imaging.[20, 36-39] Recently, we demonstrated a 
unique optically guided single cell MS approach to profile hundreds to thousands of cells from 
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different tissues and organs in a single experiment using both secondary ion MS (SIMS)[38] and 
matrix-assisted laser desorption / ionization (MALDI) MS.[37, 39, 40]  
In the current work, we performed mass spectral classification of cell types from 
sequential MALDI MS analyses of the same cells, revealing heterogeneity in peptides and small 
proteins. The majority of the detected peptides were tentatively identified in a prior peptidomic 
study using liquid chromatography (LC) coupled with electrospray ionization (ESI) Fourier 
transform-ion cyclotron resonance (FT-ICR) MS and tandem MS (MS/MS), in combination with 
direct tissue analysis using MALDI-TOF MS.[41] Previously unreported signals that appear to be 
peptides were detected from a rare cell type.  
4.2 Experimental Section 
Chemicals and Matrix Preparation 
All chemicals except where stated otherwise were purchased from MilliporeSigma (St. 
Louis, MO) and used without further purification. DHB matrix solution was prepared by 
dissolving DHB (99% purity) to 50 mg/mL in 1:1 (v/v) LC-grade ethanol/water and 0.1% 
trifluoroacetic acid (TFA) solvent. 
Sample Preparation 
Single cell samples and tissue extracts were prepared from a total of three 2.5–3 month-
old male Sprague-Dawley outbred rats (Rattus norvegicus) (www.envigo.com). The animals 
were housed on a 12-h light cycle and fed ad libitum. Animal euthanasia was performed in 
accordance with the appropriate institutional animal care guidelines (the Illinois Institutional 
Animal Care and Use Committee), and in full compliance with federal guidelines for the humane 
care and treatment of animals. The studies were planned in accordance with the ARRIVE 
guidelines.[60] Rats were killed by quick decapitation using a sharp guillotine. Rat trunks were 
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placed on ice, where all surgical procedures were performed. Ten to twenty DRG per animal 
were surgically isolated during the ~10-min dissection procedure and placed into ~5 mL of cold 
modified Gey’s balanced salt solution (mGBSS) containing (in mM): 1.5 CaCl2, 4.9 KCl, 0.2 
KH2PO4, 11 MgCl2, 0.3 MgSO4, 138 NaCl, 27.7 NaHCO3, 0.8 Na2HPO4, 25 HEPES, and 10 
glucose, pH 7.2. 
Single cell dissociation.  
The DRG were incubated in 300 µL of 0.25% collagenase P in oxygenated Hank’s 
balance salt solution (HBSS) for 90 min to remove the surrounding connective tissue and isolate 
individual neurons. The sample was then centrifuged at 11,000 rpm for 3 min and the 
supernatant removed. The resulting pellet was washed with 500 µL HBSS. Next, the DRG pellet 
was treated with 500 µL of 0.25% trypsin in HBSS for 20 min, followed by centrifugation at 
11,000 rpm to remove the supernatant. Finally, the DRG pellet was placed in 300 µL of 1% fetal 
bovine serum (FBS) in HBSS containing 33 µg/mL Hoechst 33342 nuclear stain (Thermo Fisher 
Scientific, Waltham, MA; 10 µL of 1 mg/mL stock solution). Following a 20-min incubation, 
DRG were mechanically dissociated by trituration. Cells were stabilized using an equal volume 
(300 µL) of a mixture of 80% glycerol, 20% mGBSS (v/v), and after 5–10 min, plated on ITO-
coated glass slides (25 mm × 75 mm). The samples were then stored at room temperature, in the 
dark overnight, to allow the cells to adhere onto the ITO-glass surface. Excess glycerol-
containing media was removed from the preparations shortly before analysis and the entire 
substrate was washed with 1 mL of 150 mM ammonium acetate (pH = 10). This wash removes 
excess glycerol and does not induce observable damage to the cells.[37-40] Optical images of the 
substrate and cell populations were obtained, followed by matrix application and MS analysis. 
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All steps following washing were performed on the same day to prevent sample degradation and 
are detailed below.   
Samples from each animal were treated in separate Eppendorf tubes (1.5 mL) and divided 
across a total of four ITO-slides; each slide contained cells from every animal in discrete 
locations to assess possible batch effects.  
Tissue extraction. 
 Isolated DRG were transferred into 1 mL of aqueous salt solution containing 0.15 M 
NaCl, 1 mM CaCl2, 1 mM HEPES for 4 h at 4 
oC. The sample was then centrifuged at 6000 rpm 
for 1 h and the supernatant collected. The supernatant was salted out with dry (NH4)2SO4 in the 
presence of 0.01 M EDTA and stored for three days at 4oC. The obtained solution was then 
centrifuged at 11,000 rpm for 1 h and the supernatant was separated from the pellet. The 
supernatant was desalted by solid phase extraction using a Discovery DSC-18 52603-U tube 
(MilliporeSigma). The resulting samples were aliquoted and freeze dried using a miVac Duo-
Concentrator (GeneVac, Ipswich, UK]). 
Optical Imaging and Determination of Sample Coordinates for Individual Cells 
Each dispersed cell population on an ITO-coated glass slide was imaged using an Axio 
Imager M2 (Carl Zeiss, Oberkochen, Germany) in fluorescence and brightfield modes. An X-
CITE 120 mercury lamp (Lumen Dynamics, Mississauga, Canada) and a 31000v2 DAPI filter 
set (Chroma Technology, Irvine, CA) were employed for fluorescence imaging. A 10× objective 
was used to obtain a mosaic image of the targeted surface with 13% overlap between 
neighboring images. Images were taken using an AxioCam ICC camera (Carl Zeiss) with a 
resolution of 1936 × 1460 pixels. The final image was loaded into the lab-built microMS 
software[56] (available at (http://neuroproteomics.scs.illinois.edu/microMS.htm) for either manual 
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or automatic cell finding. Individual cells (50–200 cells per animal in each replicate) were 
manually selected from whole slide microscope images. Each cell was selected based on both 
fluorescence and brightfield images. In some cases, if the fluorescent signal was faint, the cells 
were still selected if the brightfield image showed a well-defined cell shape. Fiducial marks were 
used to register the image coordinates to the x,y translation stage coordinate of the mass 
spectrometers via the microMS software.[56] On the basis of the registration, the cell coordinates 
were saved in a custom geometry file for the MALDI MS FlexControl software (Bruker, 
Billerica, MA) for mass spectral acquisition. 
Matrix Application 
ITO-coated glass slides with dispersed cells were affixed onto a rotating plate for 
automatic matrix application, as described elsewhere.[40] The distance between the spray tip and 
the rotating plate was 2 cm, with a nitrogen gas pressure of 50 psi. The solution flow rate was set 
to10 mL/h, resulting in a matrix coating of 15 mg/cm2, respectively.  
MS Measurements of Substance P Standards using CHCA and DHB 
Substance P standards were prepared by serial dilution of the stock solution (1 mg/mL in 
water) to the desired concentrations (100 pM to 1 fM). The matrices for triple-layer application 
were prepared followed a previous protocol by Li and co-workers.[61,62] The first layer was 
formed by pipetting 0.5 µL of 100 mM CHCA in 40/60 v/v methanol/acetone on a polished 
MALDI steel plate, and allowed to crystallize. The second layer was formed by adding 0.4 µL of 
saturated CHCA in 30/70 v/v methanol/water. After the second layer was crystallized, 1 µL of 
substance P standard was plated in the center of the matrix spot and allowed to dry. A gentle 
wash was then performed using 0.1% TFA in water for 15 s; the liquid was blown off with 
compressed air. For the DHB dried droplet approach, 1 µL of DHB matrix was plated on the 
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same substrate, immediately followed by 1 µL of substance P standard. The sample spot was 
allowed to crystallize before analysis. 
MS Instrumentation 
An ultrafleXtreme MALDI TOF/TOF mass spectrometer (Bruker) with a frequency 
tripled Nd:YAG solid state laser was used for cell analyte profiling using the optically guided 
approach. Single cell MALDI MS analysis was performed in two stages. In the first stage (LM 
analysis), the molecular mass scan window was set to m/z 400−6000 and the laser was operated 
in the “Ultra” mode, producing a ∼100-μm diameter footprint. Each spectrum obtained in TOF 
reflectron mode represents the summed signals acquired during 1,000 laser shots fired at 1 kHz. 
In the second stage (HM analysis), the molecular mass window was working in linear TOF 
mode. The mass range was set to m/z 4,000–20,000 and the laser was operated in the “Small” 
mode (~50 µm) footprint. The FlexControl AutoXecute feature was utilized with the custom 
geometry file as previously reported.[37-40] 
A 7T SolariX XR FT-ICR mass spectrometer (Bruker) equipped with a dual ESI/MALDI 
source and managed by the ftmsControl software (v. 2.1.0, Bruker) was used to measure the 
molecular masses of peptides in the tissue extracts at higher resolution. External linear 
calibration was performed using perfluoroheptanoic acid (PFHA) clusters prior to MALDI MS 
analysis. Spectra were acquired in a mass range from 500–15,000, yielding a transient length of 
2.4 s. Instrumental parameters of importance include a source funnel RF amplitude of 300 Vpp, 
TOF delay of 2.8 ms, accumulation hexapole of 1.4 MHz and 2000 Vpp, and ICR sweep 
excitation of 20%. Spectra were acquired with 150 laser shots using the small laser setting (~40-
µm footprint) at 50–80% laser power and a frequency of 1000 Hz. Data was recalibrated in 
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DataAnalysis (v. 4.4, Build 200.55.2969, Bruker) using internal quadratic calibration with PFHA 
clusters for accurate mass values.  
Data Analysis 
Acquired spectra were imported into MATLAB (MathWorks, Inc., Natick, MA). Spectral 
preprocessing consisted of baseline correction, noise-smoothing, normalization, and resampling 
to a bin width of 0.5 m/z. Mass spectra were normalized with the msnorm function in MATLAB 
to standardize the area under the curve to the group median. PCA was performed on all cells 
(both LM and HM) for m/z 400–6,000 (Figure 4.3) and 4,000–20,000, respectively. Peaks of 
highest variance for each range were selected for targeted spectral-type comparisons. Cells were 
considered to contain the m/z value if they exhibited a spectral peak with a S/N >3, otherwise the 
intensity for that m/z was set to 0 for successive analyses. The correlation heatmap was generated 
with all pairwise combinations of each peptide marker for all cells. The correlations, , were 
plotted as blue and red gradients for positive and negative correlations, respectively (  ≤ 0.05). 
Correlations not significantly different than 0 (  > 0.05) are represented as white, whereas the 
intensity of blue and red represents the magnitude of correlation between peptide markers. The 
correlation values were clustered by HCA using an unweighted average distance to produce 
groups of m/z values. Peptide markers possessing both a statistically significant positive 
correlation within the population and negative correlation (  ≤ 0.05) to those outside of the 
population were selected as representative peptide markers for A-type, B-type, and C-type cells. 
97   
 
4.3 Results and Discussion 
Optically Guided Single Cell MALDI MS of DRG Cell Populations for High-Throughput 
Profiling of Lipids and Peptides  
Single cells from enzymatically dissociated DRG from three animals were prepared 
following an established protocol.[37-40] The dissociated cells were placed onto four indium tin 
oxide (ITO)-coated conductive glass substrates in three separated regions marked for samples 
from individual animals (see Figure 4.1). Additional details can be found in the Experimental 
section. Each cell was sequentially interrogated twice with a Bruker ultrafleXtreme MALDI-
TOF/TOF mass spectrometer. The first set of measurements utilized a 100-µm laser spot size and 
MS acquisition in reflectron mode optimized for the m/z 400–6,000 mass range, referred to as 
low molecular (LM) mass analysis. These settings were used previously for single cell profiling 
of rat pituitary[37] and islets of Langerhans.[39, 40] Next, the same cells were individually re-
analyzed with a 50-µm laser spot size with MS acquisition in linear detection mode, optimized 
for higher molecular weight molecules (m/z 4,000–20,000), and referred to as high molecular 
(HM) mass analysis. The smaller beam size used for the HM analysis provides a higher laser 
fluence (at the same laser power and setting), which is necessary for desorbing and ionizing 
cellular analytes. To ensure that the same target spots/cells were assayed by both LM and HM 
analyses, the sample slide was not removed until both analyses were finished. 
Figure 4.2 shows representative mass spectra of single DRG cells randomly selected from 
the LM analysis, all of which contain peaks corresponding to lipid monomers, dimers, and 
occasionally, peaks of lipid trimers and some peptides. The average lipid profile of DRG cells 
obtained from MALDI MS is shown in Figure 4.2E, which includes predominantly 
phosphatidylcholines (PCs). The same class of lipids was also primarily observed in a single cell 
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SIMS profiling study using an ionic liquid matrix.[38] We acknowledge that several matrices and 
nanoparticles have been designed to improve the detection of low-abundance lipid classes.[42] 
However, since our goal was to detect lipids, peptides, and small proteins in the same cells, we 
used 2,5-dihydroxybenzoic acid (DHB) as the matrix. The signals with the most abundant 
intensities correspond to PC(34:1) at m/z 760.6, followed by PC(32:0) at m/z 734.6, and PC(36:1) 
at m/z 788.6. Similarly, lipid dimer peaks of homo- and heterodimers of PC(34:1) are among the 
most intense for the m/z 1200–1600 region, identified by accurate molecular masses and MS/MS 
data (see Supporting Information Figures S1 and S2). The MS/MS data were obtained by 
randomly ablating a sample surface region containing many cells or cell clusters. Of note, the 
signal intensity of the heterodimer of PC(36:1) with PC(34:1) is more abundant than that of the 
heterodimer of PC(32:0) with PC(34:1), although their monomer signal intensities have the 
opposite intensity relation. Many cells also show mass spectral peaks above m/z 2,000, as 
discussed below. 
MALDI MS Single Cell Profiling and FT-ICR MS on DRG Analyte Extracts Detects Peptides 
that Reflect DRG Cell Heterogeneity  
The single cell mass spectra obtained from our LM analysis were subjected to principal 
component analysis (PCA), as shown in Figure 4.3. The score plot (Figure 4.3A) shows overlap 
of data points acquired from cells isolated from different animals, demonstrating low batch-to-
batch variation. PC1 primarily separated cells based on differences in the intensity of lipid 
signals (68.8% of variation explained), partially reflecting methodological variation in cell 
targeting accuracy and cell morphology. The PC2 loading plot (Figure 4.3B) is populated with a 
series of mass spectral peaks tentatively assigned to peptides, but not lipids, based on their mass 
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range and isotopic distribution. We note that heterogeneity in matrix application and the overall 
weak intensities of these peaks lowers the precision of m/z measurements.  
As such, some of the m/z values derived from the average profile (Figure 4.3B), 
especially those at high masses, correspond to the average molecular masses rather than 
monoisotopic masses. For example, the mass spectral peak at m/z 4406 in Figure 4.3B has a 
monoisotopic mass of 4404. However, there is no signal with m/z 4404 detected in our prior LC-
MS peptidomics work on tissue extracts and releasates.[41] Il’ina et al.[43] identified a group of 
peptides in Wistar rat brain extract, referred to as membrane-tropic homeostatic tissue-specific 
bioregulators, including a peptide at m/z 4403; unfortunately, the primary sequence of the 
peptide was not reported, and so this remains unknown. High-mass resolution MALDI MS 
measurements of the extracts were performed using a Bruker SolariX FT-ICR mass 
spectrometer. Our results are summarized in Table 1, where the observed molecular masses are 
matched to the list of peptides from our previous report.[41]  
The FT-ICR MS results indicate that the isotopically resolved ion at m/z 4404.672 
corresponds to the averaged peak at m/z 4406 in the TOF MS measurements. The intensity of m/z 
4404.672 from the DRG extract was weak, preventing direct MS/MS sequencing. Accurate FT-
ICR MS data from this work, along with published information,[41] was used to support the 
identification of several other peptides observed in our single cell profiling experiments, 
including vimentin, thymosin beta isoforms, and neurofilaments, in which the peptides from the 
two latter classes of proteins were also detected in single cell measurements. Peptides derived 
from gamma-synuclein were also detected in the extracts, but were absent from the single cell 
data. Other mass spectral peaks detected in the single cell experiments were mass matched to the 
list of peptides detected in the prior LC-MS study[41]. Many of the peaks observed here are 
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consistent with signals of peptides derived from myelin protein P0 (m/z 1947, 2263, and 3989) 
and myelin basic protein S (m/z 4337). Myelin basic protein, the second most abundant protein in 
the central nervous system, is encoded in a large complex of oligodendrocyte lineage genes.[44] 
Previous studies have shown that myelin proteins are found predominantly in myelinating glial 
and immune cells. Several functions are attributed to myelin proteins, including maintaining the 
adhesion of the cytosolic surface of multilayered compact myelin, and interacting with 
polyanionic proteins such as actin, tubulin, Ca2+-calmodulin, etc.[44, 45] Adult Schwann cells, on 
the other hand, express negligible levels of myelin glycoprotein P0.[46] Vimentin is another 
protein that has been found to be abundant in satellite glial cells,[47-49] and in neurons at the early 
stage of development and following injury.[50-52] Other peptides (m/z 2141, 2920, 3015, and 
3093; see Table S1) are likely derived from neurofilament polypeptides found in DRG 
neurons.[53] Neurofilaments are involved in axonogenesis and neurite extension.[51, 52, 54] 
Approximately 40% of the rat lumbar DRG neurons are characterized by a high content of 
phosphorylated heavy-chain neurofilaments.[1, 53, 54]  
Dividing the cell population based on the PC2 score allows coarse classification of the 
cellular population. The mass spectra of cells found on the negative side of PC2 primarily 
contained peptide peaks in the m/z 2,000–3,000 region, without peaks at higher masses. These 
species, tentatively assigned to myelin and neurofilament proteins, were often detected together 
with signals from lipid trimers. One notable peak is m/z 2263, which falls within the lipid trimer 
mass range (~m/z 2,200–2,500). MS/MS was performed on m/z 2263 to deconvolve the possible 
contributions of lipid trimers having similar masses (±1 Da). The LIFT-TOF/TOF product-ion 
mass spectrum of m/z 2263 (±5 Da precursor mass selection window) obtained by random 
continuous acquisition of data from many cells and cell clusters yielded intense peaks 
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corresponding to lipids. The fragments are consistent with the precursor ions being a sodiated 
lipid trimer composed of a PC(34:1) dimer and another lipid with m/z 723.6 (neutral loss to 
produce a PC(34:1) dimer), for a theoretical m/z of 2264.72. Since it is not possible to isolate m/z 
2263.27 (tentatively, a myelin protein P0 fragment) from m/z 2264.72 (a lipid) with the 
TOF/TOF instrument used here, we cannot assign identity of m/z 2263 signal solely to a peptide 
fragment. However, the presence of several cells with intense peaks at m/z 2263 in the absence of 
any other lipid trimers suggests that another component is detectible and is unlikely to be a lipid 
trimer. 
Cells with positive PC2 scores predominantly contained higher mass peaks assigned to 
peptides derived from thymosin beta-4 (m/z 4716) and myelin basic protein S (m/z 4337). 
Previous immunohistochemical work showed that thymosin beta-4 is located in both the cell 
bodies and axons of neurons.[55] As mentioned above, peaks at m/z 4404 and 5487 did not match 
any entry in the peptide database generated by our prior LC-MS analysis of tissue extracts.[41] 
Overall, the PC2 loading plot and direct survey of individual mass spectra indicate the presence 
of heterogeneity in the cellular peptide content, including molecules related to myelin proteins 
(P0 and basic protein S), neurofilaments, thymosin beta-4, and the uncharacterized peptides at 
m/z 4404 and m/z 5487. 
An alternative explanation for the observed heterogeneity is that the differences in 
peptide content are due to experimental artifacts; i.e., the sensitivity of detection of high mass 
peptides is disproportionately affected by spatial cell targeting accuracy, MALDI matrix 
deposition and crystallization, cell size and/or instrument parameters/performance. To 
investigate this possibility, we examined individual DRG mass spectra and microscopy images to 
determine how the MS data correlate with morphological differences (Figure 4.4). The four 
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examined cells were from the same sample slide, and assayed in the same batch using identical 
instrument settings. In this case, similar targeting accuracy was achieved.[39, 56] Despite the 
similarity of the methodological parameters, all four cells displayed mass spectral heterogeneity. 
Furthermore, cells with mass spectra containing the same major peaks as those shown in Figure 
4.4 were reproducibly found in data sets across animals and batches. These spectra indicate that 
the observed qualitative differences reflect biological phenotypes rather than analytical 
uncertainties. Focusing on the representative cells, cell A (Figure 4.4A and 4.4E-row 1) is non-
circular with a diameter of 15 µm. Its mass spectrum shows intense lipid signals without any 
peaks above m/z 2,000, except m/z 2264 (myelin protein P0 or a lipid trimer). The size and 
mostly undetectable peptide content of cell A makes it a candidate for identification as a 
supporting cell, such as a glia. Cell B (Figure 4.4B and 4.4E-row 2) appears to have a nucleus 
that comprises most of its volume. Interestingly, the mass spectrum from cell B displays intense 
lipid signals, along with at least four major peaks at m/z 2031, 3777, 3989, and 4963. As 
discussed above, the peaks are tentatively assigned to vimentin, transitional endoplasmic 
reticulum ATPase (TER ATPase), myelin protein P0, and thymosin beta-4, respectively. Cells C 
and D display larger overall sizes with more distinct membrane boundaries, as seen in their 
brightfield images (Figure 4.4E, rows 3 and 4). The morphology of cell C is non-circular with 
two localized sites exhibiting intense Hoechst fluorescence. These images suggest either that cell 
C maintained a connection with a supporting cell (marked with a red circle), or that it was 
mechanically damaged during deposition and part of the nucleus detached from its cell body, 
evidenced by the faint nuclear stain in the cell body. Cell D is also large and presents diffuse 
nuclear fluorescence, which we observed regularly with other types of large cells. Both of the 
latter cells produced mass spectra containing the same major peaks at m/z 4337 and 4404 (Figure 
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4.4C, D), suggesting that these tentative peptides are primarily found in large DRG cells. 
Furthermore, due to the presence of neurofilament-related signals, it is likely that cells C and D 
are DRG neurons. In addition, cells C and D are 9.7 mm apart on the slide, eliminating the 
possibility that the detection of peptide signals, especially m/z 4337 and 4404, is biased by cell 
location on the slide.  
Cells mechanically damaged during sample preparation should have limited effect on the 
analysis of cellular peptide content. Our work and that of others have demonstrated that 
treatment with MALDI matrix yields similar results to sample fixation.[57, 58] Cells that rupture 
would lose much of their peptide content; hence these cells would lack peptide peaks and be 
excluded from further analysis. Additionally, restricting analysis to cells sufficiently separated 
from each other ensures that cell-to-cell contamination does not occur. Accordingly, we conclude 
that the diverse morphology observed between cells is not an indication of disturbance caused by 
sample treatment. 
Sequential MALDI MS Profiling Improves Analyte Coverage and Detection of High Molecular 
Mass Species and Reveals Peptide Heterogeneity in Morphologically Similar Cells  
As expected, cell morphology does not predict peptide content; cells with morphologies 
similar to cell D (Figure 4.4) did not necessarily contain a detectable amount of peptide at m/z 
4404. Figure 4.5A–F presents mass spectra of three cells (cells E, F and G) with similar 
morphologies (roughly circular with a diameter of ~25 µm) to cell D (Figure 4.4). Cells E and F 
have a similar LM peptide content as cells C and D in Figure 44., with the pair of mass spectral 
peaks at m/z 4337 and m/z 4404, but very minor peaks within the m/z 2,000–3,000 range. On the 
other hand, cell G, while having a similar morphology, exhibits a chemical profile populated 
with intense signals of m/z 2142, 2264, and 3094, but no signals at higher masses. This cell’s 
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peptide content is different from the four cells shown in Figure 4, except for m/z 2264, which is 
common with cell A. Since m/z 2142 and 3094 are tentatively assigned to peptides from 
neurofilament heavy and medium proteins, respectively, cells G and H in Figure 4.5 represent a 
population of neurofilament-rich cells. As mentioned above, neurofilaments play a major role in 
the developmental regulation of neuronal types in rat DRG.[59]  
We note that a major drawback of LM analysis lies in the low intensities of the mass 
spectral peaks within the m/z 4,000–6,000 mass range. To circumvent this issue, we performed 
HM analysis with a method optimized for the m/z 4,000–20,000 mass range at the expense of 
mass resolution. Following LM analysis, the same cells were subjected to HM analysis to cover 
the analyte range from m/z 4,000–20,000. The relative signal intensities of peptide peaks in the 
overlapping region between LM and HM analysis (i.e., m/z 4,000–6,000) increased by at least an 
order of magnitude. For example, m/z 5487 is barely observed in cells C and D (Figure 4.4) and 
is apparently absent in cells E and F (Figure 4.5) after LM analysis. When the same cells were 
examined with HM analysis, the mass spectra showed intense signals of m/z 5487 and large 
signal enhancements for m/z 4337 and 4404. As shown in the right panels of Figure 4.5, the HM 
analysis reveals additional heterogeneity between cells E, F and cells G, H, including several 
smaller peptide signals in Figure 4.5B, D and polypeptides/small proteins in Figure 4.5F, H. The 
apparent peptide and protein content heterogeneity may reflect the existence of multiple DRG 
cell types, even for those with similar morphologies. Overall, these observations highlight the 
utility of sequential analyses on the same cells and specifically suggest that the DRG population 
may be stratified by peptides found exclusively in specific cellular groups. Nevertheless, a 
thorough, quantitative analysis is necessary to identify these peptide markers, as discussed 
below. 
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Classification of DRG Cells Based on Direct MALDI MS Peptide Profiling 
The spectra of the representative cells shown above suggest a cellular classification 
scheme according to the intensities of selected mass spectral peaks. Visual examination of the 
mass spectral features shown in Figure 4.5 suggests that based on peptide content there are at 
least two DRG subpopulations present. Based on the PC2 loading plot (Figure 4.3), m/z values 
with high loadings were selected as potential peptide markers as they represent the highest 
source of variance in the dataset. The pairwise linear correlation coefficients, , were calculated 
between each putative biomarker for all cells, with  < 0.05 indicating statistical significance. 
The correlation matrix was plotted where blue and red represent positive and negative 
correlations, respectively, that are statistically significant. An ideal set of biomarkers would 
show high, positive correlations with all members of the set and large, negative correlations with 
all ions outside the set. The potential peptide markers were sorted with hierarchical clustering 
analysis (HCA), revealing roughly three populations of cells termed A-, B-, and C-type, defined 
by 19 markers (Figure 4.6A).  
The peptide markers for type A include m/z 4337, 4404, 5487, and 4926 in both LM and 
HM, and m/z 6295 in HM. For type B, the peptide markers are m/z 1947, 2031, 2142, 2263, 
2792, and 3015 in LM, and m/z 7985 and 8269 in HM. For type C, the peptide markers are all in 
HM: m/z 6666 and 9437, and the tentative proteins at 11.3, 12.5, 14 and 14.5 kDa. Some ions 
chosen by PCA were excluded due to their positive correlation with markers from other cell 
types, including m/z 3777 and 3989, which were excluded from type B due to positive 
correlation with markers in type C, and m/z 4078 and 4717 in type C as they show some 
significant overlap with markers in type A (Figure 4.6A).  
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With the set of ions selected, each cell was tested for membership in the respective group. 
A cell was considered a member of a given type if the cell contained any peptide markers with a 
signal-to-noise ratio (S/N) >3. Overall, the peptide markers from three groups successfully 
classified 919 cells (78% of the total cells analyzed from three animals) into three populations: 
498 cells in type A, 386 cells in type B, and 211 cells in type C. Additionally, 129 cells 
contained both markers of types A and B, 69 cells contained both markers of types A and C, and 
67 cells contained both markers of types B and C (Figure 4.6B). Finally, 24 cells contained 
peptide markers of all three cell types. With this classification approach, cells sorted into a group 
may express a single marker, or multiple markers from both LM and HM analyses.  
Additional insights are provided by comparing the cellular classifications utilizing 
markers of LM and HM analyses separately; 89% of the LM-A cells (133 out of 149 cells 
stratified by LM-A markers) exhibit the markers characteristic for HM-A cells. Since the type A 
classification is based on the same ions appearing in both LM and HM (e.g., m/z 4404), the 
significant overlap between LM-A and HM-A is consistent with positive correlation among the 
markers. The small disparity highlights the difference in optimization between the methods. 
Other reasons for the disparity may include matrix depletion after LM analysis, leading to 
inadequate HM signal from some cells, or a decrease in ion suppression (due to lipid removal) 
after LM analysis, improving analyte detection in HM analysis of other cells. These reasons hold 
true for all cell types, not just type A. Nonetheless, most cells in LM-A are also in HM-A and 
vice versa, which indicates a fairly robust repeatability of measurements between these analyses. 
Since the two analyses were performed sequentially, without removing the samples from the 
mass spectrometer, this difference is not due to spatial target accuracy. 
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The type B classification shows a larger disparity between HM and LM analyses, where 
LM and HM markers do not share common peptides. Only 41% of cells (130 out of 315) in LM-
B are also in HM-B. The leaner overlap between the two classes indicates that type B is more 
heterogeneous.  
The type C classification was missed in the original assessment using only mass spectral 
types (Figure 4.5). As mentioned above, the two biomarkers of LM-C, m/z 4078 and 4717, have 
a poor S/N in LM and positively correlate with markers of A-type (Figure 4.6A). The HM 
biomarkers, especially m/z 9437, are more prominent and HM analysis also shows enhanced 
signals of m/z 4078 and 4717. As a result, LM-C markers were unable to classify cells as C-type, 
whereas HM-C markers helped categorize 211 cells.  
Taken together, the three cell types account for 78% of the cells analyzed (919 of 1171 
cells from three animals). Cells containing none of the peptide markers are typified by a lack of 
any peptide signal. Presumably the peptide content of the unclassified cells is below the LOD of 
our instrument. Figure 4.6C shows a 3D scatter plot of the signal intensities of three distinct 
peptide markers (m/z 4404 for A-type, m/z 1947 for B-type, and m/z 9437 for C-type), showing 
good separation between classes for these m/z values.  
The peptides or small proteins detected in the HM analysis were not characterized due to 
the limitations of the TOF/TOF MS/MS instrument at that mass range. Our prior LC-MS 
study[41] focused on smaller peptides, so sequencing would require additional peptidomic 
measurements optimized for higher molecular mass species. As a discovery research outcome, 
the mass spectral types are largely distinct and HCA on the marker correlation matrix 
demonstrates one method for identifying cellular biomarkers using just single cell MS data sets.  
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The data shown in Figures 4.5 and 4.6 also demonstrate that although MALDI MS 
consumes analytes, our results show that the remaining single cell material, including the 
associated amount of MALDI matrix, is sufficient to perform sequential analysis of the same 
cells. In previous studies on rat cerebellar cells, we demonstrated that MALDI MS measurements 
can be performed to gain additional chemical information after the cells are analyzed with 
SIMS.[56] We have also off-line hyphenated MALDI MS with CE-MS via a liquid microjunction 
surface sampling probe to measure amino acids and dopamine in peptide-profiled individual 
rodent pancreatic islet α and β cells.[39] The present study illustrates the first example of 
sequential MALDI MS analysis for improved analyte coverage from lipids to peptides and small 
proteins at the single cell level. 
Several peptides previously reported to be localized within the DRG were not detected, 
including CGRP, which is expressed in over half of small DRG neurons, along with 
neuropeptides such as substance P, somatostatin, vasoactive intestinal polypeptide, and galanin.[1, 
4] Their absence in our measurements could be caused by analyte stability issues (proteolysis), 
ion suppression during analyte ionization and detection, analyte loss due to sample rinse, or 
analytes being present at levels below our LODs. Another possibility is that the fully processed 
peptides are mostly localized to cell processes that were not targeted in our experiments as we 
analyzed somata. Moreover, the choice of MALDI matrices may play a key role. For example, 
we note that substance P is not detected using the DHB dried droplet approach over a range of 
concentrations from 100 pM to 1 fM. However, when using triple-layer α-cyano-4-
hydroxycinnamic acid (CHCA) matrix/sample preparation, we detect substance P over this 
concentration range (see Supporting Information Figure S12). Nevertheless, variation in matrix 
layers remains challenging for applications on biological samples, and thus, requires further 
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optimization. Regardless, the detected compounds allow cell type classification. Our work 
extends the analyte coverage for chemical profiling into the range of small proteins at the level of 
individual mammalian cells.  
4.4 Summary and Conclusions 
The heterogeneity and chemistry of individual cells are often hidden in the ensemble-
average data sets resulting from traditional bulk analysis. Here, optically guided single cell MS 
profiling was utilized to investigate the chemical content of isolated DRG cells in a high-
throughput manner. A unique property of the approach is sequential MALDI MS analyses; we 
assayed more than 1,000 individual DRG cells and identified lipids, peptides, and small proteins. 
The chemical content of each cell is represented by two mass spectra, which together cover the 
mass range from m/z 400 to 20,000. The first LM analysis yielded mass spectral information 
about lipids and peptides up to m/z 6,000 with high resolution, and the second HM analysis 
captured high molecular weight polypeptides and small proteins in the same cell up to m/z 
20,000. The mass spectra reflect the nature of cell types and morphologies. We also show that 
although MALDI MS is generally considered destructive for small samples, the remaining 
cellular material after the initial analysis was sufficient for a second follow-up MS analysis.  
As applied to the rodent DRG, our workflow enabled detection of a number of analytes, 
including several peptides derived from myelin protein P0, myelin basic protein, neurofilaments, 
vimentin, and thymosin beta, at single cell levels. Small cells tend to contain fewer peptides than 
large cells, with myelin protein P0 and vimentin among the most common. These are proteins 
known to be expressed at high concentrations in glial cells.[44-47] In addition, cells appearing as 
structurally damaged with intact nuclei showed peptide signals putatively assigned to TER 
ATPase and thymosin beta-4. We also detected uncharacterized putative peptides at m/z 4404 
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and m/z 5487, together with myelin basic protein S and neurofilament peptides in a 
subpopulation of large cells. Of note, peptides from neurofilament proteins, which contribute to 
axonogenesis and neurite growth,[50, 53, 54] were detected in many cells. The identities of these 
peptides were evaluated by measuring the exact molecular masses of peptides in a tissue extract 
via FT-ICR MS and matching them to corresponding theoretical data as well as previously 
published information on DRG neuron chemical profiles. These measurements also revealed 
more peptides derived from the aforementioned proteins. 
The mass spectra were classified into three types, A, B and C, based on different peptide 
signal profiles, in which types B and C are more chemically heterogeneous than type A. This 
result could be due to the fact that type-A cells were selected based on the presence of the same 
ion (m/z 4404) in the results of both LM and HM analyses. We also detected small proteins at 14 
kDa that appear to be specific for cell type B. These three mass spectral types account for 78% of 
the cells analyzed in samples from three animals. In a previous report, Usoskin et al.[7] classified 
DRG based on neuropeptides, and showed that 11% of DRG cells are neuropeptidergic and 
express high levels of substance P (Tac1 gene), trkA (Ntrk1), and CGRP. In contrast, our 
approach is untargeted. Future work will aim to characterize neuropeptides at the single cell level 
and further refine our subpopulation classification. 
Single cell techniques are often evaluated in terms of the number of cells that can be 
analyzed per experiment (the breadth of cellular profiling) and the number of detected analytes 
per cell (the depth of cellular profiling). We show that our optically guided MS technique not 
only assays a large number of cells, but also provides coverage of lipids, peptides, and small 
proteins in individual cells.  
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4.6 Figures and Table  
 
Figure 4.1 Optically guided high-throughput single cell MS profiling of rat DRG cells. Intact 
DRG were enzymatically dissociated and stained with a fluorescent nuclear dye. Isolated cells on 
ITO-coated glass substrates are located with brightfield and fluorescence imaging and targeted 
for MS analysis.  
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Figure 4.2 A–D) Representative mass spectra in the LM range (m/z 400–6000) acquired from 
single DRG cells. Each inset highlights the m/z range above 2,000. E) Average lipid profile of 
DRG cells; a) lipid monomers and b) lipid dimers. 
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Figure 4.3 PCA of MS data acquired from populations of single DRG cells. A) Score plot of 
data obtained from the LM analysis with 95% confidence ellipses. B) PC2 loading plot of the m/z 
>2,000 region showing mass spectral peaks that vary the most in the analyzed data set according 
to PC2, including numerous peptides. “n” indicates the number of cells examined in each animal. 
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Figure 4.4 Examples of the biochemical and morphological variability of DRG cells. A–D) 
Mass spectra of four different DRG cells; E) the corresponding cell fluorescence and brightfield 
images collected from the same animal. The scale bar for all images is 50 µm. The green circle 
approximates the LM analysis laser footprint (~100 µm). The red circle in the cell C image 
annotates the nucleus-like structure, as discussed in the main text. Mass spectral peaks are 
labeled with m/z values, where the asterisk indicates the average molecular mass. 
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Figure 4.5 Examples of the biochemical and morphological variability of DRG cells analyzed 
with sequential (LM followed by HM) MALDI MS profiling. A–J) Representative mass spectra 
obtained from sequential MALDI MS profiling of DRG cells. The combined fluorescence and 
brightfield images of the cells are shown in the right panels. The scale bar is 50 µm. Two 
MALDI MS (low mass and high mass) analyses were performed on the same cell, corresponding 
mass spectra shown in the same row and color. Major mass spectral peaks are annotated with m/z 
values. The last cell (shown in orange, panels I, J), which is cell B from Figure 5.4, is 
morphologically and biochemically distinct from the other cells. 
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Figure 4.6 Classification of DRG cells in MALDI MS data sets. A) Heatmap represents 
covariance of intensities for m/z values selected from PC2 and sorted via HCA. HM peptide 
markers are bold. B) Venn diagram representing results of HCA of acquired mass spectra shows 
three primary cellular populations, A-type (n = 482), B-type (n = 386), and C-type (n = 211). The 
size of each set is drawn proportionally to reflect its total number of cells. “n” indicates the total 
number of cells in each population. C) Peptide markers are selected for cellular subgroups of A-
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2328.162 2328.1573 2.02 
Neurofilament light 
polypeptide 
Y.YTSHVQEEQSEVEETIEATK.A 2337.079 2337.0729 2.61 
Neurofilament light 
polypeptide 



























3297.528 3297.5353 -2.21 
Unidentified -- 4131.338 -- -- 
Unidentified -- 4470.472 -- -- 
Unidentified -- 4404.672 -- -- 





4961.453 4961.4930 -8.06b 
Table 4.1 FT-ICR MS measurements of DRG tissue extracts. Peptide identity assignments are 
based on mass matching with the previous peptidomic characterizations using LC-MS.[41]  
The “period” in the peptide sequences indicates the cleavage site; residues before and 
after it are not considered part of the primary sequence used to compute the m/z value. “+42” 
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Table 4.1 (cont.) indicates acetylation. The bolded m/z values were also detected in the single 
cell profiling experiment.  
a Signal observed in the prior LC-MS study, but the primary sequence of related compound was 
not determined.  
b A high ppm value suggests less confidence in the peptide match. 
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CHAPTER 5 
SINGLE CELL MALDI MS SUPERVISED BY IMMUNOCYTOCHEMICAL CLASSIFICATIONS 
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5.1 Introduction  
Mammalian brain function critically relies upon cellular heterogeneity,[1-3] and 
explorations of this heterogeneity have exploded with the advent of single cell transcriptomics.[4] 
Cell morphology, the most traditional metric of cell classification, correlates shape to the 
function of cells.[5,6] Cell chemistry also correlates to function; for example, the biophysical 
properties of the cell membrane are governed by its lipid composition.[7-9] Chemical analysis of 
single cells has entered a new era because of recent advances in mass spectrometry (MS).[10] For 
126   
 
example, high-throughput single cell matrix-assisted laser desorption/ionization (MALDI) MS is 
capable of directly assaying hundreds of chemical compounds within biological specimens.[11] 
While single cell MALDI MS produces rich spectral profiles for label-free classifications, the 
results can be difficult to correlate to canonical cell types.[12, 13]  
Immunocytochemistry (ICC) is effective for classifying cells as it can be used to target a 
plethora of different molecules, such as neurotransmitters, neuropeptides, and proteins that 
distinguish cell types.[14] Fluorescence overlap of labels typically limits plexity to fewer than ten 
compounds.[15] Most ICC protocols require sample fixation and lipid removal, crosslinking 
and/or removing many compounds that are easily ionized by MALDI MS.[16] ICC has been 
combined with tissue imaging and a few examples applied the methods to single cell MS.[17, 18] 
Directly coupling ICC and MS on the same cell was reported in 2012,[18] however, ICC was 
performed first, limiting the analysis to high-abundance peptides within a small number of cells. 
Here we describe a workflow enabling high throughput MALDI MS of thousands of cells, 
followed by cell classification via ICC. By performing ICC after MALDI-MS, we can expand 
chemical interrogation to include lipids and small metabolites, which are essential for brain 
function.[19-22] Our dataset here consists of over 1800 rodent cerebellar cells assayed using 
microMS, a cell finding and analysis software.[23] We demonstrate the approach by examining 
chemical differences between two of the most common cell types in the brain – astrocytes and 
neurons. Because the lipid differences between astrocytes and neurons are both poorly 
understood and modest, ICC classification was imperative to discovering statistically distinct 
features between these important cell types, particularly within primary isolated and mixed cell 
populations.   
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5.2 Experimental  
Chemicals.  
2,5-Dihydroxybenzoic acid (DHB), bovine serum albumin (BSA), Tween 20, and ethanol 
were purchased from Sigma-Aldrich (St. Louis, MO). 4% paraformaldehyde (PFA) in phosphate 
buffered saline (PBS) was purchased from Affymetrix (Santa Clara, CA). Anti-glial fibrillary 
acidic protein (mouse anti-GFAP) (MAB360) and anti-neurofilament light chain (rabbit anti-NF-
L) (AB9568) were purchased from EMD Millipore (Billerica, MA). Dylight 550 secondary 
antibody (goat anti-mouse) was purchased from Thermo Scientific (Hudson, NH). Alex Fluor 
488 secondary antibody (goat anti-rabbit), phosphate buffered saline, Hoechst 33342, and 10% 
normal goat serum were purchased from Life Technologies (Gaithersburg, MD). Peptide 
Calibration Standard Kit II (angiotensin II, angiotensin I, substance P, bombesin, ACTH clip 
1−17, ACTH clip 18−39, somatostatin 28, bradykinin fragment 1−7) was purchased from Bruker 
Corp. (Billerica, MA). All other reagents were purchased from Sigma Aldrich. All reagents were 
used as received (> 98% purity) without further purification. 
Animals.  
Six, 2–2.5-month-old male Sprague Dawley outbred rats (Rattus norvegicus) 
(www.envigo.com) were housed on a 12-h light cycle and fed ad libitum. Animal euthanasia 
was performed in accordance with the appropriate institutional animal care guidelines (the 
Illinois Institutional Animal Care and Use Committee), and in full compliance with federal 
guidelines for the humane care and treatment of animals. 
Cell Dissociation.  
Dissected cerebellum tissues were incubated with a solution of 1% Hoechst 33342 in 
oxygenated modified Gey’s balanced salt solution (mGBSS) for 30 minutes at 37°C. The 
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mGBSS solution was removed and tissues incubated with an oxygenated solution of 6 units/mL 
of papain, 1 mM L-cysteine, and 0.5 mM ethylenediaminetetraacetic acid for 80 minutes at 37°C. 
Tissue was then mechanically dissociated in mGBSS with 0.04% PFA for cell stabilization 
through mechanical dissociation. The PFA concentration was optimized to maximize cell 
integrity and quality of mass spectra (data not shown). Following dissociation, glycerol was 
added to a final concentration of 40% and 150 µL of cell suspension was transferred onto indium 
tin oxide (ITO) coated glass slides (Delta Technologies, Loveland, CO) or non-coated glass 
slides (LabMed, Ft. Lauderale, Florida) for MS analysis or immunostaining control experiments, 
respectively. Fiducial markers used for registration were etched using a diamond-tipped pen 
prior to cell plating. 
Each slide held cells from three biological replicates plated in duplicate in a random 
coordinate on a gridded pattern. This design of experiments helps control batch variation and 
possible position-dependent artifacts. Immunostaining controls, consisting of a mixture of three 
animals, were placed on diagonals at the upper right and lower left positions the slide (Figure 
5.1). Six animals were used for a total of eight ITO and eight glass slides. Cell populations were 
kept isolated with stretched parafilm “M” strips while the cells were adhering (Bemis Company, 
Inc., Neenah, WI). After ~18 hours, the parafilm “M” strips were removed and cells were stained 
with Hoechst 33342 (1 µg/mL in mGBSS) for 15 minutes before quickly rinsing twice with 500 
µL of 150 mM ammonium acetate.  
Optical Imaging.  
Brightfield and fluorescence images were acquired on a Zeiss Axio M2 microscope 
(Zeiss, Jena, Germany) equipped with an Ab cam Icc5 camera, X-cite Series 120 Q mercury 
lamp (Lumen Dynamics, Mississauga, Canada), and a HAL 100 halogen illuminator (Zeiss, Jena, 
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Germany). DAPI (ex. 335-383 nm; em. 420-470 nm), GFP (ex. 450-490 nm; em. 500-550), and 
DsRed (ex. 538-562 nm; em. 570-640) dichroics were used for fluorescence excitation. The 
images were acquired with a 10x objective (1 pixel width is 0.55 µm) with a 13% overlap 
produced during image tiling. Images were processed and exported on ZEN software version 2 
blue edition (Zeiss, Jena, Germany). Images were exported as big tiff files. Only Hoechst 33342 
fluorescence images were acquired for MALDI-MS analysis, whereas all three filters were used 
after ICC staining. Cells without antibody incubation were used to measure cellular 
autofluorescence during image post-processing.  
microMS Analysis.  
            microMS was used as previously described. Briefly, cells were found using the high 
fluorescence from Hoechst 33342 and were filtered by size, shape and distance to reduce time 
spent analyzing debris and artifacts from cell sampling. microMS was used to register 
microscopy images with the MALDI MS stage.  
Matrix Application and MS Analysis.  
After full-slide imaging was performed, slides were coated with a 50 mg/mL DHB 
solution dissolved in 1:1 ethanol: water with 0.1% trifluoroacetic acid using an automatic sprayer 
described previously.[39] The matrix solution was nebulized at 10 mL/hr using N2 gas at 50 psi 
with 100 passes. Samples were taped to a rotating plate and the spray was placed 3 cm above the 
samples. The total amount of matrix applied was between 0.1 and 0.2 mg/cm2. 
Single-cell analysis was performed on an ultrafleXtreme II TOF/TOF mass spectrometer 
(Bruker Corp., Billerica, MA) with a mass window of 500-3000. The “Ultra” (~100 µm 
footprint) laser setting was used and 300 laser shots were accumulated at 1000 Hz and 60% laser 
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energy for each cell. Cell coordinates were obtained in microMS and filtered with a 100 µm 
distance filter to prevent cellular contamination.[41]  (Figure 5.2A).  
Cerebral lipid extracts were prepared using the Bligh-Dyer method. Direct infusion 
electrospray ionization of a cerebellum lipid extract (~1 mg of dried cerebral lipid extract was 
resuspended in 1 mL of 50:50 methanol and water) was performed for high mass accuracy and 
collision induced dissociation (CID) of selected lipids. Lipid identifications were performed with 
a solariX XR 7T Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer (Bruker 
Corp., Billerica, MA) with a mass window of either 100-3000 or 150-3000, yielding a transient 
length of 1.96 and 2.94 seconds, respectively. Direct infusion electrospray ionization (ESI) of a 
cerebellum lipid extract was performed for high mass accuracy and collision induced 
dissociation of lipids (Figure 5.3). Sample was delivered at 120 µl/hr and a capillary voltage of 
3900 V. Complete isolation of the lipids was sometimes not possible, so there may be 
contamination of tandem MS spectra by neighboring lipid features; however, the most abundant 
fragment ions were used for feature assignment. The LIPID MAPS database was used in tandem 
with CID spectra for assigning lipid species.[1] CID spectra were recalibrated using the molecular 
ion. 
Matrix Removal, Sample Fixation, and ICC.  
Matrix was removed during cellular fixation by incubating the cells in a 4% solution of 
PFA in PBS for five minutes. The fixation solution was then changed and the cells were 
incubated for an additional ten minutes followed by a three-minute rinse in PBS. Slides were 
then incubated for 45 minutes at room temperature in a blocking buffer solution consisting of 50 
mg/mL BSA, 10% (v/v) goat serum, and 0.5% (v/v) Tween-20 in PBS. Slides were rinsed again 
in PBS for three minutes following blocking. A hydrophobic pen was used to isolate antibody 
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controls and reduce the quantity of antibody solution required. Fixed cells were immunostained 
with primary antibodies against GFAP and NF-L for two days at 4°C in antibody buffer (1% 
BSA and 0.5% Tween-20 in PBS; 1:1000 dilution of each antibody). Cells were then stained 
over another two-day incubation with the fluorescently labelled secondary antibodies in the same 
antibody buffer at 1:100 dilution (Figure 5.2B). Slides were washed in PBS three times for three 
minutes after each antibody incubation. Stained samples were imaged using an Axio M2 imager 
as described above (Figure 5.2C). 
Image Registration and Analysis.  
To relate the immunostained images to the mass spectra, the cell locations were identified 
by registering the images obtained before MS with the post-ICC images using the custom 
MATLAB (R2015B) scripts provided as Supplementary Information (WinZip file). First, 
brightfield images taken before matrix application and after immunostaining underwent point-
based registration via manual overlay, which greatly improved the performance of later, 
automatic registration procedures. For each cell analyzed by MALDI MS, a 90-pixel by 90-pixel 
area with the cell in the center was located in the post-ICC image using the initial, manual 
transformation. An intensity-based registration was then performed between the two Hoechst 
33342 fluorescence images, which highlight the cell nucleus. Cells that did not display 
fluorescence signal after matrix removal or failed to converge upon registration were eliminated 
from analysis. The removed population represented cells that moved further than ~25 µm from 
the starting point or changed drastically following staining (e.g., because of contamination from 
debris or other cells). It was necessary to perform automatic registration on a cell-by-cell basis to 
correct any stitching artifacts and ensure accurate overlays of cell positions. Red and green 
intensities within the ICC image were averaged at each cell location over an area corresponding 
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to the cell boundary, as determined by microMS.[4] Following this procedure, each cell had a 
corresponding mass spectrum and average fluorescence intensity in each channel. 
The fluorescence intensities were used to classify the immunoprofiles with batch-specific 
cutoffs. Two fluorescence controls (antibody blanks) located on the opposite corners of the slide 
were used to determine the intensity values for a positive fluorescence signal. A histogram of 
fluorescence intensity was produced, and an appropriate cutoff determined as a constant value 
(5% of max range) above the maximum fluorescence intensity of the cells located within the 
antibody blanks.  
The ICC-enriched dataset was utilized for supervised multivariate analysis of the MALDI 
MS results.  Single cell mass spectra were imported using the readbrukermaldi 
(https://github.com/AlexHenderson/readbrukermaldi) function, binned at 0.05 Da for peak 
peaking and normalized to total ion count (TIC). Spectra were sorted into GFAP-positive and 
NF-L-positive groups; cells with neither stain were excluded because a negative stain could be 
attributed to methodological artifacts.  
Statistics.  
Comparisons between cells that were immediately fixed and cells that underwent MALDI 
matrix removal and subsequent ICC were compared using a two-tailed t-test (n = 6 animals, p-
value = 0.002) because the staining profiles were normally distributed. The total number of 
stained cells was statistically different at the 95% confidence interval. Comparisons of staining 
proportions between matrix-removed and control ICC were made using the proportions test (ICC 
only, number of cells = 5435; matrix removal, number of cells = 5646; n = 6 animals for both 
treatments, p-value = 0.886 and z-value = –0.49). A proportions test was used to compare the 
proportion of stained cells under each condition, rather than the average number in each 
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population.  A rank sum test was used to determine ions of significant difference between the 
two immunostained populations with false discovery rate correction (n = 6 animals). A rank sum 
test was used to determine significant metabolic differences between the two cell classes as 
opposed to a t-test because the MS data was not normally distributed. As such, a rank sum test is 
the most appropriate statistical test to use, because it does not depend on normality. T-distributed 
stochastic neighbor embedding and hierarchical clustering were performed using default 
MATLAB functions to visualize heterogeneity possessed by NF-L and GFAP positive cells. 
Optimal clusters were determined via the evalclusters function utilizing silhouette evaluation.  
Number of Cells at Each Stage.  
~586,000 structures were deposited on eight slides and, of these, ~275,000 were ICC 
positive. To reduce cell-to-cell contamination during MS analysis, only fluorescent, cell-like 
structures that were >100 µm away (two-fold greater than the diameter of the laser probe) from 
other cell-like structures were analyzed by MALDI MS (~41,000 structures). Of these 41,000 
structures, 1816 cells had detectable lipids, were not delocalized during the matrix removal or 
ICC processes, not covered with the hydrophobic pen, and were ICC positive. Separately, the 
number of ICC-positive cells for statistical comparison of ICC-only (5435 cells) and MALDI 
matrix-removed (5646 cells) conditions were manually determined because microMS did not 
allow us to distinguish bare nuclei without a cellular membrane. Sixty areas of ~100 cells of each 
condition over the eight slides were used to count the number of ICC-positive cells, ICC-
negative cells, and bare nuclei. Bare nuclei were disregarded in the statistical comparisons. 
5.3 Results and Discussion 
Most ICC procedures greatly reduce MS quality, especially from single cells where 
material is limited.  While mass spectra acquired from unfixed single cells contained peaks 
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consistent with small metabolites and lipid species at high intensity, after performing the fixation 
procedure (as required for most ICC protocols), the resulting mass spectra showed weaker 
metabolite peak intensities (~90% lower) as well a polymer contaminant (Figure 5.1). Thus, we 
decided to perform ICC after MALDI MS (Figure 5.1A-C) similarly to our recent paper coupling 
vibrational spectroscopy and MALDI MS;[24] using MALDI MS first, we observe high-quality 
mass spectra of molecules, including small metabolites and lipids. For this procedure to succeed, 
next we need to remove the MALDI matrix (e.g., 2,5-dihydroxybenzoic acid) that is thoroughly 
co-crystalized with the cells, keep the cells anchored to the same location on the slide, and 
finally, the antibody must still recognize its epitope, even after the MALDI measurement. We 
found that the common fixative paraformaldehyde was effective in both fixing the cells and 
removing the MALDI matrix (Figure 5.3G). Importantly, a high proportion of cells (~95%) did 
not move during matrix removal (Figure 5.4, insets). While ICC requires long incubations that 
can lead to cell delocalization, we find that between matrix removal (Figure 5.4A, left) and 
second antibody incubation (Figure 4A, right), ~88% of the cells stayed in the same location, 
while only a few were delocalized (Figure 4A, red arrows). Relying on image registration as a 
metric for cell retention, the registration procedure used here successfully matched 71±18% of 
cells within a 25 µm field of view.  
Using the optimized procedure, cells within the cerebellum were classified as glial 
fibrillary acidic protein (GFAP) positive, neurofilament-L (NF-L) positive, or ICC negative. 
While GFAP is not a universal astrocytic marker, most astrocytes within the cerebellum can be 
labeled immunopositively by GFAP. Similarly, most neurons express NF-L antigens. The cells 
that were ICC negative may be other cell types that lack these antigens, or they may be cells 
damaged during cell dissociation and/or MALDI MS process, and thus did not immunostain 
135   
 
appropriately. Due to their ambiguous identification, ICC-negative cells were excluded from the 
mass spectral analysis.  
Ultimately, ~586,000 cell-like structures were deposited on eight slides. To reduce cell-
to-cell contamination during MS analysis, only fluorescent, cell-like structures that were >100 
µm away (two-fold greater than the diameter of the laser probe) from other cell-like structures 
were analyzed by MALDI MS (~41,000 structures). Of these 41,000 cells, 10,000 were in the 
control areas on the slide that were not immunostained. Further, ~12,000 cells were not present 
within the 25 µm field of view and were assumed to be delocalized. Bare nuclei were not 
excluded from the analysis because Hoechst 33342 is signal is indistinguishable between these 
two populations. We assume that bare nuclei are not ICC positive and negatively impact the 
MALDI-MS ICC efficiency. Of the remaining cells, 1816 cells were ICC positive. It is 
imperative for chemical analysis of thousands of cells to be feasible because of the brain’s 
complexity, which we have achieved here. 
Previous lipidomic research of astrocytes and neurons relied on cell lines or cultured 
primary cells to study metabolic differences.[25-27] The chemical nature of neurons and astrocytes 
results from their position within a large network of cells; all contextual information is lost 
during cell culture. Astrocyte cell lines for example, lose GFAP immunoreactivity, the primary 
astrocytic marker. Because the dissociated cells used here are rapidly transferred from the brain, 
they retain many defining features, albeit the native cell position is entirely lost. The chemical 
information gained from dissociated cells is similar to primary astrocyte cultures.[28] Our 
protocol, however, allows for targeted analysis of cell types, without having to purify cultures of 
a specific cell type and could easily be adaptable to primary cultures. 
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To assess the effect of MALDI MS on the ICC profiles, immunostaining efficiency was 
compared between cells subjected to matrix removal and cells that were fixed and 
immunostained immediately after dissociation. Unsurprisingly, cells stained more efficiently 
when immediately fixed and stained (Figure 5.4B). The differences in staining could be caused 
by many factors, including the effects of matrix removal or laser irradiation. On control slides, 
72% of cells stained, with this number decreasing to 46% following matrix removal, after bare 
nuclei were removed from cell counts. The discrepancy between treatments is significant (p-
value = 0.002, two-tailed t-test), but if we assume the control treatment as an upper limit, more 
than half of the cells that could immunostain were still characterized following MALDI MS. 
Additionally, the relative amount of each population remained consistent between control and 
matrix-removed cells (p-value = 0.886 and z-value = –0.49; proportions test). The consistent 
proportion of GFAP- and NF-L-positive cells is important; if one population had been 
disproportionately affected by the MALDI MS measurement process, the derived chemical 
inferences may be affected. 
 Using our MALDI MS-ICC approach, we can directly correlate the ICC profile, cell 
image, and mass spectrum for each cell (Figure 5.5A-D). Both NF-L positive cells (Figure 5.5A-
B) and GFAP-positive cells (Figure 5.5C-D) have the capacity to stain with high-quality mass 
spectra that include many lipid features that are absent from MS of fixed cells. Even after laser 
ablation and matrix removal, each cell remains intact (Figure 5.5A-D insets) and maintains 
structural features present during cell plating for easy recognition post-analysis, except for what 
appears to be nuclei leakage that sometimes occurs after MS processing (Figure 5.5C). Even 
though the cell is visibly damaged, it still immunostains, demonstrating the robustness of the 
targeted antigens. While cells may stain similarly, they may not possess identical mass spectral 
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features revealing the importance of single cell measurements as well as bulk measurements.  
Further, the heterogeneity of each class of cells can further be visualized by t-distributed 
stochastic neighbor embedding (t-SNE) and hierarchical clustering analysis (HCA) (Figure 5.5E-
F). NF-L and GFAP positive cells can be subsequently clustered into five and four 
subpopulations, respectively, based on their mass spectral features. The presence of multiple 
clusters may demonstrate that even though cells may stain similarly, they may not possess 
identical mass spectral features and could belong to subcellular populations. Thus, our 
preliminary results revealing the importance of single cell measurements as well as bulk 
measurements for chemical analysis of the brain by MS.   
While lipids are known to have important biological functions in the brain relating to 
communication, metabolism, and transport, the specific function of many individual lipids is 
unknown. Partly, this results from the difficulty in measuring large numbers of lipids in complex 
samples, identifying the saturation points of lipids, and limited databases containing lipidomic 
information (particularly when compared to genomics and proteomics).[29] MS is one of the only 
techniques capable of lipid identification in complex samples, such as single cells, and is one of 
the leading methods for lipidomic analysis. Because MALDI MS is a highly sensitive technique, 
we detected an average of 99 molecular features within the single cells and found that 17 lipids 
had statistically distinct abundances between neurons and astrocytes (Table 5.1). Statistical 
differences were determined using a rank sum test with a false discovery rate correction and 
high-resolution FT-ICR MS analysis was used for identification. Ultimately, we were unable to 
perform direct tandem MS of the lipids from single cells that were ICC positive because of the 
required fixation step. As such, we performed a lipid extract of bulk cerebral tissue for high mass 
accuracy and tandem MS FT-ICR MS analysis to assign the statistically significant lipids under 
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these experimental conditions. The lipids of interest were detected within multiple cells, so we 
believe that they would also be detected in bulk tissue extract. While there are several examples 
of multiple lipids resolved by FT-ICR MS analysis making assignments ambiguous (Table 5.1, 
ex. m/z value 731), many of the lipids were sufficiently isolated from other spectral features, 
increasing confidence of the lipid assignments. All but three lipids had mass errors of less than 1 
ppm and tandem MS (MS/MS) was possible for all but four of the lipids with errors less than 5 
ppm (Table 5.1).  
The 17 lipid differences that we detect here would likely not be observed in bulk tissue 
analysis because of ion suppression, instrumental dynamic range, and difficulties isolating 
neurons and astrocytes. Because we perform single cell analysis and can average groups of cells 
together, we can identify small, yet consistent lipid differences between astrocytes and neurons. 
Biological membranes are highly conserved because they must spontaneously form lipid bilayers 
within water, so differences may relate to essential functional or structural. Determining the 
function of these lipids is beyond the scope of this communication; however, combining MALDI 
MS with ICC has narrowed targets for functional analyses down to a small number of lipids from 
the thousands known to be present in the brain.   
From lipidomics, the functional consequences of the lipid differences can be putatively 
explored. Five lipids were present at higher intensity within astrocytes, four of which are 
phosphatidylethanolamines (PEs), such as PE(36:1). PE lipids, in particular, are important for 
determining membrane curvature as well as contractile ring disassembly at the cleavage furrow 
following cytokinesis.[30-33] The higher PE abundance in astrocytes may reflect their replication 
rate compared to neurons and their greater curvature. PE lipids have also been implicated in 
vesicle fusion and release for neurotransmission, potentially explaining the presence of PEs in 
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neurons as well as astrocytes.[33, 34] Another 12 lipids had higher abundances in neurons (e.g. 
PC(40:6) and TG(42:4). Many of the statistically different lipids enriched within neurons include 
phosphatidylcholines (PCs), which are common in lipid membranes and serve as the source for 
choline used in neurotransmission.[35] The remaining lipids are more difficult to relate to cell 
physiology; however, their relative abundance may reflect the distinct shapes or functions of 
neurons or astrocytes. Because biological membranes are highly conserved structures, we are 
excited that single cell MALDI MS can detect these subtle differences and ICC allows us to 
connect them to cell type.   
5.4 Conclusions 
While recent single cell heterogeneity studies within brain cells have primarily been 
spearheaded by transcriptomics, these studies are inherently devoid of information on the 
metabolites physically present within the cell. Because of this gap in information, we have 
developed an additional avenue for determining single cell metabolic information that can be tied 
directly to canonical cell types as defined by ICC. Not only can functional information be 
garnered from metabolites present within the cell, but intrinsic chemical differences, such as 
lipid composition, may provide a more robust classification metric with direct links to cell 
phenotypes. The information gained from MALDI MS-ICC can guide targeted transcriptomic 
experiments to further our knowledge of how subtle chemical changes impact the global function 
of the brain. It also enables targeted functional lipid experiments that are imperative for 
understanding many disorders as well as normal brain function. Moreover, the precise mapping 
of chemical information with ICC-established cell types within the brain is a significant 
advancement in single cell MS as previous reports have determined single cell spectral profiles 
for cell lines or from a few specific cells isolated from a brain region. Our development allows 
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the merging of the rich chemical information found within mass spectra to the well-defined 
cellular classifications from ICC from thousands of cells, enabling new insights into cell-to-cell 
differences found within the cells of the brain.  
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5.6 Figures and Table 
 
Figure 5.1 A) Representative single cell spectrum from an unfixed cerebellum cell. B) Single 
cell spectrum of the same cell from A following fixation. After fixation, the MALDI-MS 
spectrum contains a number of artifacts and additional features that hinder characterization of 
cellular content. 
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Figure 5.2 Schematic representation of the major steps of the MALDI MS-ICC approach. A) 
microMS is used to find the location of the ~586,000 cells on the slides. Single cell MALDI MS 
is performed on ~41,000 cell-like structures that are 100 µm apart. B) Simultaneous MALDI 
matrix removal and cell fixation with a solution of 4% PFA in PBS was performed before 
immunostaining against GFAP and NF-L. ~275,000 cells on the slide immunostain successfully. 
C) Mass spectra and ICC profiles can be directly compared because cells stay in the same 
location. 1816 cells contained quality mass spectra and ICC profiles.  
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Figure 5.3 Cells remain in the same position after MALDI matrix removal and cell fixation if an 
organic solution is not present but are dislocated in other cases. Overlaid Hoechst-stained images 
are used to track cell positions, where purple represents high intensity Hoechst fluorescence (the 
position of a cell) in the initial image and green represents high intensity Hoechst fluorescence in 
the image following treatment. A) Overlaid image of a slide after matrix removal using ethanol, 
where most of the cells are delocalized. B, C) Magnified regions of cells pre- (top) and post- 
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Figure 5.3 (cont.) treatment (bottom). D) Using an aqueous solution, cells remain in the same 
position during cell fixation (before (top) and after (bottom) fixation). E, F) Magnified regions of 
cells demonstrating they retain their orientation. G) Overlaid image of a slide with simultaneous 
matrix removal and fixation with H, I magnified regions showing the cells stay in the same 
position after matrix removal (before (top) and after (bottom) fixation). The scale bar is 200 µm 
(A, D, G) and 50 µm (B, C, E, F, H, I). 
 
















Figure 5.4 A) The left image is a subset of cells before the ICC procedure and the right image is 
a subset of cells after ICC (scale bar = 100 µm). Red arrows indicate several cells that were 
dislocated during the ICC procedure. B) Graph comparing a subset of immunopositive cells in 
dissociated cells that were immediately fixed (ICC only, number of distinct cells = 5435, n = 6 
animals) and cells that underwent MALDI matrix removal and subsequent ICC (number of 
distinct cells = 5646, n = 6 animals). The total number of stained cells were statistically different 
at the 95% confidence interval and error bars represent the standard deviation. The proportion of 
GFAP- to NF-L positive cells was not statistically different between the matrix-removed and 
ICC-only cells. 























Figure 5.5 High-quality single cell mass spectra and ICC images can acquired and compared for 
over a thousand cells. A) Single cell spectrum for the NF-L-positive cell displayed in the inset. 
B) Second NF-L positive cell with similar mass spectral features. C) GFAP-positive single cell 
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Figure 5.5 (cont.) spectra that is visibly different from the second chosen GFAP-positive cell 
(D). Green and red fluorescence corresponds to NF-F and GFAP, respectively, while blue 
fluorecsence corresponds to a nuclear dye. E) t-SNE plot of NF-L positive cells colored to 
correspond to the five clusters determined by HCA. F) t-SNE plot of GFAP positive cells 
colored to correspond to the four clusters determined by HCA. 




Figure 5.6 A) Example slide layout for MALDI-MS with follow-up ICC. The “ICC control” 
areas contain a mixture of cells from all three animals. ICC controls are subjected to laser 
ablation but not antibody incubation with either primary or secondary antibody and help 
establish fluorescence intensity cutoffs during image analysis. Numbered regions indicate the 
location of three animals on the slide, with duplicates. The position of cells from each animal and 
its replicate are randomized while ICC controls are always positioned on the diagonals. B) 
Parafilm M is added to prevent cells from intermixing during settling. 
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Figure 5.7 Collision induced dissociation (CID) spectra for compounds assigned in Table 5.1. 
Assignments were made based on characteristic fragments (e.g., PC head group at m/z 
184.0733), the LIPID MAPS database, and high mass accuracy measurements (<5 ppm). 
Putative lipid species were identified using LIPID MAPS and checked against CID spectra for 
the presence of the head group and side chain fragments. Positive assignments were made if 
characteristic head group and lipid tails were manually identified within the CID spectra with 
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Figure 5.7 (cont.) less than a 5 ppm mass error. CID energies were varied for optimal signal-to-
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Measured m/z Value PPM Error Assignment Type 
Relative 
Enrichment 


































































































Table 5.1 (cont.) List of compounds that were determined to be significantly different (p-
value<<0.05) between GFAP- and NF-L-positive cells (n = 1547). Compounds were identified 
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Table 5.1 (cont.) using cerebellum lipid extracts with 7T Fourier transform ion cyclotron 
resonance mass spectrometry via high mass accuracy and tandem MS unless otherwise indicated.  
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CHAPTER 6 
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RESOLUTION MASS SPECTROMETRY 
Notes and Acknowledgements 
This chapter is adapted from a completed manuscript coauthored with Joseph F. Ellis, 
Amelia E. Triplett, Stanislav S. Rubakhin, and Jonathan V. Sweedler, submitted for publication 
in 2019. Dr. S.S. Rubakhin and A.E. Triplett aided in sample preparation, while J.F. Ellis aided 
in data analysis and wrote all scripts related to the manuscript. A.E. Triplett also aided in lipid 
assignments. Prof. J.V. Sweedler aided in manuscript writing and concept development. The 
authors gratefully acknowledge support from the National Institutes of Health, Award Number 
P30 DA018310 from the National Institute on Drug Abuse, and from the National Institute of 
Mental Health, Award Number 1U01 MH109062. E.K. Neumann acknowledges support from 
the National Science Foundation Graduate Research Fellowship Program and E.K. Neumann and 
J.F. Ellis acknowledge the Springborn Fellowship. The authors also thank Dr. Troy J. Comi for 
useful discussions and Dr. Shannon Cornett for custom Bruker Corporation script to aid in 
exportation of data.   
6.1 Introduction 
 Single cell measurements are imperative for understanding the function and microstructure 
of highly complex biological systems. Further, representative single cell analysis within such 
complex biological systems is further complicated by the sheer number of cells, specifically for 
the mammalian brain that contains over a trillion cells.[1] These cells are often morphologically, 
functionally, and/or chemically defined and can be categorized into cell classes and subclasses.[2-
9] 
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A robust classification and sub-classification of individual cells in large cellular populations 
beyond traditional immunocytochemical and electrophysiological profiles has primarily been 
spearheaded by the single cell transcriptomics community, and the transcriptomics data has 
helped to uncover and explore important neurological functions.[10] However, the specific lipids 
found within a cell depends on a complex interplay between the cellular enzymes encoded by the 
cell transcriptome,[11] the cellular environment,[12] and organismal metabolic state.[13-15] The 
ability to probe lipid heterogeneity within the brain has lagged behind the ability to characterize 
other molecular classes at the single cell level, because of their inherent complexity, and the 
difficulty creating selective immunohistochemical and fluorescence probes.[15] 
Single cell mass spectrometry (MS) methods have been at the forefront of chemical analysis 
for decades and helped decipher the roles of many different functional molecules, such as 
neuropeptides.[16] MS approaches compliment transcriptomics efforts by detecting the physical 
presence of endogenous metabolites, peptides, and proteins rather than the gene expression 
profiles that suggest cellular potential rather than actual chemical contents. Recently, high-
throughput single cell matrix-assisted laser desorption/ionization (MALDI) MS approaches have 
been developed to characterize chemical heterogeneity of cellular populations by detecting tens 
to hundreds of chemicals within a single cell. The fast acquisition rate (on the order of seconds) 
allows for thousands of cells to be profiled in a day, proving the method capable of multiplexed, 
chemical investigation of complex and abundant biological systems.[17-20] 
Typical lipidomics experiments survey the lipid content through sampling larger samples but 
this does not necessarily detect lipids that are in a small subset of cells within the system;[21] nor 
provide information on their distributions. Because transcriptomics provides information on gene 
expression and antibodies are not available to probe specific lipids found within the cellular 
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membrane, there is currently no available approach to obtain such information. LC-MS allows 
the characterization of the brain lipidome,[22] but provides little information on their distribution, 
and may miss lipids that are at significant levels within a cell. MS imaging (MSI) is well suited 
for lipid analysis on a pixel-by-pixel basis, and recent advances have allowed MSI to reach 
cellular resolutions, although it is difficult to perform these measurements without custom 
instrumentation.[23,24] In addition, even when MSI obtains a pixel size at the level of (or even 
better than) single cells, more than one cell is likely interrogated due to the highly intertwined 
nature of brain cells (e.g. neurons and astrocytes). By using well-established dissociation 
methods and depositing cells diffusely, we ensure that only individual cells are sampled.[19,20]  
Here, we perform microscopy-guided profiling to probe over thirty thousand cells with 
MALDI Fourier transform ion cyclotron resonance (FT-ICR) MS to explore the lipid 
heterogeneity within the cells of the rat cerebellum. To date, this is the largest number of cells 
profiled within a single cell MS experiment. Additionally, FT-ICR MS measurements provide 
high-resolution and high-mass accuracy measurements that aid in assignment of over 500 
putative lipid spectral features. As tandem MS of the compounds within each cell is problematic 
given the small amount present, especially when identifying low-abundance, rare chemical 
species, we assigned our lipid peaks based on liquid chromatography (LC)-MS databases and 
data repositories of lipids. 
6.2 Experimental Section 
Chemicals 
Chemicals were purchased from Sigma Aldrich and used without further purification 
unless otherwise specified. 
 
159   
 
Animals 
15 2–2.5-month-old male Sprague Dawley outbred rats (Rattus norvegicus) 
(www.envigo.com) were housed on a 12-h light cycle and fed ad libitum. Animal euthanasia 
was performed in accordance with the appropriate institutional animal care guidelines (the 
Illinois Institutional Animal Care and Use Committee), and in full compliance with federal 
guidelines for the humane care and treatment of animals. 
Tissue Dissociation and Preparation of Individual Cell Populations 
Dissected cerebellum tissues were treated with the papain dissociation system 
(Worthington Biochemical, Lakewood, NJ). Briefly, tissues were incubated with an oxygenated 
solution of 20 units/mL of papain, 1 mM L-cysteine, and 0.5 mM ethylenediaminetetraacetic 
acid dissolved in Earle's balanced salt solution for 80 min at 34 °C. Tissue was then 
mechanically dissociated in modified Gey’s balanced salt solution (mGBSS) containing (in 
mM): 1.5 CaCl2, 5 KCl, 0.2 KH2PO4, 11 MgCl2, 0.3 MgSO4, 138 NaCl, 28 NaHCO3, and 0.8 
Na2HPO4, and 25 HEPES, pH 7.2 and supplemented with 0.04% paraformaldehyde (PFA) for 
cell stabilization through mechanical dissociation. Following dissociation, glycerol was added to 
a final concentration of 40% (v/v) and 50 µL of cell suspension was transferred onto non-coated 
microscopy glass slides (LabMed, Ft. Lauderdale, Florida) that had been etched with fiducial 
marks and washed with ethanol prior to plating. 
Each slide held cells from three biological replicates plated in duplicate in a random 
coordinate on a gridded pattern. This design of experiments helps control batch variation and 
possible position-dependent artifacts. After ~18 h, cells were stained with Hoechst 33342 (1 
µg/mL in mGBSS) for 15 min before quickly rinsing twice with 500 µL of 150 mM ammonium 
acetate. In total fifteen animals across fifteen slides were analyzed for approximately 35,000 
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cells. Five thousand objects were later removed because they did not have insufficient lipid 
signal and were assumed to be cellular debris and other fluorescent objects. 
Optical Imaging 
Brightfield and fluorescence images were acquired on a Zeiss Axio M2 microscope 
(Zeiss, Jena, Germany) equipped with an Ab cam Icc5 camera, X-cite Series 120 Q mercury 
lamp (Lumen Dynamics, Mississauga, Canada), and a HAL 100 halogen illuminator (Zeiss, Jena, 
Germany). The DAPI (ex. 335-383 nm; em. 420-470 nm) dichroic was used for fluorescence 
excitation. The images were acquired with a 10x objective (1-pixel width is 0.55 µm) with a 13% 
overlap produced during image tiling. Images were processed and exported on ZEN software 
version 2 blue edition (Zeiss, Jena, Germany). Images were exported as big tiff files. 
Sample Preparation Including MALDI Matrix Application and MS Analysis 
Slides were coated with a 50 mg/mL DHB solution dissolved in 1:1 ethanol: water with 
0.1% trifluoroacetic acid using an automatic sprayer described previously.[18] The matrix solution 
was nebulized at 10 mL/hr using N2 gas at 50 psi with 100 passes. Samples were taped to a 
rotating plate and the spray was placed 3 cm above the samples. The total amount of matrix 
applied was between 0.1 and 0.2 mg/cm2. 
Single cell MALDI mass spectra were acquired on the solariX XR 7T FT-ICR mass 
spectrometer (Bruker Corp., Billerica, MA) with a mass window of 150-3000, yielding a 
transient length of 2.94 sec. The ultra large laser setting was used with a laser footprint of 
approximately 100 µm. 50 laser shots were accumulated with a frequency of 1000 Hz at 50% of 
the maximum power settings. Single cell coordinates and a custom geometry file were 
ascertained from microMS, as previously described,[20] as well as an Excel file for the target 
automation function on ftmsControl (v. 2.1.0, Bruker Corp.). Cells were filtered by distance to 
161   
 
remove cells that were not 100 µm apart and size to remove cell nuclei. The acquisition was 
randomized across all three animals on the slide. Further instrumental parameters are supplied in 
a text document in the SI. Single Cell mass spectra are made publicly available for download at 
the Illinois Databank. 
Cerebellum tissue was a homogenized within a solution of 1:2 chloroform:menthanol 
(v:v). Contaminates were removed by centrifuging with water and the organic layer was dried 
down. Lipid extract was resuspended in a 1:1 ratio of chloroform to a solution of MALDI matrix 
(50 mg/mL DHB solution dissolved in 1:1 ethanol: water with 0.1% trifluoroacetic acid) and 
spotted onto a Bruker 364 spot target. 
MALDI-MS of lipid extract was acquired using the same mass window, laser size, and 
frequency. 150 laser shots were accumulated at 60% of the maximum power settings. Direct 
infusion electrospray ionization (ESI) of a cerebellum lipid extract was performed for 
comparison with single cell results. ESI flow rate was 150 µL/hr and a capillary voltage of 3900 
V.  
Data Analysis and Statistics 
Single cell mass spectra were converted into Bruker .d into .xml files using a custom 
script using the Automation Engine within Data Analysis software (v. 4.4, build 200.55.2969, 
Bruker Corp.). Data was then imported into MATLAB 2017A (The MathWorks, Inc., Natick, 
MA) using a custom script to parse individual xml files for m/z value, intensity, and resolution. 
Data for each cell were combined into a single dataset. Each slide was independently recalibrated 
with [PC(32:0)+H]+, [PC(34:3)+H]+, and [PC(34:1)+H]+ at m/z 734.56943, 756.55378, or 
760.58416, respectively, to correct for mass shifts. Cells not containing at least one of these 
lipids were excluded for further analysis. Single cell mass spectra were aligned with non-uniform 
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piecemeal bin widths—as mass resolution changes as a function of m/z value for FT-ICR MS. 
For example, the bin width at m/z 150 was 0.001 and 0.05 Da at m/z 2500, with 10 additional 
divisions between. Bin widths were estimated as the average peak width at m/z values and 
constructed as piecewise linear divisions over the entire spectral range. All intensities were root-
mean-square (RMS) normalized. 
Peaks between m/z value of 700-900 with mass defects greater than 0.3 Da or less than 
0.8 Da were kept for multivariate statistical analysis. The intensity matrix from the selected lipid 
range was imported into R, where the matrix was mean-centered and z-scored prior to 
dimensionality reduction using principal component analysis (PCA). 2-D visualization was 
performed using the first 100 PC scores for t-distributed stochastic neighbor embedding (t-SNE) 
with a perplexity of 30 and max iterations of 2500.48 Clustering was performed on the t-SNE 
Euclidean coordinates using the Louvain clustering method weighting each edge in the graph by 
the Jaccard overlap index. R scripts for this method were obtained and modified from Shekhar et 
al. 2016.49,50 
To determine which t-SNE clusters were more similar to neurons or astrocytes, we 
incorporated a neuron/astrocyte relative enrichment spectrum as a training set from the previous 
chapter (< 3 ppm error). A Pearson pairwise linear correlation was used to compare the reduced 
spectrum to the relative enrichment training spectrum and the correlation matrix was 
subsequently mean-centered and plotted with a cutoff similarity of 5%. 
Lipid class information was derived by concatenating the assigned lipids into a single 
matrix containing all lipids within that class and then summing the intensities after normalizing 
to the maximum lipid intensity within that class. The relative abundance of each respective lipid 
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class was plotted on the t-SNE plot using the “Hot” color map (MATLAB) between the 
normalized minimum (0) and maximum intensity (64).  
Rare cell finding methods were based on Ong et al. Anal. Chem 2015,[17] where lower 
principal components were used to target unique populations that contributed to lower degrees of 
variance. In MATLAB, the RMS normalized intensity matrix for the lipid range was mean-
centered for PCA. Using only the PCs contributing to the top 90% of the total variance, the PC 
scores were back-projected and subtracted from the preprocessed spectra resulting in a 
‘difference mass spectrum’. 
Lipids were subsequently assigned using high mass accuracy, LIPID MAPS structural 
computational database,[26] and previously published biological data (i.e. lipids found only within 
bacterial systems were excluded). All m/z values containing less than 10 cells were removed 
from selection. The 10 m/z values contributing most to the difference mass spectrum were 
selected as rare lipids and labeled with their putative lipid identity from LIPID MAPS. Lipid 
assignments all consisted of errors less than 5 ppm, although most assignments consisted of 
errors less than 3 ppm. Lipids found in less than 10 cells were removed from the study because 
these spectral features were likely a result of a small mass shift or contamination and, typically, 
not found between more than one biological replicate. 
6.3 Results and Discussion 
Single Cell MALDI FT-ICR Analysis  
We dissociate our cells onto a slide, locate these features and probe them via MALDI MS 
using microMS.[20] We first image the slide and determine the locations of the cell nuclei; we 
filter the fluorescent nuclei to exclude structures located less than 100 µm apart and objects that 
appear non-cellular by shape and size (e.g. debris, broken cells, and bare nuclei). Filtering by 
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distance and size reduce cell-to-cell contamination of the single cell spectra. We then acquire 
mass spectra on each of the thousands of remaining cells.  An advantage of this approach is that 
only cell-like features are measured; a typical MSI experiment spends most of its time sampling 
the space between dispersed cells or may probe only a portion of the cell depending where the 
cell is within the MSI rastering pattern. Once the spectra are obtained, spectral features with 
mass defects between 0.3 and 0.8 m/z values were used to find lipid candidates. Each selected 
m/z value was then matched against the LIPID MAPS structural computational database[25,26] to 
assign putative identifies for each spectral feature. Only candidates with mass errors lower than 5 
ppm were considered, although most errors were below a 3 ppm threshold.  
Using this procedure, we detected 520 distinct spectral features within the lipid mass 
region of ~30k rat cerebellum cells (Table 6.1), with the individual spectra available at the 
Illinois databank. The number of detected features is an order of magnitude higher than the 
number of lipid features detected within a lipid extract analyzed by either MALDI FT-ICR MS 
(34 lipid features) or ESI FT-ICR MS (52 lipid features; Figure 6.1). Typical lipidomics 
experiments survey the lipid content through comprehensive lipid extractions followed by LC-
MS.21 While lipid extracts from larger structures allows one to characterize hundreds of lipids, it 
does not provide details on cell heterogeneity nor details on lipids found only in the occasional 
cell, even if the lipid is at high levels in that cell. The single cell approach circumvents these 
issues, especially for low-abundance compounds found at higher levels within a subpopulation of 
cells. The largest limitation is limiting identifications to LC-MS based databases because of our 
inability to perform high quality tandem MS. 
On average we detected 34 lipids within each cell (ranging between 1 and 116) from 
these different lipid classes: phosphatidylcholine (PC), phosphatidylinositol (PI), 
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phosphatidylethanolamine (PE), phosphatidylserine (PS), triglyceride (TG), diglycerides (DG), 
hexcerimides, and phosphatidic acids (PA), demonstrating the capacity to detect many types of 
molecules using single cell MALDI MS. In total, 297 of filtered spectral features were matched 
to known lipids within the LIPID MAPS database with the aforementioned criteria. 
As expected for positive-mode MALDI MS, most of the assigned lipids were 
phospholipids likely originating from the outer plasma membrane. Differences within the 
abundance of these lipids impact membrane fluidity and curvature; the lipid composition can be 
correlated to cellular outgrowth and morphology. Other lipids are involved within cell-to-cell 
signaling or cellular division. The rich diversity of lipids has been noted within literature,[27-29] 
and our capacity to detect many different types of lipids is necessary for beginning to understand 
lipid heterogeneity on cellular resolutions. Moreover, the clusters identified within this dataset 
are primarily a result of natural variations within the cerebellum as opposed to animal-to-animal 
differences or sample preparation because neither of these experimental variables explain the 
extent of clustering found within the dataset (Figure 6.1). 
Lipid Clustering and Classification 
We use the detected lipid features to cluster individual cells using t-distributed stochastic 
neighbor embedding (t-SNE) with subsequent Louvain-Jaccard clustering. Overall, 101 distinct 
clusters are identified by the Louvain-Jaccard clustering criteria (Figure 6.2A). There are less 
than 30 canonical cell types within the cerebellum,[30,31] so obtaining 101 clusters shows the 
sensitivity of our analytical approach. Cluster 1 was the largest cluster and contained 882 cells, 
while clusters 100 and 101 were the smallest with 31 cells each.  
While our experimental conditions prevent directly correlating our clusters to ICC 
profiles of canonical cell types within the brain (e.g. neurons and glia), we characterize a 
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surprisingly large lipid diversity and distribution within the cerebellum.  To better relate this 
diversity to brain chemistry, we can use previously ascertained lipid profiles of neurons and 
astrocytes to determine if a cluster is more similar to neurons, astrocytes, or neither (Figure 
6.2B). Even though the lipid profiles were determined using different instrumentation and 
animals, we found clusters that correlate highly with either neurons or astrocytes, such as cluster 
11 and 39. Because ICC was not performed on the cells discussed here, we believe that MS lipid 
profiles themselves could be sufficient for independent classification of canonical cells within 
the brain. This is of particular interest, because of the inherent difficulties and limitations of 
antibody classifications. Moreover, each cluster is chemically different, so the various neuron-
like clusters could represent neuronal subclasses that differ by their lipid constituents (e.g. 
clusters 39 and 72). A similar statement could be said for astrocytes as well as the clusters that 
do not correlate with either neurons or astrocytes. The clusters that do not correlate with 
astrocytes nor neurons are likely a mixture of glia (excluding astrocytes), oligodendrocytes, 
neurons or astrocytes that would not have stained in the previous study, and other cell types. 
Some of these clusters could likely be classified with additional MS training from other ICC-
based classifications and is certainly a future direction of follow-up studies using this approach.  
By recoloring each cluster within the t-SNE plot, we can visualize the distribution of 
specific lipid classes and use this information to begin to parse out why each of these clusters are 
different. For example, PA lipids are higher abundance within cluster 78 compared to all other 
lipid classes and TG lipids are in higher abundance within clusters 99 and 49 compared to DG 
and PS lipids (Figure 6.3). While the distribution for each of the lipid classes can be ascertained, 
we only show a graphic for PC (Figure 6.2C), SM (Figure 6.2D), and PG (Figure 6.2E) lipids for 
clarity; however, the other classes can be found within Figure 6.3. PC lipids appear ubiquitous 
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within the profiled cells, which is in good agreement with their common and relatively high 
abundance within cell membranes, as well as their high ionization efficiency.[32-34] Perhaps what 
is even more interesting is the overlap between neuron-like cells and clusters containing a high 
abundance of SM lipids (e.g. clusters 11, 62, and 69 Figure 6.2D), as SM lipids are well known 
to compose neurons and are implicated in diseases that affect neurons.[35-38] While certain SM 
lipids are present in most cellular membranes, the ones localized to neuron-like clusters may be 
related to specific neuron morphology and function. PG lipids, however, are not as widespread as 
either PC or SM lipids and are localized to only a few clusters, such as clusters 5, 25, and 68 
(Figure 6.2E). Because none of the lipid classes have identical distributions within cells and their 
subsequent clusters, t-SNE allows us to visualize this heterogeneity within the profiled cells and 
their relative abundance.  
Average Cluster Spectra and Rare Lipid Analysis  
Further, we can begin discriminating the lipid profile of each cluster by averaging the 
spectra acquired from each corresponding cell (Figure 6.4 and 6.5). Of the 520 spectral features 
detected within the cells, 57% of the compounds were not be matched to known lipids and are 
the emphasis of follow-up studies. [PC(32:0)+H]+ (m/z = 734.5712) and [PC(34:1)+H]+ (m/z = 
760.5845) correspond to spectral features that are present within 99% and 90% of cells, 
respectively, indicating that these are highly conserved lipids as has previously been shown.39-41 
There are others, such as putative [PE(42:8)+H-H2O]
+ and [PG(40:2(OH))+Na]+, which are only 
present within a few clusters because they are only observed in a small number of cells. Each 
cluster has distinct lipid profiles, some of which vary quite wildly, such as clusters 28 and 91 that 
clearly differ in number of lipid signatures and their relative intensities (Figure 6.4), especially 
with [HexCer(t34:2)+K]+ (m/z 752.5074) and [PC(34:1)+Na]+ (m/z 782.5652). While average 
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mass spectra for only eight clusters are displayed in Figure 6.4, similar results are obtained for 
the other clusters and are illustrated within the Figure 6.5. 
Moreover, we can use our rich dataset to find lipids that are uncommon and detected 
within a small number of cells. Using the method described in detail within the methods section, 
we determined 10 spectral features that detected in less than 6.5% of cells with one unknown 
compound present in as little as 0.1% of the cells (Figure 6.6A). Because of their relatively low 
abundance, we assume that these lipids are often overlooked using traditional visualization 
methods. A peak for putative [PE(42:8)+H-H2O]
+ at an m/z value of 798.5414 is shown along 
with its C13 peak (m/z 799.5453), demonstrating that this is a rare lipid rather than an artifact 
(Figure 6.6B top) and for putative [PG(40:2(OH))+Na]+ at an m/z value of 869.5807, with the 
exception that its C13 peak is not completely resolved from the peak at m/z 870.5856 (Figure 
6.6B bottom). Nonetheless, this single cell MALDI MS method can be used to not only find rare 
lipid features among hundreds of more highly abundant chemical species but also locate these 
interesting cells for follow-up analysis with other analytical approaches.[42-44]  
We have demonstrated the utility of high throughput single cell MALDI MS for in depth 
chemical characterization of single mammalian cells. In sum, we detect 520 lipid features within 
thirty thousand individual cells using MALDI FT-ICR MS. From the information gained here, 
we are able to determine 101 significantly different clusters ranging in size using a combination 
of t-SNE and Louvain-Jaccard clustering, correlate some of the resulting clusters to previously 
ascertained astrocytic and neuronal lipid markers and visualize the localization of different lipid 
classes. Each cluster is represented by different lipid profiles, while still having some conserved 
lipid features, such as PC(32:0). Some of the spectral features were located only in a small 
number of cells, perhaps relating to rare functions possessed by brain cells. 
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We focused on lipid profiling within this study due to the functional importance of lipids 
within the brain and as well as the significant technical difficulties surrounding lipidomics, 
particularly at cellular resolutions.[45-47] Our ability to characterize thousands of cells for their 
lipid contents will enable lipid heterogeneity to be studied at an unprecedented level, allowing 
the interactions between cellular phenotype to be linked to the transcriptome and organismal 
state. Of course, the approaches can be expanded to include additional molecular classes such as 
metabolites, peptides, and proteins. A last exciting ability is to target the rare cells highlighted 
here for follow-up analysis with other analytical approaches such as CE-MS[42] and vibrational 
spectroscopy,[44] as the MALDI measurement leaves enough material behind to enable such 
measurements and multimodal analysis has demonstrated enhanced classification schemes.[43] 
While the described approach can easily be optimized for other brain regions and other animal 
models, the future of these experiments lies in the quality and abundance of chemical 
information held within each single cell that is acquired and can be used to tackle the poorly 
understood lipidome. Using this information, we can relate lipid profiles to known cellular 
functional and morphological differences among canonical cell types that has yet to be 
understood or even studied. 
6.4 Conclusions 
We have demonstrated a method for high-throughput analysis of the 520 lipids within 
thirty thousand individual cells using MALDI FT-ICR MS. From the information gained here, 
we are able to determine 101 significantly different clusters using a combination of T-SNE and 
Louvain-Jaccard clustering ranging in size. Each cluster is markedly different, while still having 
some conserved lipid features, such as PC(32:0). Some of the spectral features were located only 
in a small number of cells, perhaps relating to rare functions possessed by brain cells. Ultimately, 
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we have developed a protocol that allows for chemical exploration of the chemical heterogeneity 
within the brain, although we focus on the lipidome here. We focused on lipids because they 
have been known to have vast functional importance within the brain, but truly little is known 
about them.[24-26] While this method can easily be optimized for other brain regions and other 
animal models, the future of these experiments lies in the quality and abundance of chemical 
information held within each single cell that is acquired and can be used to tackle the poorly 
understood lipidome. Using this information, we can start ascertaining the functional relationship 
to this chemical heterogeneity and relate it to functional and shape differences among canonical 
cell types that has yet to be understood or even studied. Further work will involve identifying the 
structure and function of these lipids in addition to testing if these spectral features are more 
robust classification criteria than traditional immunohistochemical markers, such as glial 
fibrillary acidic protein or neurofilament L.  
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6.6 Figures and Table 
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Figure 6.2 A) Single cells within the rodent cerebellum can be classified into 101 clusters based 
on their spectral features within the lipid mass range. The clustering is based on lipid content 
and/or relative signal intensity. Information from ~30k single cells are visualized using a t-SNE 
plot and clustered using the Louvain-Jaccard method. Each cluster is colored and numbered. 
Cluster 1 contains the most cells (882 cells), while clusters 100 and 101 contain the least (31 
cells) in each. B) t-SNE plot recolored to show correlation of individual cells to neuronal and 
astrocytic lipid profiles that have been previously determined. C) t-SNE recolored by relative 
amount of phosphatidylcholine, D) sphingomyelin and E) phosphatidylglycerol lipid species to 
visualize the localizations of lipid classes. 
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Figure 6.3 t-SNE plot of cells colored by analysis date. FT-ICR MS analysis was performed 
over 22 days, where each day is represented by an individual color. 
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Figure 6.4 Average spectra of all cells located within their respective clusters. Visual 
observation of the clusters shows detectable spectral diversity that can be extended to all 101 
clusters. All spectral assignments are located in in Table 6.1 in m/z order. Only eight are shown 
here for clarity. 
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Figure 6.5 (cont.) 
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Figure 6.5 (cont.) 
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Figure 6.5 (cont.) 
179   
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Figure 6.5 (cont.) 
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Figure 6.5 (cont.)
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Figure 6.5 (cont.)
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Figure 6.5 (cont.)
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Figure 6.5 (cont.) 
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Figure 6.5 (cont.) Average mass spectra for each of the 101 clusters with the highest root-mean 
square normalized intensities labelled with their respective m/z value. 
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Figure 6.6 A) Spectra features that are detected within less than 6.5% of the analyzed cerebral 
cells as determined by reverse principal component analysis. A variety of lipid classes are 
represented within the plot. Some features are detected in less than 0.1% of analyzed cells. B) 
Two single cell mass spectra that highlight two of the rare spectral features, demonstrating that 
the features have adequate signal-to-noise ratios and expected isotopic patterns. The insets 
indicate that these are real spectral features rather than random noise or spectral artifacts. 
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700.3737   not matched  14 
700.4568 700.454796 C37H67NO9P [PE(32:4(OH))+H]
+ 2.8610 3794 
700.4752 700.475925 C34H71NO11P [PG(28:0(OH))+NH4]
+ -1.0350 13 
700.5093   not matched  172 
701.4621 701.462310 C41H65O9 [MGDG(32:6)+H-H2O]
+ -0.2994 79 
701.4848 701.486430 C37H70N2O8P [PE(32:4)+NH4]
+ -2.3236 1095 
702.4883   not matched  246 
703.5006 703.502080 C37H72N2O8P [PE(32:3)+NH4]
+ -2.1038 206 
703.5811   not matched  115 
704.5838 704.582366 C43H78NO6 [TG(40:4)+NH4]
+ 2.0352 16 
705.3712   not matched  159 
705.5234   not matched  3152 
706.3747 706.377333 C30H61NO15P [MIPC(d18:0)+H]
+ -3.7275 31 
706.5077   not matched  20151 
706.5269   not matched  519 
706.5418   not matched  4776 








707.5086 707.509260 C41H71O9 [MGDG(32:3)+H-H2O]
+ -0.9328 14423 
707.5384   not matched  2736 
707.5462   not matched  12 
707.6687 707.670058 C49H87O2 [CE(22:1)+H]
+ -1.9190 15 
708.4859   not matched  26 





708.5419   not matched  325 
709.4011   not matched  334 












710.4046   not matched  40 
710.4650   not matched  5735 
710.5008   not matched  775 
711.4668   not matched  922 
711.5044 711.504760 C37H73N2O7PNa [SM(t32:2)+Na]
+ -0.5060 25 
712.4817   not matched  74 
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713.3855 713.387170 C33H62O14P [PI(24:1(OH))+H]
+ -2.3409 113 





713.5990 713.595587 C41H82N2O5P [SM(d36:1)+H-H2O]
+ 4.7828 10 
714.3689   not matched  142 
714.3794 714.382419 C32H61NO14P [MIPC(d20:1)+H-H2O]
+ -4.2260 518 
715.3872   not matched  843 
715.4004 715.402820 C33H64O14P [PI(24:0(OH))+H]
+ -3.3827 35 
715.4179 715.418076 C37H64O11P [LPI(28:4)+H-H2O]
+ -0.2460 348 
716.3900 716.389942 C34H64NO10PK [PS(28:1)+K]
+ 0.0810 642 
716.4512   not matched  11118 
716.4608 716.462561 C39H68NO7PNa [LPE(34:6)+Na]
+ -2.4579 27 
717.3830   not matched  45 
717.3935   not matched  88 
717.4539 717.454819 C39H66O10Na [MGDG(30:4)+Na]
+ -1.2809 1121 





719.5003 719.496995 C37H72N2O9P [PE(32:3(OH))+NH4]
+ 4.5935 39 








720.5581   not matched  26 
721.5092 721.512645 C37H74N2O9P [PE(32:2(OH))+NH4]
+ -4.7747 29 
721.6868   not matched  36 
722.3649 722.364121 C32H62NO12PK [PI-Cer(t26:1)+K]
+ 1.0784 45 
722.4996   not matched  10499 
722.5206   not matched  12 
722.6895   not matched  23 





723.5023 723.501769 C39H72O10Na [MGDG(30:1)+Na]
+ 0.7339 1258 
724.4787 724.476041 C38H71NO9K [HexCer(t32:2)+K]
+ 3.6702 19754 
724.4989   not matched  1315 
724.5155   not matched  411 
725.4812   not matched  12585 
725.5112 725.511582 C41H74O8P [PA(38:4)+H]
+ -0.5265 2137 
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725.5587 725.556796 C39H79N2O6PNa [SM(d34:1)+Na]
+ 2.6242 20 





726.5137   not matched  65 
727.4623 727.465695 C38H68N2O9P [LPS(32:6)+NH4]
+ -4.6669 132 
727.5011 727.502080 C39H72N2O8P [PE(34:5)+NH4]
+ -1.3471 102 
727.5861   not matched  13 
728.5048 728.507225 C36H75NO11P [PG(30:0(OH))+NH4]
+ -3.3287 12 




















732.3545   not matched  1113 
732.4433   not matched  2177 











732.5558 732.556151 C47H74NO5 [DG(44:11)+NH4]
+ -0.4791 5859 
732.6108 732.613666 C45H82NO6 [TG(42:4)+NH4]
+ -3.9120 20487 
733.3583 733.361610 C39H57O11S [SQDG(30:8)+H-H2O]
+ -4.5135 674 
733.4470 733.443897 C41H66O9P [PA(38:8(OH))+H]
+ 4.2307 62 









733.5582   not matched  606 
733.6145 733.612937 C49H81O4 [DG(46:7)+H-H2O]
+ 2.1306 1687 
734.3569   not matched  39 
734.3657   not matched  16 





734.5707 734.569432 C40H81NO8P [PC(32:0)+H]
+ 1.7262 29772 
735.3781 735.377260 C39H59O11S [SQDG(30:7)+H-H2O]
+ 1.1423 48 
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735.5381 735.540560 C43H75O9 [MGDG(34:3)+H-H2O]
+ -3.3445 17 
735.5744   not matched  29185 
736.5781   not matched  24055 
737.5030 737.499433 C39H75N2O6PK [SM(d34:3)+K]
+ 4.8366 41 









738.4305   not matched  27 
738.4930   not matched  4816 
738.5142 738.515074 C41H72NO10 [MGDG(32:5)+NH4]
+ -1.1834 27 





739.4954   not matched  790 
740.4716 740.470840 C36H71NO12P [PI-[Cer(t30:1)+H]
+ 1.0264 7351 
741.4316 741.433726 C39H66O11P [LPI(30:5)+H-H2O]
+ -2.8674 416 
741.4753   not matched  476 
743.4928   not matched  60 
743.5790   not matched  11 
744.4090   not matched  15 
744.4790   not matched  106 
744.5715   not matched  15 





745.5077   not matched  1082 




746.4951   not matched  66 
746.5114 746.511917 C43H73NO7P [PE(38:6)+H-H2O]
+ -0.6925 275 








747.3689   not matched  51 
747.4626 747.459547 C42H68O9P [PG(36:7)+H-H2O]
+ 4.0845 4848 
747.5238 747.528295 C39H76N2O9P [PE(34:3(OH))+NH4]
+ -6.0131 192 
747.6101   not matched  1648 
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748.6126   not matched  25 
749.3913 749.390657 C35H66O12SK [SQDG(26:0)+K]
+ 0.8580 19 
749.5100 749.509177 C41H75O8PNa [PA(38:3)+Na]
+ 1.0980 40 
749.5888   not matched  147 
749.7138   not matched  43 
750.5275   not matched  72 








750.5850 750.585439 C42H81NO8Na [HexCer(d36:1)+Na]
+ -0.5849 172 
750.7175   not matched  30 





751.5887   not matched  18 
751.7212   not matched  10 
752.5074 752.507341 C40H75NO9K [HexCer(t34:2)+K]
+ 0.0784 18212 
752.5287   not matched  146 
752.5437   not matched  76 
753.4249   not matched  213 
753.4449 753.446729 C39H71O9PK [PA(36:3(OH))+K]
+ -2.4275 22 
753.5112   not matched  10491 
753.5887 753.588096 C41H83N2O6PNa [SM(d36:1)+Na]
+ 0.8015 15657 
754.4286   not matched  20 
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754.5136 754.513360 C38H76NO11S [SHexCer(d32:0)+H]
+ 0.3181 336 















755.3611   not matched  89 






755.6661 755.667653 C51H88O2Na [CE(24:2)+Na]
+ -2.0551 23 





756.6698   not matched  10 
757.5548   not matched  24669 
757.5636 757.562033 C40H83N2O6PK [PE-Cer(d38:0)+K]
+ 2.0685 63 
758.5586   not matched  5831 
















759.5735   not matched  456 





760.4723 760.467798 C41H72NO7PK [PE(P-36:5)+K]
+ 5.9200 1111 
760.4848   not matched  41 
760.5773   not matched  2765 










760.6398   not matched  363 
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761.4760 761.475197 C43H70O9P [PA(40:8(OH))+H]
+ 1.0545 69 
761.5885   not matched  25796 




762.4535 762.452784 C36H70NO12PNa [PI-Cer(t30:1)+Na]
+ 0.9391 613 





762.5922   not matched  13216 














763.6047   not matched  24782 
764.6060   not matched  11193 
765.4260   not matched  1923 
765.5335 765.530733 C41H79N2O6PK [SM(d36:3)+K]
+ 3.6145 19 
766.3535   not matched  12 
766.4284 766.426569 C38H66NO11PNa [PS(32:4(OH))+Na]
+ 2.3890 672 
766.5210   not matched  50 
768.3734   not matched  485 
768.5009 768.502140 C38H75NO12P [PI-Cer(t32:1)+H]
+ -1.6135 4258 





769.3797 769.384128 C41H63O9PK [PA(38:9(OH))+K]
+ -5.7553 20 
769.4609 769.465026 C41H70O11P [LPI(32:5)+H-H2O]
+ -5.3622 489 







769.5622 769.562033 C41H83N2O6PK [SM(d36:1)+K]
+ 0.2170 18 
769.5897   not matched  286 
770.5659 770.567026 C41H82NO8PNa [PE(36:0)+Na]
+ -1.4613 11 
771.4872   not matched  116 
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772.4422   not matched  5036 
772.5259 772.525313 C40H80NO8PK 

















773.4446   not matched  390 











773.6234   not matched  154 
774.4559   not matched  2926 




774.5234   not matched  20 
774.5322   not matched  10 
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775.4308 775.431079 C41H69O9PK [PA(38:6(OH))+K]
+ -0.3598 19 
775.4589   not matched  18 
775.4902 775.490847 C44H72O9P [PG(38:7)+H-H2O]
+ -0.8343 3774 
775.5699   not matched  16 
775.6042   not matched  189 
775.6386 775.636353 C53H84O2Na [CE(26:6)+Na]
+ 2.8970 81 





776.5027 776.504820 C38H76NO11PNa [PI-Cer(d32:0)+Na]
+ -2.7302 24 












777.3824   not matched  35 
777.5824   not matched  96 







777.7433   not matched  45 
778.6152 778.616739 C44H85NO8Na [HexCer(d38:1)+Na]
+ -1.9766 13 
778.6496   not matched  16 
778.7465   not matched  31 
779.4012 779.404864 C43H65O8PK [PA(40:10)+K]
+ -4.7010 69 
779.5480     14 








780.5496 780.551376 C42H80NO8PNa [PC(34:2)+Na]
+ -2.2753 187 
781.5293   not matched  40 
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781.6199 781.619396 C43H87N2O6PNa [SM(d38:1)+Na]
+ 0.6448 597 





















783.5715   not matched  17724 
783.6965   not matched  25 






784.5715 784.569941 C42H83NO9K [HexCer(t36:0)+K]
+ 1.9871 2035 





784.6997   not matched  15 
785.5044   not matched  50 
785.5872   not matched  9614 
786.4560   not matched  2195 
786.5903   not matched  260 









787.4591   not matched  256 
787.5185   not matched  38 
787.6013   not matched  4387 















789.5342   not matched  826 
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789.6201   not matched  20068 




790.4811 790.478363 C42H74NO8PK [PC(34:5)+K]
+ 3.4625 508 








790.6201   not matched  5319 
791.4420   not matched  13 
791.5498   not matched  76 






793.6718   not matched  114 
















795.4578   not matched  12 
795.5422 795.539909 C40H79N2O11S [SHexCer(d34:2)+NH4]
+ 2.8798 12 







796.4609   not matched  88 
796.5219 796.523924 C40H78NO12S [SHexCer(t34:1)+H]
+ -2.5410 42 


















797.4516   not matched  90 
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798.5423 798.543217 C47H77NO7P [PE(42:8)+H-H2O]
+ -1.1483 1116 
799.3642   not matched  20 











800.5392   not matched  13 
800.5580 800.558867 C47H79NO7P [PE(42:7)+H-H2O]
+ -1.0829 32 
801.3689   not matched  35 





802.4518   not matched  6386 
802.4877   not matched  1872 
802.5174 802.514749 C44H78NO7PK [PC(P-36:5)+K]
+ 3.3034 193 

















803.4550   not matched  1900 
803.5300 803.533380 C45H76N2O8P [PE(40:9)+NH4]
+ -4.2064 82 
804.3535   not matched  1498 
804.5113 804.514990 C43H76NO9PNa [PE(38:5(OH))+Na]
+  25 

















805.3566   not matched  726 
805.5051   not matched  22 
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805.7739   not matched  16 
806.3692   not matched  255 






















806.6801   not matched  23 
807.3739   not matched  40 
807.5739 807.574577 C43H84O11P [PI(O-34:0)+H-H2O]
+ -0.8383 1492 
808.3693   not matched  10 








808.5802 808.578068 C42H82NO13 [LacCer(d30:0)+H]
+ 2.6367 1669 
808.6631 808.663690 C46H91NO8Na [HexCer(d40:0)+Na]
+ -0.7296 333 
809.5584   not matched  27 
















809.6475 809.650696 C45H91N2O6PNa [SM(d40:1)+Na]
+ -3.9474 12 
809.6662   not matched  47 
810.3835 810.380049 C33H66NO17P2 [PIP(24:1(OH))+NH4]
+ 4.2585 16 
810.5741 810.575960 C42H84NO11S [SHexCer(d36:0)+H]
+ -2.2947 3191 
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811.6832   not matched  59 






811.7273 811.730253 C55H96O2Na [CE(28:2)+Na]
+ -3.6379 13 
812.5383   not matched  184 
812.6024 812.601241 C44H87NO9K [HexCer(t38:0)+K]
+ 1.4263 559 










814.4150   not matched  860 
814.4884   not matched  4021 








814.6290 814.629626 C44H90NO8PNa [PC(O-36:0(OH))+Na]
+ -0.7684 712 
814.6853   not matched  562 
815.4260   not matched  6900 
815.4916   not matched  2216 












815.6338   not matched  126 





816.4292   not matched  1004 
 
Table 6.1 (cont.) 
209   
 


















816.7011   not matched  21 
817.3574   not matched  170 
817.6480   not matched  565 
818.3699   not matched  218 
819.3747   not matched  32 
820.3873   not matched  704 
820.5279 820.527567 C49H75NO7P [PE(44:11)+H-H2O]
+ 0.4058 13 
821.3889   not matched  240 






822.6405 822.642954 C46H89NO9Na [HexCer(t40:1)+Na]
+ -2.9831 681 
823.4515 823.452208 C42H73O11PK [PG(36:5(OH))+K]
+ -0.8598 247 
823.5781 823.580725 C42H83N2O11P [PI-Cer(d36:2)+NH4]
+ -3.1873 11 
823.6438   not matched  194 
824.5532 824.555224 C42H82NO12S [SHexCer(t36:1)+H]
+ -2.4547 13 
825.4665 825.467858 C42H75O11PK [PG(36:4(OH))+K]
+ -1.6451 107 
825.5566   not matched  50 
826.4697   not matched  24 
826.5691 826.570875 C42H84NO12S [SHexCer(t36:0)+H]
+ -2.1474 332 
827.5723   not matched  44 
827.6586 827.661261 C45H93N2O7PNa [SM(t40:0)+Na]
+ -3.2151 10 
828.3937   not matched  12731 






829.3969   not matched  3277 






830.4845   not matched  6450 
830.5126 830.509663 C45H78NO8PK [PE(40:6)+K]
+ 3.5364 10 
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831.4877   not matched  2114 
831.5533 831.553447 C48H80O9P [PG(42:7)+H-H2O]
+ -0.1768 873 







832.6615 832.663690 C48H91NO8Na [HexCer(d42:2)+Na]
+ -2.6301 1666 
833.3535   not matched  167 
833.3704 833.372029 C41H62O15K [DGDG(26:7)+K]
+ -1.9547 57 










833.6647 833.662998 C47H94O9P [PA(44:0(OH))+H]
+ 2.0416 1123 







834.3604   not matched  287 
























834.6773 834.679340 C48H93NO8Na [HexCer(d42:1)+Na]
+ -2.4440 480 
834.7111   not matched  12 
835.3637   not matched  34 




835.6074 835.605877 C45H88O11P [PI(O-36:0)+H-H2O]
+ 1.8226 1358 
835.6637 835.666346 C47H93N2O6PNa [SM(d42:2)+Na]
+ -3.1663 623 
835.6806   not matched  82 
836.3819   not matched  166 
836.3969   not matched  27 
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836.6669   not matched  260 
837.3663   not matched  461 
837.3851   not matched  22 
837.5014 837.502474 C44H74N2O11P [PS(38:8(OH))+NH4]
+ -1.2824 14 












837.6664 837.669146 C45H94N2O9P [PE(40:0(OH))+NH4]
+ -3.2781 45 
837.6795 837.681996 C47H95N2O6PNa [SM(d42:1)+Na]
+ -2.9797 37 
838.3696   not matched  137 
838.5027 838.501746 C48H73NO9P [PS(42:10)+H-H2O]
+ 1.1377 1050 
838.6059 838.607260 C44H88NO11S [SHexCer(d38:0)+H]
+ -1.6217 287 
838.6265 838.629626 C46H90NO8PNa [PC(38:1)+Na]
+ -3.7275 437 
839.4459   not matched  20 







839.5697 839.566124 C42H83N2O12S [SHexCer(t36:2)+NH4]
+ 4.2593 12 




841.4618   not matched  415 
841.4805   not matched  31 
841.5630 841.558926 C46H82O11P [PG(40:5(OH))+H]
+ 4.8410 10 
841.5762 841.580056 C43H86O13P [PI(O-34:0(OH))+H]
+ -4.5818 32 
842.4181   not matched  94 
842.4650   not matched  10 
842.5212 842.523627 C42H77NO14Na [LacCer(t30:2)+Na]
+ -2.8806 2820 
842.6600 842.660926 C46H94NO8PNa [PC(O-38:0(OH))+Na]
+ -1.0989 279 
843.3688 843.369150 C37H65O17P2 [PIP(28:4(OH))+H]
+ -0.4150 62 
843.5264 843.528295 C47H76N2O9P [PE(42:11(OH))+NH4]
+ -2.2465 856 
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843.6651   not matched  31 
844.5296 844.531034 C42H80NO12PNa [PI-[Cer(t36:2)+Na]
+ -1.6980 11 







845.6810   not matched  277 
846.4817   not matched  89 




848.5613 848.562334 C42H84NO12PNa [PI-Cer(t36:0)+Na]
+ -1.2185 13 




848.6569 848.658604 C48H91NO9Na [HexCer(t42:2)+Na]
+ -2.0079 1264 






849.6002 849.600397 C49H86O9P [PA(46:6(OH))+H]
+ -0.2319 45 
849.6602   not matched  878 
850.3990   not matched  17 
850.6578   not matched  18 
850.6728 850.674254 C48H93NO9Na [HexCer(t42:1)+Na]
+ -1.7092 1661 
851.6760   not matched  707 



















853.3619   not matched  225 





854.3651   not matched  24 








856.6529 856.655599 C47H96NO7PK [PE(O-42:0)+K]
+ -3.1506 42 
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857.3861   not matched  13 






857.6561   not matched  10 
858.4156   not matched  17 
858.4794   not matched  14 

























859.4020   not matched  216 







859.5839 859.584747 C50H84O9P [PG(44:7)+H-H2O]
+ -0.9854 62 
860.4090   not matched  100 
860.4990 860.495456 C42H79NO12SK [SHexCer(t36:2)+K]
+ 4.1186 4185 
861.5023 861.502474 C46H74N2O11P [PS(40:10(OH))+NH4]
+ -0.2020 1746 
861.6673 861.669146 C47H94N2O9P [PE(42:2(OH))+NH4]
+ -2.1423 134 
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866.5355 866.533046 C50H77NO9P [PS(44:10)+H-H2O]
+ 2.8320 893 





866.6742   not matched  25 








867.6306 867.626334 C55H88O5K DG(52:10)+K]
+ 4.9169 5047 




868.5776   not matched  67 
868.6339   not matched  2300 
869.5884 869.587821 C46H87O11PNa [PG(40:2(OH))+Na]
+ 0.6658 39 
869.6109 869.611356 C45H90O13P [PI(O-36:0(OH))+H]
+ -0.5244 31 
870.3816   not matched  36 
870.4435   not matched  62 
870.5016 870.504578 C47H78NO9PK [PE(42:8(OH))+K]
+ -3.4210 45 
870.5935   not matched  12428 












871.4524 871.452208 C46H73O11PK [PG(40:9(OH))+K]
+ 0.2203 19 
871.5968 871.595981 C50H84N2O8P [PC(42:10)+NH4]
+ 0.9396 11114 
871.6981   not matched  203 
872.3975   not matched  47 
872.4125   not matched  183 
872.6001   not matched  5936 
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873.3727   not matched  212 
873.4196 873.416100 C39H71O17P2 [PIP(30:3(OH))+H]
+ 4.0072 273 
873.6033 873.600397 C51H86O9P [PA(48:8(OH))+H]
+ 3.3230 21 
873.7140   not matched  473 





874.3816   not matched  154 
874.4172   not matched  1083 
874.4360   not matched  111 
874.5166 874.520470 C46H78NO11PNa [PS(40:6(OH))+Na]
+ -4.4253 15 
874.7173   not matched  12 
875.3861   not matched  25 
875.4218   not matched  776 
876.4288   not matched  409 
876.4475   not matched  79 
876.4963 876.494013 C49H76NO8PK [PE(44:11)+K]
+ 2.6093 74 
876.5957 876.593635 C44H88NO12PNa [PI-Cer(t38:0)+Na]
+ 2.3557 1 




877.4433 877.447401 C39H75O17P2 [PIP(30:1(OH))+H]
+ -4.6738 200 
















878.4335   not matched  22 











880.3913   not matched  16 
880.6482   not matched  41 
880.7457   not matched  11 
881.7584 881.759267 C57H101O6 [TG(54:5)+H]
+ -0.9833 15 
882.4841   not matched  59 
882.5723 882.573554 C46H85NO11SNa [SHexCer(d40:3)+Na]
+ -1.4208 194 
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882.6323 882.633475 C46H92NO12S [SHexCer(t40:0)+H]
+ -1.3312 52 





886.4410   not matched  26 
887.4012   not matched  115 
888.4083   not matched  94 
888.5339 888.536272 C44H84NO12PK [PI-Cer(t38:2)+K]
+ -2.6696 3126 
889.4172   not matched  168 
889.4528   not matched  20 




889.7116 889.713296 C51H99N2O6PNa [SM(d46:3)+Na]
+ -1.9062 10 
890.4261   not matched  163 
891.4331   not matched  124 
892.5790 892.582676 C51H84NO8PNa [PE(46:9)+Na]
+ -4.1184 47 









894.5969 894.598326 C51H86NO8PNa [PE(46:8)+Na]
+ -1.5940 138 












895.6658 895.666498 C49H97N2O7PK [SM(t44:2)+K]
+ -0.7793 34 
895.6977   not matched  19 
896.6147 896.613976 C51H88NO8PNa [PE(46:7)+Na]
+ 0.8075 10641 
896.6466 896.649125 C47H94NO12S [SHexCer(t41:0)+H]
+ -2.8160 29 
897.6180 897.619121 C48H91O11PNa [PG(42:2(OH))+Na]
+ -1.2489 8816 




898.7282 898.728302 C59H96NO5 [DG(56:12)+NH4]
+ -0.1135 16 
899.6322 899.634771 C48H93O11PNa [PG(42:1(OH))+Na]
+ -2.8578 6380 
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Table 6.1 (cont.) 858 lipid features detected by high throughput single cell FT-ICR MALDI MS 
in 10 or more cells, their mass matched putative assignments, and number of cells where they are 
observed. Only lipids known to be present in mammalian tissues are used for lipid assignment.  
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CHAPTER 7 
MULTIMODAL CHEMICAL ANALYSIS OF THE BRAIN BY HIGH RESOLUTION MASS 
SPECTROMETRY AND INFRARED SPECTROSCOPIC IMAGING 
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7.1 Introduction 
The brain is a complex organ that is incompletely understood, partly due to its vast 
chemical and cellular heterogeneity. Communication between different cell types via the 
exchange of chemical signals contributes to emergent functions, including episodic and spatial 
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memory, in which the hippocampus plays a critical role.[1,2] While many morphological regions 
of the hippocampus are involved in the formation and maintenance of different memory types, 
the dentate gyrus (DG) is implicated in the formation of spatial and long-term memory.[3,4] A 
wide range  of distinct cell types are present in the DG, including granule cells, astrocytes, 
ependyma, radial glia, neuroblasts, and inhibitory neurons.[5] Several analytical approaches have 
effectively been used to advance our understanding of brain function, e.g., electrophysiology,[6] 
immunohistochemistry,[7] behavioral analysis,[8] magnetic resonance imaging,[9] among others.[10-
13] Despite this progress, there remains a need for techniques capable of untargeted, multiplex 
chemical analysis at spatial resolutions relevant to cellular length scales.   
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) 
is capable of multiplex detection and structural characterization of hundreds to thousands of 
analytes within a sample at femtomole  detection limits.[14] However, MALDI MSI typically 
obtains spatial resolutions greater than 20 µm,[15] precluding subcellular imaging of tissue 
sections using most commercial instruments. Several labs have built prototype MALDI mass 
spectrometers capable of subcellular resolution,[16,17] or used oversampling techniques on 
commercial instruments[18] to achieve smaller pixel sizes. However, these approaches can reduce 
chemical coverage due to the decreased absolute number of analytes present in a single pixel of 
the chemical image.  
Although instrument modifications are one approach to achieving higher spatial 
resolutions, an alternative is to enhance the resolution of mass spectrometry (MS) ion images 
through sharpening using another imaging modality.[19-21] When an ion distribution image is 
correlated to an underlying, high spatial resolution image, the results of sharpening are 
encouraging. However, generally only a single, high spatial resolution image is available for 
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sharpening. Pan sharpening ion images with contrasting high spatial resolution images can 
induce artifacts or degrade the quality of the original MS image. Therefore, a singular, high 
spatial resolution image limits the number and diversity of ion images suitable for sharpening, 
possibly excluding important analytes. Here, we overcome this limitation by sharpening MS 
images with those obtained using another chemical imaging approach. 
Infrared (IR) spectroscopic imaging is a non-destructive, optical imaging method that 
provides rich spectral information at micron spatial resolution.[22,23] Numerical algorithms can 
relate the data to histologic identity or transformation of constituent cells,[24-28] and provide 
images that mimic those obtained from conventional staining protocols.[29,30] The collected data 
can be used to identify classes of chemicals in tissue[31] but not most individual metabolites in 
complex biological samples. Thus, coupling IR and MSI presents a unique opportunity to 
integrate complementary spectral data and spatial resolutions. We applied this combined 
approach to measure chemical distributions present within the hippocampus, including the DG.  
Because of its promise, the integration of MSI and vibrational spectroscopy has been a 
long-term goal.[32-34] Practitioners have recorded IR imaging data prior to MSI by combining 
synchrotron Fourier transform (FT)-IR microspectroscopy with time-of-flight (TOF)-secondary 
ion mass spectrometry to study histopathological changes in hepatic steatosis.[35,36] Recently, 
hyperspectral imaging was performed with FT-IR spectroscopy, confocal Raman spectroscopy, 
and MALDI MSI on hamster brains.[37] In that work, the FT-IR and Raman spectroscopic 
analyses were conducted on the same tissue section, and MALDI MSI was used to study an 
adjacent section.  
Our goal was to demonstrate enhanced registration and image correlations using both 
modalities to interrogate the same sample. The choice of recording IR data first seems intuitive 
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and straightforward. However, as IR spatial resolution increases, the image acquisition time also 
rises to at least several hours, over which analytes in the fresh tissue (as required for MSI) may 
degrade. While MALDI MS is generally considered destructive, prior reports have shown that 
only a fraction of the sample is consumed during the measurement process.[38] After single cell 
MALDI MS, sufficient material remains for follow-up analyses.[39,40] In imaging applications, 
tissue sections are frequently stained following MSI.[41-45] The MALDI matrix 2,5-
dihydroxybenzoic acid (DHB) is utilized industrially as an antioxidant[46,47] and the vacuum 
created inside the ion source reduces oxidation during analysis.[48] This may be one of the first 
explorations of using these two imaging modalities, at their native optimal configurations, in 
which MS is performed first. Given the persistence of diagnostic information in IR imaging, 
despite the influence of various preparation conditions,[25,49-51] it is likely that IR chemical 
signatures arise from robust structural features, and different regions of the brain are likely 
conserved post-MALDI analysis as well.  
We developed a combined chemical imaging approach that allows broadened spatio-
chemical characterization of a variety of biological samples via sequential analysis of specimens 
using MSI followed by IR imaging. While counter-intuitive in terms of analysis order, the 
methodology preserves the information acquired by both analytical modalities. The resulting 
multimodal imaging dataset can be easily spatially registered through affine transformations and 
is suitable for data fusion, including pan sharpening. Compared to prior approaches for 
sharpening MS ion images utilizing optical monochrome morphological information, we used 
“chemical pan sharpening” as a means to leverage both the higher spatial resolution IR image 
and spectral content to optimally fit the ion distribution images. Finally, we determined that data 
fusion of the image sets enables discrimination between anatomically relevant brain regions. 




All chemicals were purchased from Millipore Sigma (St. Louis, MO) and used without 
further purification unless otherwise specified.  
Animals.  
Ten- to twelve-week old LE/BluGill rats (University of Illinois at Urbana-Champaign) 
were used for all studies. Use of this inbred strain greatly reduces inter-experimental variation 
common to outbred animals and allows achievement of high statistical significance with small 
sample sizes. A dense genome scan was performed at a 10 cM interval between markers on 
LE/BluGill progenitors. The results of this scan, performed by the Medical College of Wisconsin 
Human and Molecular Genetics Center as part of the National Heart, Lung, and Blood Institute 
(NHLBI) Programs for Genomic Applications (PGA) U01 HL66579, demonstrated that the 
colony is inbred, yielding one allele at each locus tested (http://pga.mcw.edu/pga-
bin/strain_desc.cgi).  
All animal-related experimental procedures were conducted at the University of Illinois 
at Urbana-Champaign under protocols approved by the Institutional Animal Care and Use 
Committee under Animal Welfare Assurance number A3118-01. All animal care and 
experiments were conducted in full compliance with the principles and procedures outlined in 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals. 
Tissue Sectioning.  
Coronal brain sections containing the hippocampus were prepared from adult LE/BluGill 
rats. Rats were sacrificed by decapitation 2 h after lights were turned on in the donor colony. 
Brains were quickly removed and placed on dry ice crushed to a fine powder. Coronal brains 
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were sectioned (20 µm) by cryostat at -17°C (Microm HM550, Thermo Fisher Scientific, 
Waltham, MA). Sections containing a similar hippocampal rostral-caudal plane from three 
separate animals were placed on the same low emission (low-E) glass slide (Kevley 
Technologies, Chesterland, OH) and stored with Drierite desiccant at –80°C until further 
analysis. Placing the three biological replicates on a single slide reduces batch variations for IR 
analysis and correlated MS analysis.  
Sample Preparation and MS Analysis.  
Tissue sections for MS analysis were warmed to room temperature in a dry nitrogen box 
for an hour before MALDI matrix application. DHB was sublimed onto tissue sections, forming 
a fine crystal layer with a thickness of ~0.3 mg/cm2 for lipid analysis using a custom sublimation 
chamber described previously.[52] Following sublimation, slides were returned to 22°C within a 
dry nitrogen box for at least 15 min. Prior to quantum cascade laser (QCL)-IR analysis (either 
before, after, or without MALDI MS analysis), sections were placed in a vacuum desiccator for 2 
h. 
Coated with DHB, hippocampal tissue sections were imaged at 1200 dpi with a flatbed 
scanner (Canon U.S.A. Inc., Melville, NY) to guide MSI. Optical images were loaded into 
flexImaging ver. 4.1 (Bruker Corp., Billerica, MA) and registered with a solariX XR 7T FT-ion 
cyclotron resonance (ICR) mass spectrometer (Bruker Corp.). Figure 7.1 displays the optimized 
protocol for correlated MALDI MSI and QCL-IR spectroscopy. Spectra were acquired in 
positive mode covering a mass range of m/z 150 to 3000, requiring a 0.7340 s transient. All MS 
data were acquired using the “minimum” laser probe setting (~25 µm diameter). The tissue was 
imaged with a 25 µm pixel size and two additional biological replicates were collected with 50 
µm pixel sizes, with corresponding data presented in the supporting information. Data at each 
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pixel was generated by accumulating ions produced during ten laser shots at 25% power and 
1000 Hz, unless otherwise specified. Reduced profile spectra were saved via FTMS control and a 
reduced file was generated within flexImaging for later import into SCiLS 2016b ver. 4.01.8720 
(Bruker Corp). Within SCiLS, spectra were root mean square (RMS) normalized and exported in 
imzml format for further analysis.  
Matrix Removal and Sample Fixation.  
After MSI analysis, hippocampal tissue sections were placed within a solution of 4% 
paraformaldehyde (PFA) in 1× phosphate buffered saline (PBS; ThermoFisher Scientific) for 15 
min to remove the MALDI matrix and concurrently fix the tissue sections. Tissues were washed 
in PBS for 3 min following fixation and briefly rinsed with Milli-Q water (Millipore, Billerica, 
MA) to remove any remaining salts. Tissues were dried under a stream of nitrogen gas and 
placed within a desiccator for 2 h before QCL-IR imaging. 
Infrared Analysis.  
IR spectroscopic images were acquired using a prototype QCL-IR system (Agilent 
Technologies, Santa Clara, CA). The discrete frequency QCL-IR system uses a room 
temperature single-point bolometer detector, with a 0.72 NA objective lens. Spectra were 
acquired in the mid-IR range, 1900–800 cm-1, at 8 cm-1 spectral resolution and 5 μm image pixel 
size in reflection mode. Spectral processing steps were implemented in MATLAB 2015b 
(MathWorks, Inc., Natick, MA) and the ENVI-IDL 4.8 environment, and saved as .mat files for 
registration with MALDI images. 
Data Registration and Analysis.  
MSI datasets were imported into MATLAB as imzml files using a modified version of 
MSIreader.[53] The series of mass spectra corresponding to each pixel with the MS image 
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consisted of m/z intensity pairs of centroid data. Mass spectra were aligned with non-uniform bin 
widths because mass resolution changes as a function of m/z value for FT-ICR MS. For example, 
the bin width at m/z 150 was 0.0004 Da and 0.05 Da at m/z 2500, with 10 additional divisions in 
between. Bin widths were estimated as the average peak width at m/z values over the range of the 
mass spectra. Bins were constructed as piecewise linear divisions over the entire spectral range. 
Next, the centroided m/z values of each peak in the spectrum were counted and placed into finer 
bin divisions (one-eighth the values provided above) for outlier noise removal. The distribution 
of peak frequency was peak-picked with a minimum peak distance of the original bin width and 
a height threshold of 0.1% of the number of pixels. These operations removed peaks found in a 
small subset of pixels, producing a tentative m/z list for the aligned data set.  
Next, the rough m/z list was refined by determining the center of mass for all peaks 
falling within the bin range.  Thus, while binning was performed for alignment, the recorded m/z 
value retained high mass accuracy from the FT-ICR MS data. Finally, the signal intensity matrix 
was populated from the exact m/z list by summing the intensities within the recorded m/z value ± 
the bin width. The resulting data matrix was suitable for performing multivariate data analysis. 
Image registration between MS and IR images was performed on the score image of 
principal component 1 (PC1) determined during principal component analysis (PCA) of the data 
matrix, which captures the majority of variance in each imaging mode. To speed computation, a 
subset of 1000 pixels was randomly chosen from each set of images to estimate the coefficient 
matrix by PCA. The entire score image was estimated by multiplying the signal intensity matrix 
by the coefficients determined with a subset of pixels. The score image resulting from PCA on a 
subset of pixels was qualitatively identical to the entire dataset and produced adequate alignment 
through image registration. 
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Next, the score images were roughly overlain by manually selecting control points from 
anatomical features present in each image. The initial, affine transformation was utilized to seed 
intensity-based registration, which produces better overlap. Manually determining the initial 
transformation was necessary to ensure consistent convergence of the intensity-based 
registration. The resulting affine transformation was then utilized to map the MS image onto the 
IR image space.  
Pan Sharpening.  
Pan sharpening was performed with a Laplacian pyramid method, which utilizes high 
spatial frequency components from the higher spatial resolution IR image to sharpen chemical 
images obtained by MSI.[21] Briefly, this implementation incorporates the affine transformation 
from registration to estimate a scaling factor, and can match arbitrary differences in scale. First, 
the scale of the transformation is utilized to determine the number of iterations to down-sample 
the IR image. Each down-sample increases the pixel size by a factor of two. To match the image 
modalities for fusion, the MS image is up-sampled slightly to the next matching size, e.g., fusing 
the 5 µm IR pixels with the 25 µm MSI pixels required interpolating the MS image to 20 µm for 
two iterations of down-sampling. 
At each iteration, the IR image is reduced with the kernel specified by Burt and Adelson, 
as implemented in the MATLAB function impyramid.[54] The difference between the effectively 
blurred reconstruction and the current image retains the high frequency features of the image, 
which is stored in the Laplacian pyramid. Once the IR image is resized to match the MS image, 
the process is repeated in reverse. At each iteration, the MS image is expanded by a factor of two 
and the Laplacian pyramid imparts the high frequency information from the IR image.  
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Midlevel Data Fusion.  
Data fusion of each image set was performed by up-sampling the MS images to match IR 
image spatial resolution. Briefly, both MS and IR images were subjected to PCA for 
dimensionality reduction while retaining 99% of variance for the IR data and PC1–PC10 for the 
MSI (~64–81% of variance). The choice of principal components attempted to balance the 
contributions of each modality while rejecting any unnecessary noise. To up-sample the MSI 
data, each score image was spatially transformed to the IR image with bilinear interpolation. 
Data fusion was conducted pixel by pixel between the IR and MS images by concatenating the 
PC scores and standardizing each principal component to be mean centered with unit variance. 
The resulting, fused image was again subjected to PCA to identify the highest-variance 
contributions. 
For unsupervised, multivariate classification, similar pixels were grouped together by k-
means clustering for each IR spectral feature image, interpolated MS image, and fused score 
image. Within the hippocampus, clustering highlights anatomical regions that are chemically 
similar to each other. The optimum number of clusters was determined by Davies-Bouldin 
cluster evaluation. Statistically significant differences in ion intensity between anatomical 
regions were tested by one-way ANOVA with multiple comparison false discovery correction. A 
post-hoc Tukey-Karmer method was used for multiple comparison tests between significantly 
different ion intensities. 
7.3 Results and Discussion 
Optimized Acquisition of Multimodal Imaging Datasets.  
Combining disparate analytical techniques frequently requires compromising established 
protocols to prepare a sample suitable for analysis by each method. The suboptimal performance 
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of a given method is an acceptable compromise if the orthogonal information acquired from the 
multimodal approach offsets the degraded data quality and/or analyte coverage compared to 
using a single method. To optimize multimodal data acquisition, a systematic assessment of 
QCL-IR and MALDI MS analyses and their interactions was performed.  
To analyze the same tissue section, some compromises between MALDI MS and IR 
imaging were required. IR imaging of tissue sections frequently employs salt plates with low IR 
absorbance, or low-E glass slides that reflect IR light effectively. Due to their lower cost, we 
utilized low-E glass slides for the IR acquisition. Initial attempts to increase low-E slide 
conductivity for MALDI-TOF analysis included gold sputtering following MALDI matrix 
application. This treatment introduced additional variance during sample preparation and left an 
insoluble residue after MALDI matrix removal, complicating subsequent IR analysis. Thus, we 
used a MALDI FT-ICR mass spectrometer, which functions appropriately with non-conductive 
substrates, likely because of the decoupling of analyte desorption/ionization and analysis, as well 
as the medium level of vacuum in the ion source.[55] We also found that spray-based MALDI 
matrix application led to unacceptable levels of analyte delocalization, as was evident in the 
resulting IR images. Thus, we applied MALDI matrix by sublimation, thereby improving IR 
imaging.  
Since IR microspectroscopy is generally assumed to be non-destructive, in our initial 
experiments, IR imaging of tissue sections was conducted first. The post-IR imaging tissues were 
degraded in quality for further MSI measurements; many chemical compounds became 
undetectable and the overall signal intensity was lower compared to control tissue analyzed 
directly with MALDI MSI. To validate this finding, adjacent tissue sections were imaged by 
MALDI MS with and without IR analysis (Figure 7.2). Optimum signal intensity was obtained 
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using MALDI MS with 25% laser power and 10 laser shots for the control sample (Figure 
7.2A(i)). Using the same settings we were unable to acquire high quality mass spectra from 
tissue after IR imaging (Figure 7.2A(ii)). For example, the RMS-normalized intensity of the base 
peak in the average mass spectrum decreased from 1.6×107 to 4×106 counts following IR 
imaging (Figure 7.2B(i) and (ii)). As shown in Figure 7.2A(iii), doubling the laser power and 
number of laser shots were necessary to regain similar signal intensity (9×107 counts) but not the 
morphological detail of the ion images. While doubling the laser power increased the raw 
intensity above values obtained in the control measurement, the observed noise level also 
became disproportionally higher (~100 fold), demonstrating that the signal-to-noise ratio was 
still worse overall. Moreover, tissue exposed to higher MALDI MS laser power was physically 
damaged, preventing follow-up staining with hematoxylin and eosin, or immunohistochemistry. 
Our finding that the tissue has degraded MS signal after IR imaging is counter intuitive as it 
disagrees with nano-IR studies which have shown minute temperature changes with QCL 
illumination.  However, lipid degradation in unfixed tissue at ambient conditions has been shown 
to reduce MSI signal quality. Exploration of the mechanism and magnitude of tissue degradation 
is beyond the scope of this manuscript but is an area warranting further investigations. Thus, the 
approach of acquiring IR data first likely leads not only to poorer mass spectral data but may also 
provide additional variability in the IR measurement itself as the sample changes. One option to 
mitigate damage could be to use a tightly controlled protocol that may also involve nitrogen 
purging. But this was not explored here. 
Next, we explored reversing the order of the multimodal measurements by first 
examining how MALDI MS alters the results of IR measurements. Adjacent hippocampus tissue 
sections were analyzed with IR imaging with various perturbations from the MALDI MSI 
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process. Tissues were either 1) directly fixed using PFA, 2) coated with DHB and then fixed, or 
3) coated with DHB, analyzed by MALDI MS, and fixed. Figure 3A displays absorbance images 
acquired at wavenumbers for the asymmetric PO2
- stretch (1248 cm-1) and amide II stretch (1656 
cm-1). Qualitatively, the images indicate no damage from MALDI desorption and no apparent 
distortion or blurring of expected morphological image features. The average absorption 
spectrum was calculated from the hippocampal region, shown as shaded regions of interest, and 
plotted for direct comparison (Figure 7.3B). The spectra indicate a slight red shift in IR spectra 
collected from tissues exposed to DHB, with no change upon laser ablation. Similar shifts have 
been reported for different fixation treatments in other studies and could arise from a change in 
the optical refractive index mismatch within tissue[56-60] as well as chemical changes to the 
protein backbone. Moreover, the shift between the amide I and amide II bands may be the result 
of an altered microenvironment, loss of some chemical species, or exposure to atmosphere. The 
tissue that was sublimed with DHB but not subjected to MALDI MS analysis had the highest 
absorbance values, whereas the tissue analyzed by MALDI MS more closely resembled the fixed 
tissue section. The spectral differences may be from residual DHB absorbing in the region of 
1500–1750 cm-1. Overall, most IR spectral features are similar between the adjacent tissue 
sections, demonstrating that performing MALDI MS before IR spectroscopy results only in 
minor changes to the IR imaging data. Compared to the drastic differences seen in MALDI MS 
performed after IR spectroscopy, the order of multimodal analysis described here provides an 
acceptable compromise.  
Chemical Pan Sharpening of Ion Images.  
A benefit of combining different imaging approaches is the increased flexibility in data 
analysis and visualization. Various types of microscopy data sets (e.g., haemotoxylin staining, 
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eosin staining, and electron microscopy) are utilized for pan sharpening of chemical imaging 
outputs. However, not all chemically unique morphological features can be observed in 
singleplex images. Also, using contrasting distributions can introduce artifacts or fail to improve 
sharpness, which is especially problematic when only a single image is available for pan 
sharpening. With additional choices for sharpening, pan sharpening can be optimized to enhance 
a given ion image without introducing artifacts. Multiplex IR datasets display a “mesoscale” 
level of detail in tissue composition, such as overall lipid, protein, and nucleotide distributions, 
but at higher spatial resolution than MSI. Thus, these images present unique opportunities for 
pan sharpening of MSI data sets. Through chemical pan sharpening, more ion images are suitable 
for sharpening as more corresponding contrast distributions can be found. Figures 7.7–7.12 show 
the effects of sharpening of single ion images with different IR bands. Two different lipid ion 
images (Figures 7.7–7.12C, F) are pan sharpened with absorbance images at two QCL-IR bands 
(Figure 7.7–7.12A, B) associated with lipids and proteins. Overall, Figures 7.7, 7.9, 7.11D, E 
show similar distributions of signal intensities because Laplacian pyramid sharpening utilizes the 
low frequency components from the MS ion image. Within the DG (Figures 7.8, 7.10, 7.12), 
many small, cellular structures arise in sharpened images from high frequency information 
contained in the 1656 cm-1 band. However, because the cell-like structures are not seen in the ion 
image, the features must arise from IR absorbance contrast and cannot be used for making 
assumptions of analyte localization within the cell bodies. While more apparent in Figure S5E, 
H, the data also demonstrate the ability of IR microscopy to detect fine tissue features that are 
invisible to MSI that may be native or arise during sample handling.  
Careful handling is paramount during tissue sampling and sectioning as sample 
preparation artifacts can be propagated to the pan-sharpened image. In Figure 7.13, the 
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sharpened image in panel G appears blurrier than the image in panel H, which is sharpened by an 
IR band exhibiting higher contrast around the DG. The example images demonstrate that the 
quality of pan sharpening depends on the contrast and distributions present in the underlying, 
higher spatial resolution images. Pan sharpening with IR distributions provides additional 
options for selecting appropriate bands for sharpening, but care is required when extrapolating 
beyond distributions present in the low spatial resolution, MS images.  
Since Laplacian pyramid fusion functions on individual ion distributions, sharpened ion 
images can be combined and presented as an RGB composite (Figures 7.4, 7.13, 7.14). Figure 
7.4A shows the RGB MS image overlaying the distribution of three compounds in the 
hippocampus. While different layers within the hippocampus are visible, the spatial resolution at 
which MSI was acquired is insufficient for distinguishing clear regional boundaries and, in some 
cases cellular localizations, within the brain tissue. However, sharpening each ion image with an 
absorbance image arising from the amide II band (1656 cm-1, Figures 7.4B, D and 7.13, 7.14, 
panels B, D) accentuates boundaries between different layers within the hippocampus. Focusing 
on the DG (Figures 7.4 and 7.13, 7.14, panels C, D) highlights the improvement in image 
quality, especially for replicates acquired at 50 µm×50 µm pixels (Figures 7.13, 7.14). After 
fusion, tissue morphology associated with known cellular structures becomes more apparent; 
e.g., the round structures within the bottom portion of the DG that appear as blurry, indistinct hot 
spots (Figure 7.4C). The resulting sharpened image is a qualitative fusion of the multimodal 
datasets, with color and brightness determined by ion abundances within a pixel and high 
frequency spatial information from the amide II stretching band. 
Midlevel Data Fusion of IR and MALDI MS Images.  
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Hyperspectral PCA score images provide measures of the tissue variance, where pixels of 
the same color represent a closer distance in the score space and therefore similar chemical 
composition. Figure 7.5 shows hyperspectral images derived from spectral PCA of IR imaging 
(Figure 7.5A) and FT-ICR-MSI (Figure 7.5B) data. The overlaid IR image produces a higher 
spatial resolution view of the DG with some cellular features visible (Figure 7.5A); however, 
only the first two principal components display meaningful morphological information as the 
third component appears to be noise. The hyperspectral PCA score images of FT-ICR MSI 
(Figure 7.5B) have noticeably poorer spatial resolution but display more chemically distinct 
regions. Distributions of individual principal components higher than PC2 demonstrate more 
noise but depict some morphological detail (Figure 7.5B). Combining the PCA score images and 
performing PCA on the fused data produces the midlevel fusion image (Figure 7.5C). The fused 
dataset shows additional layers within the hippocampus at an improved spatial resolution. The 
improvement from midlevel fusion is especially striking for replicates shown in Figures 7.15, 
7.16, where some artifacts visible in the IR images are removed from the fused images.  
For biological replicate 1, acquired at 25 µm pixel widths for MSI, Davies-Bouldin 
optimization indicates the data is well modeled with 11 unique clusters (Figure 7.17), which 
associate well with histologically defined morphological regions within the hippocampus. 
Notably, we can parse out the lucidum and alveus layers separately in segments 3 and 6, 
respectively. The unsupervised clustering effectively annotates the tissue morphology according 
to previous histological classifications. With a segment map, average IR and MS spectra for each 
region can reveal their unique chemical profiles. A representative example in shown in Figure 
7.6 (with additional replicates shown in Figures 7.18–7.20); segments 1–4 are overlaid to show a 
clear chemical separation of CA1 (blue), the lucidum layer of the CA3 (pink), the rest of CA3 
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(green), and the DG (purple). A comparison of the average absorption spectra reveals differences 
around 1250cm-1, 1550 cm-1, and 1680 cm-1 (Figure 7.6B), which are largely related to 
differences in protein. Additionally, the average mass spectra show several, significant 
differences between phosphatidylcholine (PC) lipid signal intensities, as summarized in Figure 
6C, D.  The box plots (Figure 7.6D) show four example lipid species ([PC 32:0+K]+, [PC 
34:1+K]+, [PC 36:4+K]+, and [PC 38:4+K]+) with differing abundance between segments 
corresponding to CA1, the lucidum layer of CA3, the rest of CA3, and the DG. Through data 
fusion and unsupervised clustering, significant chemical differences are detectable between 
physiologically similar regions. Neither method alone provides the chemical specificity and 
spatial resolution to differentiate between each layer. Multimodal imaging, optimized for high 
data quality, is vital for exploring chemical heterogeneity present in complex biological systems, 
including the brain.  
7.4 Conclusions 
We developed an analytical workflow that allows MALDI MS and IR spectroscopy to be 
performed on the same tissue. The workflow allows for chemical pan sharpening of MS ion 
images with a variety of IR absorption bands, providing optimized pan sharpened ion images 
with minimal artifacts. The inherent spatial agreement between modalities allowed us to 
determine lipid distributions within the DG, a morphologically and chemically complex, and 
functionally important, brain structure. Further, we developed a midlevel data fusion approach 
that allows chemical information from each technique to be combined, enhancing discrimination 
of structurally important regions by k-means clustering. Because MALDI MSI is a gentle 
ionization approach, laser damage was not observed in the IR images, making the incorporation 
of traditional staining methods feasible. Immunohistochemistry would further augment the 
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multimodal datasets with information on localization of targeted antigens within the 
hippocampus. The multimodal imaging approach presented here can be easily extended to other 
biologically important structures in the nervous system, such as the supraoptic and 
suprachiasmatic nuclei.   
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Figure 7.1 Schematic of the combined MALDI-FT-ICR-MSI with IR imaging approach. A) 
MALDI MSI is performed first, followed by (B) matrix removal and tissue fixation prior to (C) 
IR imaging. Analyzing the same tissue sample simplifies (D) data fusion compared to the more 
common use of adjacent sections.  
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Figure 7.2 Influence of conducting IR spectroscopic imaging on the quality of MALDI MSI 
data. A) MALDI MS ion image of the hippocampus (m/z 798.5407; [PC 34:1 + K]+) for (i) 
MALDI MS performed prior to IR spectroscopic imaging, (ii) after IR analysis with identical 
conditions – left side of brain section was analyzed, and (iii) right side of the same tissue section 
as in (ii) with twice the laser power and number of laser shots. B) Average, RMS normalized 
spectra for each image. 
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Figure 7.3 Influence of MALDI MSI on IR imaging data quality for rat hippocampus images. A) 
Discrete frequency IR images of the 1248 cm-1 and 1656 cm-1 bands of adjacent tissue sections 
subjected to either (top) PFA treatment, (middle) sublimation of DHB with subsequent PFA 
treatment, or (bottom) sublimation of DHB and MALDI MSI analysis, with subsequent PFA 
treatment. B) The average absorbance spectra from the color-coded regions of the hippocampus 
are overlaid. While there are several morphological differences between the three tissue sections, 
the IR spectra match. 
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Figure 7.4 RGB composite ion image: R = [PC 32:0 + K]+ (m/z 772.5253), G = [PC 40:6 + K]+ 
(m/z 872.5566), and B = [PC 34:0 + K]+ (m/z 800.5567). A) Unsharpened MS image of the 
hippocampus taken with MSI at 25 µm spatial resolution. B) MS image in A, sharpened with 
QCL-IR band at 1656 cm-1. C) Magnification of the area marked in A containing an unsharpened 
MS image of the DG (magnified inset) and one end of the CA3 region. D) Magnification of 
sharpened MS image shown in B. 
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Figure 7.5 Hyperspectral PCA score images and individual principal components showing the 
expected structures within the DG region of the rat hippocampus. Images are from (A) IR 
spectra, (B) MALDI FT-ICR-MSI, and (C) midlevel data fusion of data presented in panels A 
and B.  
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Figure 7.6 Results of k-means clustering of fused data sets. A) Segments associated with the 
CA1 (blue), lucidum layer of CA3 (pink), rest of CA3 (green), and the DG (purple) layers within 
the hippocampus. B) Average absorbance spectra for the four clusters. C) Average mass spectra 
for the specified clusters. Asterisks denote the m/z values used for the 4 boxplots presented in D. 
D) Boxplots of selected signal intensities within each highlighted cluster. Labels above each box 
denote significantly different groups by post-hoc Tukey’s honestly significant difference 
multiple comparison test. 
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Figure 7.7 Biological replicate 1. Pan sharpening of mass spectrometry (MS) ion images by 
quantum cascade laser (QCL-IR) absorbance images. A) QCL-IR image of the hippocampus 
displaying absorbance at the ester band (1088 cm-1). B) QCL-IR image of the amide II band 
(1656 cm-1). C) Matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron 
resonance (MALDI-FT-ICR) MS ion image of [PC 40:6 + K]+ (m/z 772.5252).  D, E) Ion image 
of [PC 40:6 + K]+ pan sharpened with the (D) ester band or the (E) amide II band.  (F) MALDI-
FT-ICR MS ion image of [PC 34:0 + K]+ (m/z 872.5566). G, H) Ion images of [PC 34:0 + K]+ 
sharpened with the (G) ester band or the H) amide II band. MSI was acquired with 25 µm pixel 
spacing and QCL-IR was acquired with 5 µm pixel spacing.  
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Figure 7.8 Magnified images of Figure 7.7, focusing on the DG. 
 
 




Figure 7.9 Biological replicate 2. In contrast to biological replicate 1, MSI was acquired at 50 
µm pixel size. The boxed region in panel C corresponds to the magnified in region in Figure 
7.10. 





Figure 7.10 Magnified images of Figure 7.9, focusing on the DG. 




Figure 7.11 Biological replicate 3 with MSI acquired at 50 µm pixel width. Boxed region in 
Panel C corresponds to the DG region shown in Figure 7.12.  
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Figure 7.12 Magnified images of Figure 7.11, focusing on the DG. 
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Figure 7.13 Overlay of sharpened ion images for biological replicate 2 of Figure 7.4. The red, 
green and blue channels represent the ion intensities of [PC 32:0 + K]+ (772.5253), [PC 40:6 + 
K]+ (872.5566), and [PC 34:0 + K]+ (800.5567), respectively. A) Interpolated MS image of the 
hippocampus taken at 50 µm spatial resolution. The boxed-in region is magnified in panels C 
and D. B) MS image sharpened with QCL-IR image acquired at 1656 cm-1. C) Interpolated MS 
image of hippocampal region containing one end of the CA3 region and the DG. D) Sharpened 
MS image of the same area shown in C. 
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Figure 7.14 Overlay of sharpened ion images for biological replicate 3 of Figure 7.4. The red, 
green and blue channels represent the ion intensities of [PC 32:0 + K]+ (772.5253), [PC 40:6 + 
K]+ (872.5566), and [PC 34:0 + K]+ (800.5567), respectively. A) Interpolated MS image of the 
hippocampus taken at 50 µm spatial resolution. The boxed-in region is shown in panels C and D. 
B) MS image sharpened with the QCL-IR image acquired at 1656 cm-1. C) Interpolated MS 
image of hippocampal region containing one end of the CA3 region and the DG. D) Sharpened 
MS image of the same area shown in C. 
 




Figure 7.15 Hyperspectral score images of each modality and midlevel data fusion for biological 
replicate 2. FT-ICR-MSI data were acquired with 50 µm pixel widths.  The overlay images (first 
row) are constructed by mapping principal components 1–3 to red, green and blue, respectively.  
A) QCL-IR score image and corresponding single component images. B) FT-ICR-MSI score 
image with bilinear interpolation to align with the QCL-IR image area. C) Midlevel data fusion 
image of datasets shown in corresponding images in (A) and (B). Hippocampal region, 
containing one end of the CA3 region and the DG, is depicted.  
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Figure 7.16 Hyperspectral score images of each modality and midlevel data fusion for biological 
replicate 3. FT-ICR-MSI data were acquired with 50 µm pixel widths.  The overlay images (first 
row) are constructed by mapping principal components 1–3 to red, green and blue respectively.  
A) QCL-IR score image and corresponding single component images. B) FT-ICR-MSI score 
image with bilinear interpolation to align with QCL-IR image area. C) Midlevel data fusion 
image of data sets shown in corresponding images in (A) and (B). Hippocampal region, 
containing one end of the CA3 region and the DG, is depicted. 




Figure 7.17 k-means clustering of the midlevel fused datasets of biological replicate 1, with k = 
11. Each pixel in the image is grouped into a defined cluster, signified by a distinct color. k = 11 
was found to be the optimum by Davies-Bouldin optimization metric. 




Figure 7.18 k-means clustering of the (A) QCL-IR, (B) FT-ICR MS, and (C) midlevel fused 
datasets acquired from biological replicate 1, with k = 4. Each pixel in the image is grouped into 
a defined cluster, signified by a distinct color, shown individually in rows 2 through 5. Segments 
were manually assigned colors to match the highlighted morphology across modalities and 
biological replicates.  




Figure 7.19 k-means clustering of the (A) QCL-IR, (B) FT-ICR MS, and (C) midlevel fused 
datasets of biological replicate 2, with k = 4. Each pixel in the image is grouped into a separate 
cluster, signified by a distinct color, shown individually in rows 2 through 5. Segments were 
manually assigned colors to match the highlighted morphology across modalities and biological 
replicates. 
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Figure 7.20 k-means clustering of the (A) QCL-IR, (B) FT-ICR MS, and (C) midlevel fused 
datasets of biological replicate 3, with k = 4. Each pixel in the image is grouped into a separate 
cluster, signified by a distinct color, shown individually in rows 2 through 5. Segments were 
manually assigned colors to match the highlighted morphology across modalities and biological 
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Figure 7.20 (cont.) replicates. Replicate 3 is a more caudal section of the brain than replicates 1 
and 2, as identified by the absence of the granular layer adjacent to the midline (green in segment 
2).  
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Figure 7.21 Boxplots of potassium and sodium adducts for the ions presented in the main text. 
The intensity ratios between the salt adducts generally follow the same trend.   
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CHAPTER 8 
SINGLE CELL MALDI MASS SPECTROMETRY HYPHENATED TO STIMULATED RAMAN 
SCATTERING MICROSCOPY FOR ENHANCED CHEMICAL COVERAGE 
Notes and Acknowledgements 
This chapter is adapted from a completed manuscript coauthored by Troy J. Comi, 
Sangamitra Deb, Stanislav S. Rubakhin, Martha U. Gillette, Rohit Bhargava, and Jonathan V. 
Sweedler, submitted for publication in 2019. T.J. Comi performed some data analysis and wrote 
all scripts used in the study. S. Deb performed the SRSM analysis. S.S. Rubakhin, M.U. Gillette, 
R. Bhargava, and J.V. Sweedler assisted with concept development and writing, as well as 
funded the work. We acknowledge Dr. Jennifer Mitchell for useful discussions. The authors 
gratefully acknowledge support from the National Institutes of Health, Award Number P30 
DA018310 from the National Institute on Drug Abuse, and from the National Institute of Mental 
Health, Award Number 1U01 MH109062. E.K. Neumann and T.J. Comi acknowledge support 
from the National Science Foundation Graduate Research Fellowship Program and the 
Springborn Fellowship. T.J. Comi received additional support through the Training Program at 
Chemistry-Interface with Biology (T32 GM070421). This work is also partially supported by the 
Agilent Thought Leader Award to R. Bhargava. 
8.1 Introduction  
 The brain is among the most structurally complex and chemically heterogeneous 
biological systems, in which cell-to-cell interactions regulate a variety of essential physiological 
functions such as learning and memory. Thus, single cell resolution measurements are vital for 
studying complex tissues of this type. Single cell analyses are possible with a variety of 
analytical methods and the capability to perform meaningful measurements at the single cell 
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level are an important benchmark of sensitivity and detectability. Small sample volumes, low 
absolute chemical abundances, and difficulties with sample handling limit the chemical coverage 
of most direct single cell analytical measurements. Extending these limits remains an area of 
active research.  
Genomic and transcriptomic approaches increase analytical sensitivity using 
amplification to bring concentration into the range of sensitive measures. Single cell 
transcriptomics has dominated single cell measurements in recent years[1-2] and studies on 
neurons[3] and glia[4] have revealed genetic heterogeneity with functional consequences, 
underscoring the need for greater understanding at the single cell level. In particular, greatly 
complementing transcriptomics, the direct chemical analysis of the peptide and metabolic 
contents of single cells provides a close link to cellular phenotypes.[5] 
Mass spectrometry (MS) is a powerful method for single cell measurements with high 
sensitivity and molecular specificity. We have developed microscopy-guided single cell matrix 
assisted laser desorption/ionization (MALDI) MS and applied this approach to a variety of 
rodent cellular populations.[6-9] Microscopy-guided MALDI MS analysis rates approach 1 Hz 
facilitating measurements of thousands of cells for tens to hundreds of chemicals, including 
lipids, peptides, and small metabolites. While efforts to reduce the MALDI laser spot size[10-11] or 
utilize oversampling methods have driven subcellular MS imaging,[12-13] such measurements are 
still restricted to specialty labs; commercial instrumentation more commonly achieves >10 µm 
spatial resolutions. Microscopy-guided profiling circumvents limitations in the spatial resolution 
of MALDI lasers by analyzing dispersed cells, however, subcellular morphology and original 
location within the tissue is typically lost. 
272   
 
Vibrational spectroscopy is a non-destructive method that can rapidly obtain molecular 
information and techniques such as stimulated Raman scattering microscopy (SRSM) now offer 
submicron (<0.5 µm) spatial resolution.[14-15] Further, vibrational spectroscopy is sensitive to 
changes in pH, depth, analyte concentrations, mixture complexity, and temperature, providing 
information beyond chemical composition. Unfortunately, SRSM spectral resolutions alone 
cannot identify chemical species in complex mixtures and instead requires standards, labels, or 
orthogonal approaches to verify chemical identities beyond class.[16] While multi-wavelength 
cytotyping with infrared vibrational spectroscopic imaging is feasible at micron-scale pixels, 
these spectra serve as a barcode and cannot identify specific molecules. 
Multimodal chemical analyses are becoming more common for investigations of complex 
chemical systems. Ideally, interrogating a sample with two complementary approaches provides 
chemical information greater than either approach alone.[17-20] Raman spectroscopy and MS have 
been performed on the same tissue section[21-25] often at near-cellular resolutions[26] as well as 
single cell samples.[27-28] Pioneering work by the Zenobi group correlated fluorescence 
microscopy, MS, and confocal Raman microscopy for single algal cells using microarrays for 
MS to study lower molecular weight metabolites.[27-28]  
To extend single cell multimodal analysis, we combine SRSM with MALDI FT-ICR MS 
to relate the molecular specificity of MS with subcellular images from SRSM for several 
hundred rodent hippocampal cells. Although SRSM is non-destructive, we found performing 
MALDI MS first to be optimal as it improves the effective throughput of SRSM acquisition by 
targeting only cells with adequate MS signal intensity. By combining the two techniques on the 
same single cell, we can achieve 250 nm resolution images of broad chemical classes (e.g. lipids, 
nucleic acids, and proteins) at higher sensitivity using SRSM as opposed to more traditional 
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Raman spectroscopic approaches, while still detecting discrete phospholipids, such as 
phosphatidylcholine (PC)(32:0), PC(34:1), PC(36:1), and phosphatidic acid (PA)(38:4) with the 
confidence afforded by FT-ICR MS measurements. 
8.2 Experimental  
Chemicals.  
All chemicals were purchased from Sigma Aldrich and used without further purification 
unless otherwise specified.  
Animals.  
2–2.5 month-old male Sprague Dawley outbred rats (Rattus norvegicus) 
(www.envigo.com) were housed on a 12 h light cycle and fed ad libitum. Animal euthanasia 
was performed in accordance with the appropriate institutional animal care guidelines (the 
Illinois Institutional Animal Care and Use Committee), and in full compliance with federal 
guidelines for the humane care and treatment of animals. Three rats were used in these 
experiments. 
Cell Dissociation.  
Dissected hippocampal tissues were treated with papain dissociation system 
(Worthington Biochemical, Lakewood, NJ). Briefly, tissues were incubated with an oxygenated 
solution of 20 units/mL of papain, 1 mM L-cysteine, and 0.5 mM ethylenediaminetetraacetic 
acid dissolved in Earle's balanced salt solution for 80 minutes at 34 °C. Tissue was then 
mechanically dissociated in modified Gey’s balanced salt solution (mGBSS) containing (in 
mM): 1.5 CaCl2, 5 KCl, 0.2 KH2PO4, 11 MgCl2, 0.3 MgSO4, 138 NaCl, 28 NaHCO3, and 0.8 
Na2HPO4, and 25 HEPES, pH 7.2 and supplemented with 0.04% paraformaldehyde (PFA) for 
cell stabilization through mechanical dissociation. Following dissociation, glycerol was added to 
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a final concentration of 40% (v/v) and 50 µL of cell suspension was transferred onto non-coated 
microscopy glass slides (LabMed, Ft. Lauderdale, Florida) that had been etched with fiducial 
marks and washed with ethanol prior to plating. Although conductive glass slides are more 
common for MS analysis, they are incompatible with SRSM analysis. Importantly, MALDI FT-
ICR MS can analyze samples deposited on non-conductive substrates. 
The glass slide held deposits of cells from three animals at separate locations. After ~18 
h, cells were stained with Hoechst 33342 (1 µg/mL in mGBSS) for 15 min before rinsing twice 
with 500 µL of 150 mM ammonium acetate and drying under a slow stream of nitrogen gas. 
Optical Imaging.  
Brightfield and fluorescence images were acquired on a Zeiss Axio M2 microscope 
(Zeiss, Jena, Germany) equipped with an Ab cam Icc5 camera, X-cite Series 120 Q mercury 
lamp (Lumen Dynamics, Mississauga, Canada), and a HAL 100 halogen illuminator (Zeiss, Jena, 
Germany). The DAPI dichroic (ex. 335-383 nm; em. 420-470 nm) was used for fluorescence 
excitation. The images were acquired with a 10x objective (1-pixel width is 0.55 µm) with a 13% 
overlap produced during image tiling. Images were processed and exported as big tiff files on 
ZEN 2 software (blue edition, Zeiss, Jena, Germany).  
Matrix Application and MS Analysis.  
2,5-dihydroxybenzoic acid (DHB) was sublimed onto single cell deposits forming a fine 
crystal layer with a thickness of ~0.3 mg/cm2 using a custom sublimation chamber described 
previously.17 Following sublimation, slides returned to 24 °C within a dry nitrogen box for at 
least 15 min.  
Single cell MALDI mass spectra were acquired on a solariX XR 7T FT-ICR mass 
spectrometer (Bruker Corp., Billerica, MA) with a mass window of m/z 150-3000, yielding a 
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transient length of 2.94 sec. The “ultra” laser setting was used with a laser footprint of 
approximately 100 µm. 50 laser shots were accumulated with a frequency of 1000 Hz at 50% of 
the maximum power settings. Single cell coordinates and a custom geometry file were 
ascertained from microMS, as previously described,[8] as well as an Excel file for the target 
automation function on ftmsControl (v. 2.1.0, Bruker Corp.). Cells were distance filtered to be 
100 µm apart and filtered by size to remove fluorescent debris. Mass spectrum acquisition order 
was randomized across all three animals on the slide to limit any time-dependent batch effects. 
MALDI FT-ICR mass spectra were displayed in Data Analysis (v4.4, Bruker Corp.) with a linear 
recalibration using [phosphatidylcholine (PC)(32:0)+H]+, [PC(32:0)+Na]+, and [PC(38:4)+H]+. 
Matrix Removal and Sample Fixation.  
After MS analysis, hippocampal cell dissociates were placed within a solution of 4% PFA 
in 1x phosphate buffered saline (PBS; ThermoFisher Scientific, Waltham, MA) for 10 min. The 
PFA in PBS solution was replaced with fresh solution and incubation continued for an additional 
5 min to remove MALDI matrix with concurrent cell fixation. Samples were washed in PBS for 
3 min following fixation and briefly rinsed with Mili-Q water to remove remaining salts. Finally, 
slides were dried under a stream of nitrogen gas and stored in a vacuum desiccator until SRSM 
analysis. 
SRSM Analysis.  
The microMS software was adapted to allow image registration with a custom SRSM 
system. The SRSM coordinate space was registered with optical images by extending microMS 
as previously reported.8 The stage coordinates of each cell were then used to direct acquisition of 
a ~50 µm2 image. SRSM control was slightly modified to acquire cell microarray images. 
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SRS chemical images were acquired using a two-photon laser scanning microscopy 
system built in house.[34]  The SRS imaging setup is integrated with a dual-output (1064 nm/532 
nm, 80 MHz) ultrafast oscillator (Lumera, Coherent Germany) which pumps an optical 
parametric oscillator (OPO) (Levante Emerald, APE Germany) to provide tunable (750 nm – 970 
nm) ~6 ps pulse trains of light. The OPO output is used as the pump pulse which is tuned to a 
Raman mode of interest, while the 1064 nm beam is used as the Stokes pulse. The beams are 
spatiotemporally overlapped and sent collinearly to the SRS microscope. The Stokes pulse train 
is amplitude-modulated at 7 MHz by an electro-optic modulator (EOM, Conoptics). The images 
were acquired using a 50X (0.95 NA, Zeiss) objective and a home-built large area photodiode 
(PS100-6, first sensor) detector. A high OD band-pass filter transmits the pump beam and blocks 
the Stokes beam for stimulated Raman loss (SRL) detection.[35] The detector has two 
amplification stages and separates the pump signal into AC and DC components. The SRL 
signals (based on transferred modulation from the Stokes beam to the pump beam) present in the 
AC component are demodulated and amplified by a lock-in amplifier (HF2LI, Zurich 
Instruments) with a time constant of 5 µs. Images were acquired with a 20 μs dwell time. The 
pump wavelength was tuned from 801 nm to 821 nm with 0.3 nm spacing to generate stimulated 
Raman images. The selected cells were imaged from 2780 cm-1 to 3080 cm-1 with 4.5 cm-1 
spacing (68 spectral points). Intensities at each frequency were power normalized during image 
analysis with respect to pump pulse power at the given pump wavelength. Total laser power at 
the sample plane was < 30 mW.  
Data Registration and Analysis.  
Since both MALDI MS and SRSM utilized the same optical image and cell positions, 
data coregistration was simplified to matching the optical image x,y coordinates between the 
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analyses. SRSM datasets were processed in MATLAB (The Mathworks, Nantucket, MA). The 
cells were imaged together to minimize the power variation for a given frequency. Cell images 
were normalized to pump power, accounting for power fluctuation during pump laser tuning.  
Cell boundaries and average spectra were determined with a scheme based on principal 
component analysis (PCA) outlier detection. The first principal component scores were estimated 
from a random subset of 105 pixels. From the log transformed the first principal component 
values, a t-distributed, 99% confidence interval was determined. Pixels within the interval were 
non-cellular background signal and removed, while the remaining 1% corresponded to cellular 
material. The binary image produced from the first principal component from each cell was 
dilated and eroded with a 3 by 3 square to fill in single pixel gaps, where the largest area was 
concerned a cell. SRS spectra within the mask were averaged, smoothed, max normalized, and 
background corrected.   
8.3 Results and Discussion  
Procedure for multimodal analysis. 
There are several considerations for single cell multi-modal spectroscopic imaging. 
Single cell locations were determined using whole-slide fluorescent microscopy of Hoechst 
33342 as previously described[8] (Figure 8.1A). In total, 9,276 cell-like structures could be found 
using microMS. After filtering the structures to maintain a minimum 100 µm nearest neighbor 
distance (the size of the laser footprint) and by size to reduce the likelihood of analyzing debris, 
only 1,342 cells remained for single cell MALDI FT-ICR MS analysis (Figure 8.1B). While 
microMS has an option to set a minimum size for cell finding, debris can also contaminate single 
cell spectra and performing the size filter afterwards reduces contamination from neighboring 
objects. A second consideration at this stage is the acquisition time for each of the multiple 
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modalities. Using the Bruker solariX target automation routines, we acquired a single cell 
spectrum every 30 sec. SRSM takes approximately 10 min to acquire a single cell chemical 
image for the full CH spectral range (including stage movement, calibration, and alignment), so 
performing MALDI MS prior to vibrational spectroscopy allows us to prescreen cells for SRSM 
analysis, significantly reducing SRSM sample characterization time. Third, we considered the 
effect of characterization order. Performing MS prior to vibrational spectroscopy preserves high-
quality mass spectra of the cells, similarly to that of tissue sections.[36] Finally, our choice of 
techniques is dictated by the workflow. We use MALDI FT-ICR MS, because it allows analysis 
of cells placed on nonconductive sample substrates that are compatible with SRSM 
measurements without large mass shifts and lowered sensitivity. Additionally, tandem MS is 
difficult to perform on single cells, especially after SRSM analysis (cells are fixed) and for rare 
molecules, so the extra confidence afforded by high mass accuracy FT-ICR MS measurements is 
imperative for confident chemical assignments. 
Following washing and fixation, SRSM was only performed on cells with adequate lipid 
signal from MALDI MS (596 cells; Figure 8.1C). Putative cells with insufficient lipid signatures 
likely correspond to cells damaged during the tissue dissociation process, or debris produced by 
sampling. While microMS has been used in previous reports for single cell MS analysis, here we 
adapted the software to direct the SRSM acquisition to targeted cells. microMS allows SRSM to 
image a 50 by 50 µm region encompassing each cell. Collecting Raman chemical images around 
each cell saves a significant amount of time over a single image, because most of the sample 
surface is empty. While usually not a concern in SRSM imaging experiments, distance between 
cells is a requirement to prevent cell-to-cell contamination during single cell MS analysis. 
Because the same microscope image and software is used for both MALDI MS and SRSM 
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analysis, correlating the mass spectra with the vibration spectra is trivial (Figure 8.1D) as the 
same pixel coordinate is used in both instances. 
Single cell spectra. 
 Using the developed method, mass spectra and high spatial resolution (250 nm) SRSM 
images are acquired from 596 cells isolated from three different rats. For this initial report, we 
did not perform detailed analysis of all analyzed cells, but instead highlight the information that 
can be garnered from hyphenated MALDI-MS and SRSM by choosing representative cells from 
each animal. A cell from each animal was chosen to demonstrate the performance of the method 
(Figure 8.2). While the cells possess similar lipid contents, the relative intensities of 
corresponding signals differ, suggesting the need for discriminating individual lipid species at 
cellular resolutions. Similarly, there are several lipids only present within one cell, despite many 
being contained in all three (Table 8.1).  The diversity and importance of lipids in the brain is 
well known,37-40 although single cell measurements are rarely used in accessing cellular lipid 
heterogeneity.41-42 Because the MALDI laser probe entirely covers the targeted cell, we use MS 
to collect the average lipid profile of each cell, disregarding subcellular lipid distributions, but 
obtaining specific lipid identities.  
Overall, hundreds of spectral features with a signal-to-noise ratio above 3 were detected 
within each cell, demonstrating accessible chemical information contained within single cell MS 
data. For the cells featured here, 36, 37, and 27 discrete lipid features were detected within the 
cells from animals 1, 2, and 3, respectively. Most of the lipids were phospholipids, usually 
containing a PC headgroup (Figure 8.2.i), and all but 11 could be assigned using common 
databases (Table 8.1). While MS analysis here primarily detects phospholipids, MALDI MS can 
be used to study a variety of different chemical classes[43] by altering sample preparation, many 
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of which are compatible with our developed method. Additionally, the higher confidence 
afforded by FT-ICR MS as compared to time of flight-MS is important for these single cell, 
multimodal experiments, as the lipids are removed during the fixation step prior to SRSM 
analysis. Performing tandem MS between the MS and SRS analyses on single cells is difficult 
and would perhaps result in cellular damage, reducing the quality of SRS images.  
 The high spatial resolution SRSM images reveal subcellular morphology and provide 
chemical maps of cell contents (Figure 8.2.iii). Generally, signals for a higher abundance of 
lipids (red, 2845 cm-1) are seen along the outer edges of the cells with more protein and nucleic 
acid signatures within the cellular nucleus region (blue, 2930 - 2845 cm-1).[44] These frequencies 
are considered to correspond to lipids and a combination of proteins and nucleic acids, 
respectively, although we emphasize that it is not possible to unambiguously assign every voxel 
in a complex cellular milieu to these simple categories. Nevertheless, a limited set of frequencies 
provides sufficient contrast allowing identification of cellular material. Furthermore, the high 
spatial resolution images allow us to determine the average SRS spectra for nuclei compared to 
cell body (Figure 8.2.ii). We used presence of a nuclei, size, and MS signal to determine if an 
object was a cell or piece of debris.  
 Interestingly, MS lipid intensities do not always correlate with SRS lipid signal. We 
believe that the discrepancy between the two datasets results from many factors, including 
MALDI insufficiently ionizing all classes of lipids equally and the SRS signal of non-lipid 
compounds also at 2845 cm-1. Although a direct correlation of the two approaches is not made 
for lipids, it demonstrates that MALDI MS and SRSM are sensitive to different, although 
overlapping, chemical constituents within the cell. By taking advantage of the orthogonal 
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chemical information that is detected by multiple approaches, the combined data can further 
discriminate or classify biological systems than either technique alone.[22, 29]  
 Beyond chemical information, the multimodal approach allows us to better assess 
microscopy-guided MS. SRSM was used to image 50 by 50 µm2 areas with the target cell at the 
center of each area and, as most images contain the target cell, we conclude microMS accurately 
correlates the image location of a cell with the SRSM stage position. SRSM images which do not 
contain a cell are most likely caused by the cell being removed during washing, though previous 
work indicates cell dislocation is a rare event (data not shown). Additionally, sample from 
animal 2 (Figure 8.3) shows two distinct cells in the SRSM image, as apparent from the nuclei 
and lipid signal between. The two cells were counted as a single feature in microMS because the 
nuclei overlap and are not distinguished during cell finding. Therefore, higher spatial resolution 
SRSM imaging provides additional opportunity for single cell data verification. Moreover, the 
mild sample treatment is exemplified by the close concordance between the brightfield image, 
acquired prior to matrix coating, and SRSM images. Fine cell structures including membrane 
shape survive the analysis process, demonstrating a minimal disturbance of cellular structure that 
enables both sets of chemically-rich approaches to be performed on the same single cell. 
8.4 Conclusions  
We have successfully demonstrated hyphenating MALDI FT-ICR MS and SRSM 
imaging for the same cell. The combined data allows MS characterization of discrete 
phospholipids within the cells without sacrificing high spatial resolution chemical maps provided 
by vibrational spectroscopy. Further work is required for method optimization to reduce batch 
variances and allow for more confident population analyses. Moreover, 3D chemical images or 
live cell images can be acquired with SRSM, allowing the correlated data from MALDI MS-
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SRSM to be applied to other systems where MALDI cannot be performed. Extending the 
methodology to other biological systems will allow the exploration of functionally important 
chemicals within dynamic physiological processes, such as memory or circadian rhythms. 
Analyzing populations of individual cells greatly simplifies the challenges of tissue cellular 
heterogeneity characterization and data correlation. By combining these two disparate 
chemically-rich modalities on the same single cell, we extend the information that can be gain to 
high resolution images with discrete lipid identities.  
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8.6 Figures and Table 
 
Figure 8.1 Schematic of workflow combining single cell MALDI FT-ICR MS with SRSM. 
Whole slide microscope images of populations of single cells are used to locate 9276 cell-like 
structures with microMS (A). Putative cells were determined object-to-object distances and 
object sizes filtering. 1342 targets were selected for MALDI FT-ICR MS analysis (B). Cells 
were then filtered by lipid abundance to reduce the sample size to 596 cells for SRSM analysis 
(C). In total, 379 cells had high quality mass spectra and SRSM images. 




Figure 8.2 Correlated optical, vibrational, and mass spectral single cell profiles from three 
animals. Morphological similarities between brightfield and SRSM indicate that the spectra 
belong to the same cell and that minimal morphological perturbation occurs after MALDI MS. 
Single cell selected from animal 1, along with corresponding spectra (A). The mass spectrum 
(A.i.) and vibrational spectrum (A.ii., rgb composite A.iii.) are shown for that specific cell. Cell 
selected from animal 2 (B) with resulting mass spectrum (B.i.) and vibrational spectrum (B.ii., 
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Figure 8.2 (cont.) rgb composite B.iii.). Cell selected from animal 3 (C), with resulting mass 
spectrum (C.i.) and vibrational spectrum (C.ii., rgb composite C.iii.). This cell has lower lipid 
signal in comparison to the other two.  
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Figure 8.3 Mass spectrum of two cells that appear to be a single cell with brightfield 








































1,2 [PC(32:4(OH)+H]+ 700.4547 700.454796 -0.1370 
1,2 unknown 702.3019   
1,2 unknown 703.3091   
1,2 [PA(34:1+K]+ 713.4540 713.451814 3.0640 
1,2,3 [PS(30:1)+NH4]
+ 723.4920 723.491910 0.1244 





















745.4795 745.480282 -1.0490 
2,3 [MGDG(32:0)+NH4]
+ 748.5901 748.593324 -4.3067 
3 [PS(32:1)+NH4]





751.5253 751.524827 0.6294 





754.5369 754.538131 -1.6315 
1,2,3 unknown 754.5407   










760.5855 760.585082 0.5496 
1,2,3 [PE(40:7)+H-H2O]
+ 772.5281 772.527567 0.6899 





774.6028 774.600732 2.6698 
 
















782.5683 782.569432 -1.4465 











803.5450 803.543276 2.1455 










810.6002 810.600732 -0.6563 
2 unknown 819.5219   
1,2 [PE(44:11)+H-H2O]
+ 820.5281 820.527567 0.6496 





826.5733 826.572263 1.2546 
1 [PI-Cer(t36:0)+H]+ 826.5796 826.580390 -0.9557 
3 [PE(38:1(OH))+K]+ 828.5518 828.551528 0.3283 










830.562 830.562418 -0.5033 
1,2,3 [PC(40:7)+H]+ 832.5860 832.585082 1.1026 
1,2 unknown 838.3184   
1,2 unknown 839.3275   
3 unknown 834.5195   
1,2,3 unknown 870.5883   
1,2,3 unknown 896.6077   
Table 8.1 (cont.) Assignments for lipid features detected in the three cells by MALDI FT-ICR 
MS made using high mass accuracy (<5 ppm error) and the LIPID MAPS database.  
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CHAPTER 9 
INTERROGATION OF SPATIAL METABOLOME OF GINKGO BILOBA WITH 
HIGH‐RESOLUTION MATRIX‐ASSISTED LASER DESORPTION/IONIZATION AND LASER 
DESORPTION/IONIZATION MASS SPECTROMETRY IMAGING 
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9.1 Introduction 
Ginkgo biloba is an ancient plant, the only extant species in the division Ginkgophyta, 
and therefore is considered to be a “living fossil”.[1] Because of its high economic value in the 
food, pharmaceutical, and cosmetic industries, G. biloba continues to receive much attention in 
scientific investigations.[2] In phytochemistry, a wide variety of bioactive metabolites have been 
isolated and identified from different G. biloba tissues, for example, roots, stems, leaves, and 
seeds.[1] Among them, ginkgo leaves are a productive chemical factory where diverse secondary 
metabolites are produced that have significant pharmacological activities.[3] According to clinical 
research, ginkgo leaf extracts have the potential for treatment of diseases associated with 
peripheral circulation, memory, and cognitive dysfunction.[4] Additionally, G. biloba is 
remarkable because of its high environmental adaptability and unparalleled tolerance of 
environmental stress.[5] It is a unique species representative of a whole branch of the 
phylogenetic tree of seed plants. 
Investigations employing modern plant metabolomic techniques have led to the 
comprehensive profiling of metabolites from the ginkgo plant. For example, gas chromatography 
(GC), liquid chromatography (LC), capillary electrophoresis (CE), hyphenated methods such as 
GC/LC/CE–mass spectrometry (MS), and nuclear magnetic resonance have enabled the analysis 
of large numbers of metabolites.[3] However, the spatial localization of metabolites in samples is 
often lacking because the analyses are performed on tissue homogenates. Generally, plants 
comprise at least 10 basic tissue types, with more than 15 structurally diverse cell types.[6] The 
metabolism in plant tissues is often asymmetrically distributed among different cellular and 
subcellular compartments, resulting in the heterogeneous distribution of plant metabolites. 
Therefore, it can be important to unravel and understand the spatial organization of metabolites 
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in different tissues to gain fundamental insights into the physiological, growth, development, and 
stress responses of plants. Currently, plant imaging techniques, such as light and electron 
microscopy, are used for morphological characterization and chemical localization of labelled 
components in plant tissues. However, there are significant limitations using these techniques as 
they require labelling of specific chemicals, limiting de novo investigation of unlabeled and 
unknown chemical compounds. 
MS imaging (MSI) has become an attractive molecular imaging tool for capturing the 
spatial distribution of plant metabolites.[7-11] It is label‐free, untargeted, multiplexed, and capable 
of de novo chemical discovery. Various MSI approaches have been applied to image metabolites 
within tissues. For example, matrix‐assisted laser desorption/ionization (MALDI) imaging,[12, 13] 
secondary ion mass spectrometry (SIMS),[13] and ambient ionization‐based MSI techniques such 
as desorption electrospray ionization (DESI)[14] and laser ablation electrospray ionization 
(LAESI).[15, 16] It is important to select the method most appropriate for the system of interest, 
because each approach has differences in analyte coverage, sample preparation, and spatial 
resolution. For example, SIMS can achieve high lateral resolution, generally between 50 and 
1,000 nm, to examine molecules and molecular fragments below an m/z value of 1,000. DESI 
requires minimal sample preparation but has a spatial resolution limited to around 100 μm. 
MALDI is currently the most extensively used MSI ionization method because of its broad 
analyte coverage and satisfactory spatial resolution, ranging from 10 to 100 μm using 
commercial instruments; however, a custom‐built laboratory instrument capable of 1.4 μm 
resolution has recently been reported.[17] In MALDI MSI, the type of matrix and the method of 
matrix application need to be optimized because these steps determine analyte coverage, limits of 
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detection, ionization efficiency, spatial resolution, and the ultimate quality of the ion images.[10, 
18] 
In this work, spatio‐chemical information on metabolites in a cross section of ginkgo leaf 
and in different organs has been obtained using high‐resolution Fourier transform ion cyclotron 
resonance (FT‐ICR) MALDI and laser desorption/ionization (LDI) MSI. In particular, sample 
preparation directly associated with the quality and authenticity of the MSI results was optimized 
for the ginkgo leaf. Numerous constituents, including flavonoid aglycones, biflavonoids, 
flavonoid glycosides, biginkgosides, ginkgolides, and phenolic lipids, were comprehensively 
visualized in ginkgo leaf, stem, and root for the first time. High mass accuracy and in situ tandem 
MS (MS/MS) measurements helped in identifying metabolites within the tissue sections. The 
spatial information obtained here suggests functional roles for metabolites, as well as hints at 
localized responses in the leaf to biotic and abiotic stressors. 
9.2 Materials and Methods 
Chemicals and plant samples 
Formic acid (LC–MS grade), water (LC–MS grade), acetonitrile (ACN; LC–MS grade), 
trifluoroacetic acid (TFA; LC–MS grade), 2,5‐dihydroxybenzoic acid (DHB), 
α‐cyano‐4‐hydroxycinnamic acid (CHCA), and 9‐aminoacridine (9‐AA) were purchased from 
Sigma‐Aldrich (St. Louis, MO, USA). G. biloba leaves were collected from the arboretum of 
University of Illinois at Urbana‐Champaign, USA. Additionally, 2‐year‐old G. biloba plant 
grown in botanical garden at China Pharmaceutical University, Nanjing, China, was selected for 
MSI measurement of ginkgolides in root, young stem, and leaf tissue. 
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Sample preparation for MALDI imaging 
Fresh G. biloba leaves, young stems, and root parts were immediately embedded in 10% 
gelatin (wt/vol) solutions. Initially, tissues were kept in Tissue‐Tek cryomolds (25 × 20 × 5 mm) 
and the gelatin solution was poured over them to embed the tissues; thereafter, the molds were 
transferred to a −80°C freezer for 30 min to form a solid block. For cryosectioning, the sample 
blocks were directly fixed on the sample holder of a cryostat (Leica, Germany), using deionized 
water as the adhesive. Sections of 16 μm thickness were obtained at −20 °C and thaw‐mounted 
on indium tin oxide‐coated glass slides for immediate imaging measurements. To avoid 
condensation, the tissue sections were dehydrated in a vacuum desiccator for approximate 
10 min prior to matrix application. A Zeiss Axio M2 microscope (Zeiss, Germany) was used to 
obtain optical images of the sections. 
A laboratory‐constructed automated pneumatic‐assisted matrix application system was 
used for the uniform application of MALDI matrix solution. The matrix application system and 
coating procedure were similar to previously published work with some modifications.[19] 
Briefly, 50 mg ml−1 DHB or 15 mg ml−1 CHCA dissolved in ACN:water (0.1% TFA; 7:3, 
vol/vol) was applied for the positive mode MALDI experiments. For negative mode MALDI, 
10 mg ml−1 9‐AA dissolved in methanol:water (9:1, vol/vol) was applied. For homogenous 
deposition onto the leaf samples, the nebulizer was held 3 cm above the sample and oscillated 
over the plate 100 times. The flow rate was set to 6–8 ml hr−1 and gas pressure to 50 psi, to 
deliver and nebulize the matrix solution, respectively. Additionally, DHB was sublimed using a 
home‐built apparatus described in detail elsewhere.[20] Briefly, 1 g of powdered DHB was 
distributed evenly on an aluminium foil boat, and the samples were affixed to a copper adaptor 
on the outside of the cold finger. The chamber was closed, placed in a heating mantle (Model 
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No. 0408, Glas‐Col, Terre Haute, IN, USA), and pumped to intermediate vacuum (~10 mTorr), 
and the cold finger was filled with iced water. After 2 min of temperature equilibration, the 
desired matrix coating was achieved by supplying 120 V to the heating mantle for 9.5 min for 
DHB at 55% power with a variable autotransformer (Staco Inc., Dayton, OH, USA). The 
chamber was removed from the mantle and vented to room temperature air, and the sample was 
promptly removed from the cold finger. 
MALDI MSI instrumentation and analysis parameters 
MALDI imaging was performed using a 7T solariX FT‐ICR mass spectrometer (Bruker 
Corp., Billerica, MA) equipped with a dual ESI/MALDI source and a Smartbeam II laser. 
An m/z range of 150–2,000 was acquired at 8 Mword, producing a transient length of 5.8720 ms. 
It should be noted that the length of the transient can be shortened depending on the specific 
analytes measured. Single‐scan spectra consisted of 100 accumulated laser shots at 1 kHz with 
laser focus set to “small.” MALDI images were acquired at a 50‐μm spatial resolution. 
Instrument calibration was performed using the ESI portion of the instrument with NaTFA 
clusters ranging from m/z 158.9640–1,926.6365 and a quadratic calibration of the clusters. 
Because the ESI and MALDI generated ions are transferred to and are analyzed with the same 
ion optics and detection systems, the calibration remains valid for ions generated with both ion 
sources. Data were analyzed using Data Analysis version 4.0 and flexImaging version 4.1 
software (Bruker). Additionally, initial experiments to determine the choice of matrix and some 
of the in situ MS/MS analyses were conducted using an ultrafleXtreme MALDI time‐of‐flight 
(ToF)/ToF mass spectrometer with a frequency tripled Nd:YAG solid‐state laser (Bruker Corp.). 
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Sample preparation for LC–MS/MS analysis 
The upper and lower epidermal cell layers were manually dissected from leaf cross 
sections (30 μm thickness) using sharp tungsten needles and transferred into Eppendorf tubes. 
All of the epidermis isolation steps were carried out under a stereomicroscope (Leica). Each 
sample was collected from five leaf sections and combined for subsequent solvent extraction; 
100 μl of methanol:water (1:1, vol/vol) was added into the tubes, followed by 15 min of 
sonication (8891 ultrasonic cleaner, Billerica, MA). The extracts were centrifuged at 9600 × g 
rpm for 5 min, and the supernatants were collected. The extract solutions were then dried with a 
gentle N2 stream at ambient conditions and room temperature. The dried residuals were 
reconstituted in 20 μl methanol:water (1:1, vol/vol) for subsequent LC–MS/MS analysis. 
Relative quantitation of selected flavonoids by LC–MS/MS 
LC–MS/MS was performed using an EVOQ Elite™ Triple Quadrupole mass 
spectrometer (Bruker Corp.) connected to an Advance UHPLC system (Bruker Corp.). Analytes 
were separated on a Fortis UHPLC C18 column (1.7 μm, 50 mm × 2.1 mm, Fortis Technologies 
Ltd., UK). Mobile phase A was H2O containing 0.1% formic acid and phase B was ACN. The 
gradient programme was conducted as follows: 0–15 min, 5–95% B; 15–16 min, 95% B; 16–
16.1 min, 95–5% B; and 16.1–18 min, 5% B. Total run time was 18 min. The injection volume 
was 2 μl. The mass spectrometer was operated in negative ion mode, and the EVOQ source 
parameters were as follows: heated ESI, spray voltage (−) 4,500 V; cone temperature, 250°C; 
cone gas flow, 25; heated probe temperature, 450°C; probe gas flow, 45; nebulizer gas flow, 65; 
and exhaust gas, off. Argon was used as a collision gas in the multiple reaction monitoring 
(MRM) mode. The MRM parameters, including ion transitions (precursor and product ions) for 
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each analyte, are presented in Table 9.1. EVOQ MRM chromatograms were analyzed using Data 
Review 8.2 (Bruker). 
The content of each selected analyte was measured from three replicate leaf samples. For 
comparison of averaged peak intensities of each target, analytes were acquired from the upper 
and lower epidermis, respectively; a one‐tailed Student's t‐test was calculated by Originpro 8.5 
(Northampton, MA, USA) to determine the mean differences in flavonoid content between the 
upper and lower epidermis. 
Identification of Biginkgosides  
Our initial database search, METLIN  and KNApSAcK with accurate mass match did not 
reveal reliable chemical identities. With the aid of MS/MS, important hints for the deduction of 
possible chemical structures were obtained. They were tentatively attributed to the dimer of 
flavonoid glycosides. For example, for m/z 1535.3476, the ion formula was calculated as 
[C72H72O35 + K]
+ with –0.66 ppm mass accuracy, and the characteristic fragment ions were 
obtained by MALDI CID-FT-ICR MS/MS. The fragment ion at m/z 1249.30 was assigned to the 
loss of the kaempferol group (286.05 Da), m/z 1233.30 assigned to the loss of the quercetin 
group (302.05 Da), and m/z 947.26 assigned to the loss of the kaempferol and quercetin groups 
(588.09 Da). Additionally, two minor fragment peaks at m/z 795.14 and m/z 779.15 were 
tentatively assigned to the loss of kaempferol-coumaroylglucosyl-rhamnoside (740.20 Da) and 
quercetin-coumaroylglucosyl-rhamnoside (756.19 Da). Therefore, m/z 1535.3476 was tentatively 
assigned to the potassium adduct of a dimer of kaempferol-coumaroylglucosyl-rhamnoside and 
quercetin-coumaroylglucosyl-rhamnoside. Likewise, m/z 1519.3557 and m/z 1551.3435 could be 
tentatively assigned to the potassium adduct of a dimer of kaempferol-coumaroylglucosyl-
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rhamnoside and the potassium adduct of a dimer of quercetin-coumaroylglucosyl-rhamnoside, 
respectively (Figure 10.2). However, it is hard to determine the origin of these dimers, which are 
possibly derived from native endogenous metabolites or occur as a result of the measurement 
process; for example, lipid dimers are often observed after laser irradiation in MALDI MS.  
Identification of Lipids 
Peak assignment of lipid-associated ions was carried out by accurate mass match and/or 
characteristic fragments aided by Lipid Maps and the METLIN database. As shown in Figure 
9.1D, numerous dominant ions with an even mass number were putatively assigned to the 
phosphatidylcholine (PC) lipids according to the predominant diagnosed fragments resulting 
from the loss of the polar choline phosphate head group (183 Da) and/or quaternary ammonia 
group (59 Da, N(CH3)3). For the other lipid-associated ions, in situ MS/MS was not available and 
so they were tentatively assigned according to accurate mass match (Table 9.2).  
Identification of Chlorophyll a 
In Figure 9.1D, a distinguished peak at m/z 871.5724 observed in mesophyll cells was 
ascribed to [chlorophyll a-Mg+3H]+ according to the accurate mass match and previously 
reported data. The loss of the central magnesium ion was due to the use of acidic matrices, e.g. 
DHB, which are known to facilitate the preferential demetalation of magnesium porphyrins. The 
identity of the peak at m/z 871.5724 was further demonstrated by other characteristic ions such as 
m/z 870.5700, corresponding to [chlorophyll a-Mg+2H]+•, and m/z 593.2759, originating from 
the loss of a phytyl residue from [chlorophyll a-Mg+ 3H]+. 
UV-B radiation Plant materials 
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12 leaves were taken from 2-year old ginkgo plants grown under same environmental 
conditions in the botanical garden at China Pharmaceutical University, Nanjing, China. 6 leaves 
were chosen as the control group, and 6 leaves were selected to conduct UV-B radiation 
experiments. UV-B treatment was carried out in UV-B chambers (Nanjing Kenfan Electronic 
Technology Co Ltd, China) with UV-B lamps emitting approximately 36 W of UV-B irradiation 
with 313 nm. The UV-B intensity was 225 μW·cm-2 determined by a UV radiometer 
(Photoelectric Instrument Factory of Beijing Normal University, China).  
In UV-B radiation experiment, the whole plant was placed in the chamber irradiated for 4 
hours. After an adaptation time of 24 h, leaf samples were picked for subsequent LC-MS/MS 
analysis. For control group, leaf samples were directly collected before UV-B radiation for 
subsequent LC-MS/MS analysis. Each leaf sample was extracted with 1 mL of methanol, 
followed by 15 min of sonication. The extracts were centrifuged at 13,000 rpm for 5 min and the 
supernatants were collected. The 90 µL supernatant added with the 10 µL internal standard 
solution (naringin, 0.27 mg/mL) was filtrated through a 0.22 mm membrane prior to LC MS/MS 
analysis. 
Relative quantitation of selected flavonoids by LC-MS/MS 
LC-MS/MS analysis of samples with and without UV-B exposure was performed using 
an Agilent 6460 Triple Quadrupole mass spectrometer connected to Agilent series1290 Infinity 
HPLC system (Agilent Technologies, USA). Analytes were separated on an Agilent ZORBAX 
Extend C18 column (4.6 × 50 mm, 1.8 μm). Mobile phase A was H2O containing 0.1% formic 
acid and phase B was acetonitrile. The gradient program was conducted as follows: 0–15 min, 5–
95% B; 15–17 min, 95% B; 17–17.1 min, 95–5% B; 17.1–18 min, 5% B. Total run time was 18 
min. The injection volume was 2 μL. The mass spectrometer was operated in the negative ion 
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mode and the source parameters were as follows: drying gas temperature, 300 °C; drying gas 
flow, 5 L/min; nebulizer pressure, 45 psi; capillary voltage, 3500 V. N2 was used as a collision 
gas in the multiple reaction monitoring (MRM) mode. The MRM parameters, including ion 
transitions (precursor and product ions) for each analyte, are presented in Table 9.1. Data 
acquisition was performed with Mass Hunter Workstation (Agilent Technologies, USA).  
The content of each selected analyte was measured from 6 replicate leaf samples from the 
control group and UV-B treated group. For comparison of averaged peak intensities of each 
target, analytes were acquired from two groups, respectively; a one-tailed Student’s t test was 
calculated by Originpro 8.5 (Northampton, MA, USA) to determine the mean differences in 
flavonoid content between the control group and UV-B treated group. 
9.3 Results 
Characterizing metabolite profiles of ginkgo leaf using MALDI and LDI MS 
Initially, leaf cross sections were probed by MALDI‐ToF MS to determine the optimal 
MALDI matrix. Several matrices (DHB and CHCA for positive ion mode and 9‐AA for negative 
ion mode), the amount of matrix applied onto the sample, and two matrix application approaches 
(automatic sprayer and sublimation) were assessed for achieving comprehensive detection of 
metabolites within the ginkgo leaf. Briefly, biflavonoids, flavonoid glycosides, and lipids were 
more readily detected with DHB compared with CHCA in positive mode, with few flavonoids 
detected with 9‐AA in negative mode (Figure 9.2). Therefore, DHB was selected for analyzing 
ginkgo leaf sections in positive ion mode. 
Low molecular weight compounds, such as flavonoid aglycones, were not readily 
resolved using MALDI‐ToF MS due to interfering DHB matrix peaks in the low mass range 
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(<m/z 500), whereas they were easily resolved using MALDI FT‐ICR MS (Figure 9.1). 
Additionally, LDI was used to detect the ultraviolet (UV)‐absorbing flavonoids within the 
ginkgo leaf. As expected, ions associated with flavonoid aglycones (Figure 9.3A) and 
biflavonoids (Figure 9.3B) were observed in negative mode LDI MS; however, few flavonoid 
glycosides were detected. Interestingly, many unexpected, tissue‐specific ions were exclusively 
detected in the secretory cavities of ginkgo leaves with negative mode LDI MS (Figure 9.3C), 
which were subsequently identified as ginkgolic acids and cardanols according to their accurate 
masses and MS/MS analysis (Figures 9.1F).  
Representative single‐pixel matrix‐assisted laser desorption/ionization (MALDI) and 
laser desorption/ionization (LDI) Fourier‐transform ion cyclotron resonance mass spectra 
acquired from a cross section of ginkgo leaf. (A, B, C, and E) Positive (POS) mode MALDI 
mass spectrum of flavonoids obtained from upper epidermis. (D) Positive mode MALDI mass 
spectrum of lipids and chlorophylls obtained from mesophyll. (F) Negative (NEG) mode LDI 
mass spectrum of ginkgolic acids and cardanols obtained from secretory cavity. (G) Negative 
mode LDI mass spectrum of flavonoid aglycones obtained from upper epidermis. Identified 
compounds are labelled with measured mass. See Tables 9.3-6 for more details. 
Additionally, two matrix application approaches, air‐assisted sprayer (wet coating) and 
sublimation (dry coating), were compared for optimal signal intensity and analyte coverage, as 
well as minimization of metabolite delocalization. As shown in Figure 9.4, 
biflavonoid‐associated ions were detected from the epidermis with both application approaches; 
the flavonoid glycosides were rarely observed after sublimation. Therefore, a 
laboratory‐constructed air‐assisted sprayer was used to provide homogenous coating across the 
leaf cross sections.[19] 
304   
 
Although high accuracy mass peaks are often detected in MSI, in situ assignment of these 
peaks to specific metabolites remains a challenge for MSI. Here, we facilitated assignments by 
performing follow‐up measurements with high‐resolution FT‐ICR MS and in situ MS/MS, 
accomplished via either ToF/ToF MS/MS or collision‐induced dissociation MS/MS using the 
FT‐ICR mass spectrometer (Tables 9.3–9.6). Figure 9.1 shows representative MALDI and LDI 
FT‐ICR mass spectra obtained from a cross section of ginkgo leaf. Most ions corresponding to 
flavonoid aglycones were sufficiently resolved from matrix ions (Figure 9.1A). In positive ion 
mode, flavonoid aglycones and biflavonoids were readily detected as protonated ions; however, 
flavonoid glycosides were mainly detected as sodium‐ and/or potassium‐adduct ions (Table 9.3). 
More detailed structural information was subsequently obtained using MS/MS. However, in situ 
MS/MS was not always possible because some ions were too low in abundance, or characteristic 
fragment ions were not detected. Furthermore, as shown in Figure 9.1G, three pairs of 
characteristic flavonoid aglycones peaks were observed, for example, m/z 284.0331 and 
285.0409, m/z 300.0279 and 301.0359, m/z 314.0437 and 315.0517. These are deprotonated ions 
[M−H]− and radical product ions [M−H−H]−• due to the presence of a free 4′‐OH group on the 
B‐ring of some aglycones.[21] 
Interestingly, as shown in Figure 1e, three intense peaks around m/z 1,500 were 
exclusively observed in the epidermis. They were tentatively attributed to the dimer of flavonoid 
glycosides, after high accurate mass and MS/MS information was considered. For 
example, m/z 1,519.3557 (calculated for [C72H72O34 + K]
+, Δ = 1.34 ppm) was putatively 
assigned as a dimeric derivative of kaempferol coumaroyl diglycoside (C36H36O17). In a recent 
report, a new class of flavonoid glycoside cyclodimers, named biginkgosides, were isolated from 
ginkgo leaf extract, supporting our MALDI MS results. Therefore, m/z 1,519.3557 was 
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tentatively assigned to isomeric biginkgosides ([biginkgoside B/E/I + K]+), m/z 1,535.3476 
assigned to [biginkgoside F + K]+, and m/z 1,551.3435 assigned to the other isomeric 
biginkgosides also adducted with potassium ([biginkgoside A/C/D/G/H + K]+; Table 9.4). 
In Figure 9.1F, a series of ions was observed in the low mass range around m/z 300 with a 
specific mass shift (e.g., m/z 26.0156 (CH═CH) and m/z 28.0313 (CH2─CH2)), suggesting the 
possible occurrence of lipid‐associated ions. They were only observed in the secretory cavities 
from the leaf section. Combined high accurate mass and characteristic fragment ions obtained 
with LIFT™ ToF/ToF MS/MS, ions with a common loss of 44.0 Da (CO2) were assigned to 
ginkgolic acids (GAs), whereas ions with a common fragment of m/z 105.8 ([C7H6O]
−•) were 
assigned to cardanols.[22] In total, seven GAs with different alkyl side chains and degrees of 
unsaturation were identified, including GA (C13:0, C15:2, C15:1, C15:0, C17:3, C17:2, and 
C17:1) (Table 9.5). Four cardanols were also identified, including cardanol (C13:0, C15:1, 
C15:0, and C17:1) (Table 9.5). Besides the above‐mentioned metabolites, ginkgolides, 
saccharides, various phospholipids, and chlorophyll a (m/z 871.5724, [chlorophyll a‐Mg + 3H]+) 
were also detected in leaf cross sections. Peak assignment of these ions is summarized in the  
Compound Identification section of the experimental and Table 9.6). 
MALDI/LDI MSI reveals heterogeneous distribution of metabolites in the ginkgo plant 
Ginkgo leaves are fragile tissues of less than 1 mm thick, making direct cryosectioning 
challenging, especially while maintaining tissue integrity and avoiding metabolite delocalization. 
In this work, fresh leaf tissues were embedded in gelatin solutions before cryosectioning to 
improve the cross sections available for MSI (Figure 9.5). The optical image in Figure 9.5 of a 
leaf cross section shows the main compartments: epidermis, vascular bundle, mesophyll, and 
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secretory cavity. Summaries of the distinctive spatial distributions of various kinds of 
metabolites are shown in Figures 9.6, 9.7, and 9.8. Figure 9.96 shows two‐dimensional ion 
intensity maps of flavonoid aglycones, biflavonoids, flavonoid glycosides, and biginkgosides, 
which mainly accumulate in the upper and lower epidermis. GAs and cardanols were exclusively 
detected within highly specialized cell compartments—secretory cavities (Figure 9.7). The 
distributions of ginkgolide A (m/z 447.1052) and a group of isomers of ginkgolide 
(m/z 463.1001; ginkgolide B/J/M/K) are located within both the epidermis and mesophylls as 
compared with flavonoids (Figure 9.8), which were only detected in the epidermis. High 
abundances of saccharides and lipid‐associated ions were observed mostly in the mesophyll 
layers (Figure 9.8). Several m/z values specifically found in the secretory cavities were 
tentatively assigned to lipid‐associated ions according to accurate mass match in the METLIN 
database; however, further work is required to identify these ions (Figure 9.9). As expected, 
chlorophyll a was visualized within chloroplasts, which are responsible for the characteristic 
green color in plants. Additionally, organ‐specific distributions of ginkgolides belonging to the 
terpene lactones were observed. As shown in Figure 9.10, ginkgolide A, B, and/or other isomers 
are mainly detected in the cortex and phloem region of root and mesophylls of leaf. The highest 
amount of ginkgolides is detected in the root tissue and decreased in the order of the leaf and 
young stem. 
LC–MS validation of uneven distribution of major flavonoids in epidermis 
As shown in Figure 9.4, a non‐uniform distribution of flavonoids exists between the 
upper and lower leaf epidermis, indicating a higher abundance of flavonoids in the upper leaf 
epidermis. To validate this difference in distribution observed in MALDI MSI, the upper and 
lower epidermal cell layers were dissected separately from leaf cross sections (free of mesophyll, 
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inset in Figure 9.11); thereafter, extraction and LC–MS/MS analysis were performed for relative 
quantitation of the content of each selected flavonoid (Table 9.1). As shown in Table 9.1, nine 
compounds belonging to flavonoid aglycone, biflavonoids, and flavonoid glycosides, 
respectively, were selected to validate the imaging results. Figure 9.11 shows the mean content 
of selected flavonoids between the upper and lower epidermis. Statistical analyses of the mean 
difference showed that the relative amount of each selected flavonoids was significantly higher 
at the upper epidermal layer compared with the lower side (≥99.5 confidence level), which 
correlated well with the distribution pattern observed in the MALDI imaging results. 
9.4 Discussion  
Although many experiments have been focused on the characterization and functional 
analysis of bioactive components in G. biloba, their spatial distributions oftentimes remain 
unresolved. Unlike well‐established approaches for visualization of morphological structures and 
localization of macromolecules such as genes and enzymes, precisely determining the spatial 
distribution of individual metabolites using optical techniques is difficult when most of the 
compounds are uncharacterized or unknown. Therefore, unambiguous mapping of the specific 
sites of production, transportation, and accumulation of many metabolites in tissues has yet to be 
realized. Here, we demonstrate that MALDI and LDI FT‐ICR MSI are well suited for 
investigating spatial metabolome of ginkgo leaf. Additionally, to validate the observed 
differences in metabolites between the upper and lower epidermis, and to verify that the 
observed distributions are not sample preparation artefacts, we performed LC–MS/MS 
(Figure 7). The LC–MS/MS data demonstrated a similar significant difference in the abundance 
of detected flavonoids between the upper and lower epidermis. 
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One challenge we encountered was preparing high‐quality cryosections from the leaf for 
subsequent MSI measurements. As shown in Figure 9.4, ginkgo leaf tissues have complex and 
intricate structures, such as stomas, a loosely packed mesophyll layer, and large intercellular 
spaces and resin canals, which must be intact after sectioning for accurate metabolite mapping. 
Tissue embedding is an efficient way to preserve plant tissues in their original form and 
structure; however, the most common type of embedding using optimal temperature cutting 
material is incompatible with MSI as it strongly suppresses other ions.[23, 24] As such, we tested a 
variety of conditions (data not shown) and found that a 10% gelatin solution allowed for 
sectioning with minimal distortion or deterioration of the tissue. With gelatin embedding, we 
were able to section tissues between 12 and 16 μm, which provided an effective tissue thickness, 
overall ion intensity, and laser focus for MSI. 
Figure 9.6 displays the distribution patterns of four different classes of flavonoids: 
aglycones and related glycosides, biflavonoids, and biginkgosides. The distribution of the 
flavonoids shared some similarities; for example, they were colocalized within the epidermis 
with higher abundance on the upper side. As previous shown, the heterogeneous distribution of 
chalcone synthase bioactivity (a key enzyme in flavonoid biosynthesis) was investigated in the 
leaf of the Pisum mutant; results showed that the majority of chalcone synthase activity was 
present exclusively in the epidermis, and the total activity measured in the upper epidermis was 
quite high compared with the lower side.[25] Flavonoids have been reported to protect plants from 
UV‐B radiation[26] and to act as a chemical barrier to herbivores.[27] Here, a UV‐B radiation 
experiments were performed to investigate the change of flavonoids in ginkgo leaves quantified 
using LC–MS/MS. As shown in Figure 9.12, after 4‐hr radiation, an increasing trend of target 
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flavonoids was observed, indicating the ginkgo leaves can protect themselves from radiation 
exposure by increasing UV‐absorbing flavonoids. 
We also detected flavonoid cyclodimers that were localized to the epidermal region of the 
gingko leaf (Figure 9.6). Biginkgosides B, E, and/or I (m/z 1,519.3557) and biginkgoside F (m/z 
1,535.3476) were mainly located in the upper epidermis, whereas biginkgoside A, C, D, G, and 
H (m/z 1,551.3435) was detected in both the upper and lower epidermis, despite being from the 
same chemical class. Classical staining approaches (e.g., AlCl3 solution) would be unable to 
detect this difference, further demonstrating the utility of MSI. Although the roles of these 
flavonoid cyclodimers have yet to be determined, the distribution patterns obtained here for the 
first time may be significant for understanding what biotic factors trigger the production of these 
unusual dimeric derivatives, their corresponding heterogeneous accumulation patterns, as well as 
their function in ginkgo leaf development. Investigations of natural products in ginkgo leaf have 
been performed using effective dereplication strategies for a long time, but these flavonoids were 
only just recently reported.[28] One possible explanation of their recent discovery and observation 
here is that rare components with low abundance may not be observed during whole sample 
homogenization but amendable to MSI because of their localized nature. MALDI MSI is well 
suited for dereplication of spatially localized novel metabolites from plants, especially 
considering its minimal sample preparation steps.[29, 30] 
Besides being a flavonoid‐rich resource, gingko leaf also has toxic phenolic lipids (e.g., 
GAs and cardanols), which can cause allergic reactions.[2] Therefore, the United States 
Pharmacopeia prescribes an upper limit for the GA content of G. biloba extract. Using negative 
mode LDI MS, we detected these toxic phenolic lipids exclusively in the secretory cavities of 
ginkgo leaf (Figure 9.4). The mature cavity appears round and as a lipophilic droplet embedded 
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in mesophyll tissues. In situ MS/MS analysis of these compounds was not possible because of 
their low abundance and small sampling area; therefore, a sharp glass capillary was used to 
extract these lipophilic droplets directly onto a MALDI 384 target plate for LDI MS/MS 
analysis. With this complementary method, the identities of phenolic lipids in the secretory 
cavities were verified, validating the MALDI imaging results. Moreover, signals related to 
phenolic lipids were not observed in other parts of the leaf section, indicating that there was no 
redistribution of lipophilic droplets because of the steps taken to ensure optimal sample 
preparation. 
Phenolic lipids, such as anacardic acids and cardanols, have been shown to inhibit 
bacterial, fungal, protozoan, and parasite growth, indicating that they may play important roles in 
chemical defense mechanisms.[31] Interestingly, previous studies have demonstrated that resin 
ducts in the secondary phloem of Rhus glabra L.,[32] the shoot of Mangifera indica L.,[33] and the 
root of Thapsia garganica[34] also store lipophilic components with the toxic properties. In our 
study, toxic phenol lipids were localized in the secretory cavities of ginkgo leaf tissue. This 
commonality found between the different plant families suggests that the secretory structures 
function as a pool to store the toxic metabolites, which can be released upon leaf crush to protect 
against herbivory.[35] 
Another significant metabolite class is the terpene lactones (e.g., ginkgolides), here 
mainly localized to cortex and phloem region of root tissue and leaf epidermis and mesophyll 
(Figure 9.7 and 9.8). Of course, accurate mass measurements do not differentiate isomers, such 
as ginkgolide B, J, M, and K (C20H24O10, [M + K]
+, m/z 463.1001). Although in situ MS/MS is 
an effective approach for isomeric identification, characteristic fragments are often not detected 
because of the low abundance of the parent ion. High‐resolution ion mobility MS would be an 
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alternative option for separating isomeric metabolite ions based on their mobility in a high 
electrical field.[36] The spatial distribution of ginkgolides visualized with MSI is consistent with 
previous research performed using various techniques, such as isotope labelling, gene expression 
analysis, and tissue‐specific metabolite profiling.[37, 38] These prior results suggest that the site of 
ginkgolide biosynthesis is localized in the root, and the products are then translocated and 
accumulated mainly in the leaf tissues. In situ interrogation of spatial distribution of metabolites 
with MSI provides more straightforward and rich information; the MSI results are in agreement 
with the above‐mentioned methods. However, because of the complex interplay between 
biosynthesis and transport in the plant, it was not immediately clear in which organ or tissue 
metabolites are synthesized using only MSI. Therefore, a combination of multimodal imaging 
such as MSI and in situ hybridization is an effective method for the precise interpretation of 
complex biosynthesis of natural products.[39] Additionally, as the ginkgolides are a class of 
pharmacologically active ingredients with significant clinical applications, the imaging results 
obtained here may provide insights on how to increase the accumulation of bioactive ginkgolides 
in leaf tissue via abiotic stress or establish a high‐yield cell culture system. 
Owing to the inherent capability of MSI for untargeted imaging, the spatial distribution of 
carbohydrates, phospholipids, and chlorophyll a were also revealed (Figure 9.10). For example, 
two distinct distribution patterns of lipids were observed in ginkgo leaf. Most lipids were 
detected in the mesophyll (Figure 9.10), whereas others were only localized in secretory cavities 
(Figure 9.9). Phospholipids are more than just structural components of membranes; evidence 
suggests that they can act as second messengers in plant cells[40] and can be rapidly formed and 
turned over within seconds to minutes in response to a variety of stress treatments via the 
activation of lipid kinases or phospholipases. Surprisingly, few spatio‐chemical analyses of lipids 
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in plant tissues have been reported. This is partly due to a lack of specific dyes and labelling 
techniques. Ion images of lipids should improve the understanding of the distinct function of 
individual lipids (or lipid classes) and have the potential to aid in deciphering the roles of lipids 
as signaling molecules in plant growth and development, as well as abiotic and biotic stress 
responses. 
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9.6 Figures and Tables 
 
 
Figure 9.1 Representative single‐pixel matrix‐assisted laser desorption/ionization (MALDI) and 
laser desorption/ionization (LDI) Fourier‐transform ion cyclotron resonance mass spectra 
acquired from a cross section of ginkgo leaf. (a, b, c, and e) Positive (POS) mode MALDI mass 
spectrum of flavonoids obtained from upper epidermis. (d) Positive mode MALDI mass  
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Figure 9.1 (cont.) spectrum of lipids and chlorophylls obtained from mesophyll. (f) Negative 
(NEG) mode LDI mass spectrum of ginkgolic acids and cardanols obtained from secretory 
cavity. (g) Negative mode LDI mass spectrum of flavonoid aglycones obtained from upper 
epidermis. Identified compounds are labelled with measured mass.  
 




Figure 9.2 Representative single-pixel MALDI ToF mass spectra acquired from the cross 
section of the ginkgo leaf spray-coated with (A) DHB, (B) CHCA, and (C) 9-AA. Identified 
metabolites are labeled with a red asterisk. 
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Figure 9.3 Representative single-pixel negative mode LDI-ToF mass spectra acquired from a 
cross section of the ginkgo leaf. Negative mode MALDI mass spectra of (A) flavonoid aglycones 
and (B) biflavonoids obtained from upper epidermis. (C) Negative mode LDI mass spectrum of 
ginkgolic acids and cardanols obtained from secretory cavity. Identified specific metabolites are 
labeled with a red asterisk.  
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Figure 9.4 Representative single-pixel positive mode MALDI-ToF mass spectra acquired from a 
cross section of the ginkgo leaf (A) spray-coated with DHB and (B) sublimed with DHB. 
Identified metabolites are labeled with a red asterisk. 
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Figure 9.5 Optical images of Ginkgo biloba L. leaf, a leaf cross section, and a close‐up view of a 
cross section of the intervein region and secretory cavity. 
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Figure 9.6 Positive mode MALDI images of selected flavonoid ions, including aglycones 
(m/z 271.0601–317.0655), biflavonoids (m/z 539.0973–583.1235), glycosides (m/z 617.1477–
795.1745), and biginkgosides (m/z 1,519.3537–1,551.3435) in ginkgo leaf. Ion images were 
recorded with a step size of 50 μm. The mass accuracy was less than 2 ppm, and a bin width 
of m/z = ±5 ppm was used for image generation. Glc: glucoside/glucosyl moiety; K: kaempferol; 
Rha: rhamnoside/rhamnosyl moiety; Q: quercetin. 
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Figure 9.7 Negative mode LDI images of ginkgolic acid (GA) ions (m/z 319.2279–373.2748) 
and cardanol ions (m/z 275.2380–329.2850) in ginkgo leaf. Ion images were recorded with a 
scanning step size of 50 μm. The mass accuracy was better than 2 ppm, and a bin width 
of m/z = ±5 ppm was used for image generation. The secretory cavities in the leaf are marked 
with a red circle.  
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Figure 9.8 Positive mode MALDI images of selected other ions, including saccharides 
(m/z 219.0266 and 381.0794), ginkgolides (m/z 447.1052 and 463.1001), an unknown compound 
(m/z 742.4805), phosphatidylcholines (PCs) (m/z 796.5253–824.5566), and a fragment ion of 
chlorophyll a (m/z871.5732) in ginkgo leaf. Ion images were recorded with a scanning step size 
of 50 μm. The mass accuracy was better than 2 ppm, and a bin width of m/z = ±5 ppm was used 
for image generation.  
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Figure 9.9 Positive mode MALDI images of unknown ions observed in the secretory cavities of 
the ginkgo leaf. Ion images were recorded with a scanning step size of 50 μm, and a bin width of 
m/z = ± 5 ppm was used for image generation. 
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Figure 9.10 Positive mode MALDI images of ginkgolide ions, including ginkgolide A 
(m/z 447.1052) and ginkgolide isomers B/J/M/K (m/z 463.1001) in ginkgo root, stem, and leaf. 
Regions selected for mass spectrometry imaging measurements are marked with white dashed 
line. Ion images were recorded with a step size of 50 μm. The mass accuracy was better than 
2 ppm, and a bin width of m/z = ±5 ppm was used for image generation. 
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Figure 9.11 Comparison of nine flavonoids in ginkgo leaf between the upper and lower 
epidermis quantified using liquid chromatography tandem mass chromatography in multiple 
reaction monitoring mode. Inset displays dissection locations. Error bars indicate the standard 
deviations of biological triplicates (n = 3). Significant differences were determined using a 
one‐tailed Student's t‐test. Significance levels: P < 0.05. 




Figure 9.12 Positive mode MALDI images of unknown ions observed in the secretory cavities 
of the ginkgo leaf. Ion images were recorded with a scanning step size of 50 μm, and a bin width 
of m/z = ± 5 ppm was used for image generation. 




Figure 9.13 Change of flavonoids in ginkgo leaves in response to UV-B radiation quantified 
using LC-MS/MS in MRM mode. Error bars indicate the standard deviations of biological 
triplicates (n = 6). Significant differences were determined using a one-tailed Student’s t-test. 












327   
 







770.2 769.0>315.0 2.70 
Quercetin 3-O-rhamnosyl-glucoside 610.2 609.0>301.0 2.87 
Kaempferol 3-O-rhamnosyl-glucoside 594.2 593.1>285.0 3.07 
Isorhamnetin 3-O-rhamnosyl-glucoside 624.2 623.3>315.0 3.12 
Kaempferol 286.1 285.0>133.2 4.07 
Amentoflavone 538.1 537.0>375.0 5.04 
Bilobetin/Sequoiaflavone 552.1 551.2>519.0 5.51 
Ginkgetin/Isoginkgetin 566.1 565.0>389.0 6.55 
Sciadopitysin 580.1 579.1>547.0 7.63 
                                  
Table 9.1 MRM transitions of target flavonoids. The identity of target analytes was verified by 














































Monosaccharide C6H12O6 180.0634 ‒ ‒ 203.0524 1.04 219.0265 0.22 ‒ 
Disaccharide C12H22O11 342.1162 ‒ ‒ 365.1056 0.45 381.0795 0.33 ‒ 
Ginkgolide A C20H24O9 408.1420 ‒ ‒ ‒ ‒ 447.1057 1.13 ‒ 
Ginkgolide B/J/M/K C20H24O10 424.1370 ‒ ‒ ‒ ‒ 463.1007 1.28 ‒ 
PC (25:0 (CHO)) C33H64NO9P 649.4319 650.4398 1.00 ‒ ‒ 688.3961 1.55 Yes 
PC (25:0(COOH)) C33H64NO10P 665.4268 666.4353 1.86 ‒ ‒ 704.3906 0.93 Yes 
PS (P-29:0) C35H68NO9P 677.4632 678.4712 1.11 ‒ ‒ 716.4273 1.35 ‒ 
PS (P-30:1) C36H68NO9P 689.4632 ‒ ‒ ‒ ‒ 728.4265 0.23 ‒ 
PA (36:4) C39H69O8P 696.4730 ‒ ‒ ‒ ‒ 735.4363 0.18 ‒ 
PA (36:3) C39H71O8P 698.4887 ‒ ‒ ‒ ‒ 737.4517 -0.16 ‒ 
PA (36:2) C39H73O8P 700.5043 ‒ ‒ ‒ ‒ 739.4685 1.40 ‒ 
PS (P-31:1) C37H70NO9P 703.4788 704.4873 1.71 ‒ ‒ ‒ ‒ ‒ 
PC (34:3) C42H78NO8P 755.5465 756.5545 0.95 ‒ ‒ 794.5100 0.42 ‒ 
PC (34:2) C42H80NO8P 757.5622 758.5701 0.88 ‒ ‒ 796.5253 -0.02 Yes 
PC (34:1) C42H82NO8P 759.5778 760.5848 -0.40 ‒ ‒ 798.5421 1.42 Yes 
PC (36:4) C44H80NO8P 781.5622 782.5701 0.85 ‒ ‒ 820.5250 -0.38 Yes 
PC (36:3) C44H82NO8P 783.5778 784.5864 1.68 ‒ ‒ 822.5415 0.65 Yes 
PC (36:2) C44H84NO8P 785.5935 786.6015 0.97 ‒ ‒ 824.5580 1.68 Yes 
Pheophorbide A C35H36N4O5 592.2686 593.2742 -2.78 ‒ ‒ ‒ ‒ ‒ 
Pheophytin A C55H74N4O5 870.5659 871.5717 -1.72 893.5564 1.41 909.5298 0.79 ‒ 
Chlorophyll A C55H72MgN4O5 892.5353 ‒ ‒ ‒ ‒ 931.4977 -0.83 ‒ 
Table 9.2 Saccharides, phospholipids, and chlorophylls assigned in G. biloba leaf tissues by 
positive mode MALDI FT-ICR MS. Metabolites were putatively identified based on high mass 

























Apigenin C15H10O5 270.0528 271.0597 -1.48 ̶ ̶ ̶ ̶ ̶ 
Kaempferol/Luteolin C15H10O6 286.0477 287.0545 -1.80 ̶ ̶ 325.0103 -1.84 ̶ 
Catechin/Epicatechin C15H14O6 290.0790 291.0862 -0.40 ̶ ̶ ̶ ̶ ̶ 
Quercetin C15H10O7 302.0427 303.0494 -1.75 ̶ ̶ ̶ ̶ Yes 
Tamarixetin/Isorhamnetin C16H12O7 316.0583 317.0650 -1.83 ̶ ̶ ̶ ̶ Yes 
Myricetin C15H10O8  318.0376 319.0445 -1.09 ̶ ̶ ̶ ̶ ̶ 
Amentoflavone C30H18O10  538.0900 539.0967 -1.07 ̶ ̶ ̶ ̶ ̶ 
Bilobetin/Sequoiaflavone C31H20O10 552.1057 553.1124 -0.95 ̶ ̶ ̶ ̶ ̶ 
Ginkgetin/Isoginkgetin C32H22O10  566.1213 567.1285 -0.13 589.1096 -1.56 605.0843 -0.26 ̶ 
Sciadopitysin C33H24O10 580.1370 581.1435 -1.25 603.1255 -1.11 619.1001 -0.01 ̶ 
5′-Methyoxy bilobetin C32H22O11  582.1162 583.1224 -1.87 ̶ ̶ ̶ ̶ ̶ 
Quercetin 3-O-
rhamnoside 
C21H20O11 448.1006 449.1076 -0.54 471.089 -1.67 487.0628 -1.89 ̶ 
Quercetin 3-O-glucoside C21H20O12 464.0955 465.1031  0.74 487.0839 -1.64 ̶ ̶ ̶ 
Isorhamnetin 3-O-
glucoside 








C27H30O16 610.1534 ̶ ̶ 633.1416 -1.60 649.1153 -1.92 Yes 
Isorhamnetin 3-O-
rhamnosyl-glucoside 
C28H32O16 624.1690 ̶ ̶ 647.1571 -1.79 663.1317 -0.75 Yes 
Methoxymyricetin 3-O-
rhamnosyl-glucoside 












C36H36O18 756.1902 ̶ ̶ 779.1779 -1.91 795.1533 -0.04 ̶ 
Quercetin 3-O-(2-O,6-O-
bis(rhamnosyl)-glucoside) 




C34H42O20 770.2270 ̶ ̶ 793.2166 0.54 809.1906 0.61 ̶ 
Biginkgoside A/C/D/G/H C72H72O34 1480.3905 ̶ ̶ ̶ ̶ 1519.3557 1.34 Yes 
Biginkgoside B/E/I C72H72O36 1512.3803 ̶ ̶ ̶ ̶ 1551.3435 0.001 Yes 
Biginkgoside F C72H72O35 1496.3854 ̶ ̶ ̶ ̶ 1535.3476 -0.67 Yes 
 
Table 9.3 Flavonoids assigned in G. biloba leaf tissues by positive mode MALDI FT-ICR MS. 
Metabolites were putatively identified based on high mass accuracy of full scan MS data and/or 
MS/MS. 












Ginkgolic acid C13:0 C20H32O3 320.2351 319.2285 1.98 
Yes 
Ginkgolic acid C15:2 C22H32O3 344.2351 343.2285 1.84 
Yes 
Ginkgolic acid C15:1 C22H34O3 346.2508 345.2439 1.10 Yes 
Ginkgolic acid C15:0 C22H36O3 348.2664 347.2598 1.82 
Yes 
Ginkgolic acid C17:3 C24H34O3 370.2508 369.2442 1.85 
Yes 
Ginkgolic acid C17:2 C24H36O3 372.2664 371.2598 1.70 
Yes 
Ginkgolic acid C17:1 C24H38O3 374.2821 373.2754 1.56 
Yes 
Cardanol C13:0 C19H32O 276.2453 275.2385 1.68 
Yes 
Cardanol C15:1 C21H34O 302.2610 301.2541 1.37 
Yes 
Cardanol C15:0 C21H36O 304.2766 303.2699 1.85 
̶ 
Cardanol C17:1 C23H38O 330.2923 329.2853 0.95 
Yes 
Kaempferol/Luteolin C15H10O6 286.0477 285.0408 1.18 
̶ 
Quercetin C15H10O7 302.0427 301.0357 1.07 
̶ 
Tamarixetin/Isorhamnetin C16H12O7 316.0583 315.0515 1.50 
̶ 
Amentoflavone C30H18O10  538.0900 537.0827 -0.04 
Yes 
Bilobetin/Sequoiaflavone C31H20O10 552.1057 551.0989 0.96 
Yes 
Ginkgetin/Isoginkgetin C32H22O10  566.1213 565.1149 1.55 
Yes 
Sciadopitysin C33H24O10 580.1370 579.1302 0.91 
Yes 



















Table 9.4 Ginkgolic acids, cardanols, and lavonoids assigned in G. biloba leaf tissues by 
negative mode MALDI FT-ICR MS. Metabolites were putatively identified based on high mass 



























Monosaccharide C6H12O6 180.0634 ‒ ‒ 203.0524 1.04 219.0265 0.22 ‒ 
Disaccharide C12H22O11 342.1162 ‒ ‒ 365.1056 0.45 381.0795 0.33 ‒ 
Ginkgolide A C20H24O9 408.1420 ‒ ‒ ‒ ‒ 447.1057 1.13 ‒ 
Ginkgolide B/J/M/K C20H24O10 424.1370 ‒ ‒ ‒ ‒ 463.1007 1.28 ‒ 
PC (25:0 (CHO)) C33H64NO9P 649.4319 650.4398 1.00 ‒ ‒ 688.3961 1.55 Yes 
PC (25:0(COOH)) C33H64NO10P 665.4268 666.4353 1.86 ‒ ‒ 704.3906 0.93 Yes 
PS (P-29:0) C35H68NO9P 677.4632 678.4712 1.11 ‒ ‒ 716.4273 1.35 ‒ 
PS (P-30:1) C36H68NO9P 689.4632 ‒ ‒ ‒ ‒ 728.4265 0.23 ‒ 
PA (36:4) C39H69O8P 696.4730 ‒ ‒ ‒ ‒ 735.4363 0.18 ‒ 
PA (36:3) C39H71O8P 698.4887 ‒ ‒ ‒ ‒ 737.4517 -0.16 ‒ 
PA (36:2) C39H73O8P 700.5043 ‒ ‒ ‒ ‒ 739.4685 1.40 ‒ 
PS (P-31:1) C37H70NO9P 703.4788 704.4873 1.71 ‒ ‒ ‒ ‒ ‒ 
PC (34:3) C42H78NO8P 755.5465 756.5545 0.95 ‒ ‒ 794.5100 0.42 ‒ 
PC (34:2) C42H80NO8P 757.5622 758.5701 0.88 ‒ ‒ 796.5253 -0.02 Yes 
PC (34:1) C42H82NO8P 759.5778 760.5848 -0.40 ‒ ‒ 798.5421 1.42 Yes 
PC (36:4) C44H80NO8P 781.5622 782.5701 0.85 ‒ ‒ 820.5250 -0.38 Yes 
PC (36:3) C44H82NO8P 783.5778 784.5864 1.68 ‒ ‒ 822.5415 0.65 Yes 
PC (36:2) C44H84NO8P 785.5935 786.6015 0.97 ‒ ‒ 824.5580 1.68 Yes 
Pheophorbide A C35H36N4O5 592.2686 593.2742 -2.78 ‒ ‒ ‒ ‒ ‒ 
Pheophytin A C55H74N4O5 870.5659 871.5717 -1.72 893.5564 1.41 909.5298 0.79 ‒ 
Chlorophyll A C55H72MgN4O5 892.5353 ‒ ‒ ‒ ‒ 931.4977 -0.83 ‒ 
 
 Table 9.5 Saccharides, phospholipids, and chlorophylls assigned in G. biloba leaf tissues by 
positive mode MALDI FT-ICR MS. Metabolites were putatively identified based on high mass 
accuracy of full scan MS data and/or MS/MS. 
 
332   
 
9.7 References  
(1) B. Singh, P. Kaur, Gopichand, R. D. Singh, P. S. Ahuja, Fitoterapia 2008, 79, 401-418. 
(2) M. Hemshekhar, M. Sebastin Santhosh, K. Kemparaju, K. S. Girish, Basic & Clinical 
Pharmacology & Toxicology 2012, 110, 122-132. 
(3) T. A. van Beek, Journal of Chromatography A 2002, 967, 21-55. 
(4) B. J. Diamond, S. C. Shiflett, N. Feiwel, R. J. Matheis, O. Noskin, J. A. Richards, N. E. 
Schoenberger, Archives of physical medicine and rehabilitation 2000, 81, 668-678. 
(5) W. Gong, C. Chen, C. Dobeš, C.-X. Fu, M. A. Koch, Molecular Phylogenetics and 
Evolution 2008, 48, 1094-1105. 
(6) R. B. Goldberg, Science 1988, 240, 1460-1467. 
(7) B. A. Boughton, D. Thinagaran, D. Sarabia, A. Bacic, U. Roessner, Phytochemistry 
Reviews 2016, 15, 445-488. 
(8) A. D. Feenstra, L. E. Alexander, Z. Song, A. R. Korte, M. Yandeau-Nelson, B. J. 
Nikolau, Y.-J. Lee, Plant physiology 2017, pp. 00652.02017. 
(9) S. Kaspar, M. Peukert, A. Svatos, A. Matros, H.-P. Mock, PROTEOMICS 2011, 11, 
1840-1850. 
(10) Y. J. Lee, D. C. Perdian, Z. Song, E. S. Yeung, B. J. Nikolau, The Plant Journal 2012, 
70, 81-95. 
(11) Z. Li, P. W. Bohn, J. V. Sweedler, Bioresource Technology 2010, 101, 5578-5585. 
(12) D. S. Cornett, M. L. Reyzer, P. Chaurand, R. M. Caprioli, Nature Methods 2007, 4, 828. 
(13) A. Brunelle, D. Touboul, O. Laprévote, Journal of Mass Spectrometry 2005, 40, 985-999. 
(14) Z. Takáts, J. M. Wiseman, B. Gologan, R. G. Cooks, Science 2004, 306, 471-473. 
(15) D. Etalo, R. C. De Vos, M. H. Joosten, R. Hall, Plant physiology 2015, pp. 01176.02015. 
333   
 
(16) P. Nemes, A. Vertes, Analytical Chemistry 2007, 79, 8098-8106. 
(17) M. Kompauer, S. Heiles, B. Spengler, Nature Methods 2016, 14, 90. 
(18) Y. Dong, B. Li, S. Malitsky, I. Rogachev, A. Aharoni, F. Kaftan, A. Svatoš, P. 
Franceschi, Frontiers in Plant Science 2016, 7. 
(19) B. Li, T. J. Comi, T. Si, S. J. B. Dunham, J. V. Sweedler, Journal of Mass Spectrometry 
2016, 51, 1030-1035. 
(20) E. J. Lanni, S. J. B. Dunham, P. Nemes, S. S. Rubakhin, J. V. Sweedler, Journal of The 
American Society for Mass Spectrometry 2014, 25, 1897-1907. 
(21) T. Yamagaki, T. Watanabe, M. Tanaka, K. Sugahara, Journal of The American Society 
for Mass Spectrometry 2014, 25, 88-94. 
(22) P. Česla, L. Blomberg, M. Hamberg, P. Jandera, Journal of Chromatography A 2006, 
1115, 253-259. 
(23) B. Li, S. J. B. Dunham, Y. Dong, S. Yoon, M. Zeng, J. V. Sweedler, Trends in Food 
Science & Technology 2016, 47, 50-63. 
(24) S. A. Schwartz, M. L. Reyzer, R. M. Caprioli, Journal of Mass Spectrometry 2003, 38, 
699-708. 
(25) G. Hrazdina, in Phenolic Metabolism in Plants (Eds.: H. A. Stafford, R. K. Ibrahim), 
Springer US, Boston, MA, 1992, pp. 1-23. 
(26) P. CASATI, V. WALBOT, Plant, Cell & Environment 2005, 28, 788-799. 
(27) G. Liang, Y. Guo, B. G. Rector, Journal of Economic Entomology 2003, 96, 909-913. 
(28) G.-L. Ma, J. Xiong, G.-X. Yang, L.-L. Pan, C.-L. Hu, W. Wang, H. Fan, Q.-H. Zhao, H.-
Y. Zhang, J.-F. Hu, Journal of Natural Products 2016, 79, 1354-1364. 
(29) K. Gorzolka, H. Bednarz, K. Niehaus, Planta 2014, 239, 1321-1335. 
334   
 
(30) B. Li, C. Knudsen, N. K. Hansen, K. Jørgensen, R. Kannangara, S. Bak, A. Takos, F. 
Rook, S. H. Hansen, B. L. Møller, C. Janfelt, N. Bjarnholt, The Plant Journal 2013, 74, 
1059-1071. 
(31) I. Kubo, K.-i. Nihei, K. Tsujimoto, Journal of Agricultural and Food Chemistry 2003, 51, 
7624-7628. 
(32) A. Fahn, R. F. Evert, American Journal of Botany 1974, 61, 1-14. 
(33) A. FAHN, D. M. JOEL, Annals of Botany 1980, 46, 225-233. 
(34) T. B. Andersen, K. A. Martinez-Swatson, S. A. Rasmussen, B. A. Boughton, K. 
Jørgensen, J. Andersen-Ranberg, N. Nyberg, S. B. Christensen, H. T. Simonsen, Plant 
physiology 2017, 174, 56-72. 
(35) B. M. Lange, Annual Review of Plant Biology 2015, 66, 139-159. 
(36) S. N. Jackson, H.-Y. J. Wang, A. S. Woods, M. Ugarov, T. Egan, J. A. Schultz, Journal 
of The American Society for Mass Spectrometry 2005, 16, 133-138. 
(37) A. Cartayrade, E. Neau, C. Sohier, J. Balz, J. Carde, J. Walter, Plant Physiology and 
Biochemistry (France) 1997. 
(38) X. Lu, H. Yang, X. Liu, Q. Shen, N. Wang, L.-w. Qi, P. Li, Frontiers in Plant Science 
2017, 8. 
(39) N. Tocci, M. Gaid, F. Kaftan, A. K. Belkheir, I. Belhadj, B. Liu, A. Svatoš, R. Hänsch, 
G. Pasqua, L. Beerhues, New Phytologist 2018, 217, 1099-1112. 
(40) H. J. G. Meijer, T. Munnik, Annual Review of Plant Biology 2003, 54, 265-306. 
 
 
 
